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 Axon guidance shapes formation of stereotyped central nervous system fiber tracts. Axons 
are directed by growth cones at their distal ends, which detect extracellular guidance cues through 
transmembrane receptors localized to the tips of bundled actin-rich filopodia. The cue netrin-1 binds 
to its receptor deleted in colorectal carcinoma (DCC) to induce changes in the dynamics of filopodia 
decorating growth cones. Alteration in filopodia is crucial to the attractive axon guidance functions of 
netrin-1, and requires function of the actin polymerase vasodilator stimulated phosphoprotein (VASP). 
Phosphorylation of VASP increases acutely in response to netrin-1, however this phosphorylation is 
not detected on the time scale over which filopodia respond to netrin, suggesting other regulatory 
mechanisms.  
 We have identified two E3 ubiquitin ligases of the tripartite motif protein (TRIM) family, TRIM9 
and TRIM67, which together regulate the nondegradative ubiquitination of VASP and are required for 
appropriate axonal and filopodial response to netrin-1, as well as development of netrin-1 dependent 
axon tracts in vivo. Both TRIMs localize to growth cone filopodia tips during development and interact 
directly with VASP. VASP is ubiquitinated in the presence of TRIM9, which alters the mobility and 
localization of VASP at filopodia tips. Deubiquitination of VASP is necessary for increase in filopodia 
number following netrin-1 treatment. TRIM67, conversely, reduces the ubiquitination of VASP, 
potentially by competing for TRIM9’s binding site for VASP. Deletion of Trim9 or Trim67 causes 
axons to be insensitive to guidance by netrin-1 in vitro.  
Both Trim deletions also alter the morphology of a netrin-1 dependent axon tract, the corpus 
callosum, in vivo. Deletion of Trim9 results in thickening of the tract due to excessive axon branching, 
while Trim67 deletion delays the approach of axons to the midline resulting in a thinner callosum. 
Loss of Trim67 also causes morphological changes to other brain regions, resulting in deficits in 
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spatial memory, motor function and sensorimotor gating in adult animals. Our data suggest that this 
pair of TRIM proteins form an inactivating/activating, yin/yang-like regulatory mechanism for VASP in 
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CHAPTER 1: REVISITING NETRIN-1: ONE WHO GUIDES (AXONS)* 
1 Axon response to the environment 
Development of an animal nervous system, from that of the nematode Caenorhabditis 
elegans to larger mammals such as humans, requires that each neuron connect to proper target 
cells. This is accomplished by the extension of a specialized projection, the axon, from the neuronal 
cell body. The growing axon traverses relatively long distances, up to several thousand times the 
diameter of the cell body, and reaches the correct region to produce the stereotyped circuits found 
across members of a species. A complex, cytoskeletal rich structure at the end of a developing axon, 
the growth cone, is responsible for not only extending the axon, but also detecting and responding to 
the extracellular signals that direct pathfinding. These signals, frequently in the form of glycoproteins 
secreted into or presented attached to the extracellular matrix, are ligands for receptors on the 
surface of the growth cone and trigger a variety of intracellular responses, including membrane 
remodeling through exocytosis and endocytosis, cytoskeletal reorganization, and modification of 
protein expression and degradation, both locally in the axon and throughout the neuron. For 
thorough, recent reviews on growth cone regulation, see “Regulation of plasma membrane expansion 
during axon formation” on membrane remodeling and addition1, “Actin based growth cone motility and 
guidance” on actin responses in the growth cone2, “Mechanochemical regulation of growth cone 
motility” on mechanosensation and mechanotransduction by growth cones3, and “Axon Guidance 
Pathways and the Control of Gene Expression” on regulation of gene expression4. This review will 
specifically focus on the mechanisms by which the guidance molecule netrin-1 produces axon 
guidance responses. 
                                                          
* This chapter previously appeared as a review in Frontiers in Cellular Neuroscience. The original citation is as 
follows: Boyer NP, Gupton SL. “Revisiting Netrin-1: One Who Guides (Axons)”. Frontiers in Cellular 
Neuroscience. July 31, 2018. v.12, p.221. 
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2 Netrin-1, the classical guidance cue 
One of the defining discoveries in the field of axon guidance demonstrated that axonal 
outgrowth promoted by a previously unknown and presumably diffusible extracellular cue, was biased 
in the direction of the cue source5. Purification of the major factors from chick brain that promoted 
axon outgrowth in embryonic rat spinal cord explants yielded two proteins homologous to the C. 
elegans unc-6 gene product required for axon guidance6, which were named netrin-1 and netrin-2 
after the Sanskrit “netr” meaning “one who guides”5. Further work would show that these were indeed 
axonal guidance cues7–13, and netrin-1 has since been one of the most well-studied members of this 
class of proteins with roles in not only axon guidance, but also axon branching14, synaptogenesis15, 
cell migration16, cell survival17, and axon regeneration18. This review, however, focuses on the 
function of netrin-1 as an axon guidance cue. Axon guidance by netrin-1 has been implicated in 
multiple developing brain regions and developing neuronal types, making it one of the most 
characterized, diversely functioning guidance cues. Fascinatingly, whereas many axon guidance cues 
have been found to act predominantly as either attractive or repulsive, and as either 
diffusible/chemotactic or adhesive/haptotactic molecules, evidence of the function of netrin-1 has 
never placed it squarely into one category (Figure 1). This diversity in function renders netrin-1 an 
ideal candidate for studies on mechanotransduction in axon guidance, as recent studies have 
emphasized the importance of substrate adhesion in netrin-1 function in vivo19–21. 
 
2.1 Attraction and repulsion 
Even from the earliest description of the C. elegans genes unc-5 (UNC5 in mammals), unc-6 
(NTN1 in mammals), and unc-40 (DCC and NEO in mammals, frazzled in Drosophila), data 
suggested that a ventral source of unc-6 both attracts and repulses axons6. Deletion of unc-6 affects 
guidance of axons that extend dorsally (repulsion) or ventrally (attraction). Dorsal guidance is 
specifically impaired by deletion of unc-5 and ventral guidance is impaired by deletion of unc-40, 
suggesting the different responses are orchestrated by distinct receptors. Later experiments using 
chick spinal explants describe a bimodal axon outgrowth response to increasing concentrations of 
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netrin-15, with the highest concentrations promoting less robust outgrowth. A concentration-
dependent bimodal response is also observed in the turning of embryonic cortical murine axons in a 
stable gradient of netrin-1 in vitro22. Elegant experiments by a number of labs over the years have 
established that this bifunctionality of netrin-1 signaling is dependent upon the receptors presented by 
the axonal growth cone. Netrin binding to the receptor deleted in colorectal cancer (DCC) results in 
attractive responses, via homodimerization of DCC (covered in detail in later sections)23–26, whereas 
heterodimerization between DCC and receptor uncoordinated locomotion 5 (UNC5) converts this 
attractive response into repulsion27–29. Intriguingly, UNC5 can also mediate shorter-range repulsive 
responses to netrin-1 in the absence of DCC30. This repulsive response requires association between 
UNC5 and the co-receptor, down syndrome cell adhesion molecule (DSCAM)31. The structures and 
outcomes of known netrin-1 receptor dimers are summarized in Figure 2. 
An important feature of many netrin-1 signaling pathways, both attractive and repulsive, 
appears to be interaction between the cytoplasmic domains of dimerized receptors (Figure 2). Netrin-
1 induces homodimerization of DCC, bringing their cytoplasmic tails into close proximity29. The close 
apposition of these domains is thought to create an assembly platform for the association of further 
signaling effectors. In the case of netrin-induced repulsion the association of the intracellular P1 
domain of DCC and a DCC-binding domain of UNC5 is also required (Figure 2)32. Whether netrin-1 
repulsion by an UNC5/DSCAM complex analogously involves association between intracellular 
domains of these two receptors remains to be determined. Though the repertoire of receptors that 
govern the attractive or repulsive responses to netrin-1 have been identified, the differences in 
intracellular signaling and mechanotransduction responses between these two modes are 
comparatively less well understood. 
 
2.1.1 Attraction:Repulsion switching 
These experiments leave us with a glaring question: what determines whether exposure to 
netrin-1 results in attraction or repulsion of an axon? There are several possibilities for this “switch”; 
1) the relative levels of each netrin-1 receptor on the surface of the growth cone; 2) a secondary 
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signal of intracellular status (such as Ca2+, cGMP or cAMP) that may activate or inhibit signaling 
pathway components, favoring either attraction or repulsion; 3) the relative affinities of individual 
receptor types for netrin-1, along with the extracellular concentration of netrin-1; or 4) the presence of 
other molecules in the extracellular environment. Current evidence suggests that all four of these 
mechanisms are capable of switching netrin-1 responses between attraction and repulsion. Known 
mechanisms that convert such netrin-1 responses are summarized in Figure 3.  
 
2.1.2 Switch 1: Membrane receptor levels 
Modulation of receptor expression levels or presentation on the surface of cells is a common 
mechanism for tuning responses to extracellular ligands33–37. Altered expression levels and/or surface 
levels of netrin receptors have also been implicated in modulating response to netrin-1. For example, 
the DNA repair gene Rad51 upregulates expression of UNC5B and UNC5C in mouse primary cortical 
neurons, and negatively regulates netrin-dependent axon branching38, typically viewed as an 
attractive response to netrin. Opposing this, endocytic internalization and membrane depletion of 
UNC5, and not DCC, converts repulsive netrin-1 responses to attraction. This UNC5 internalization is 
triggered by protein interacting with C-kinase 1 (PICK1)-dependent recruitment of active protein 
kinase Cα (PKCα) to the plasma membrane, which phosphorylates UNC5 residues S408 and 
S58739,40. Multiple studies suggest that surface levels of DCC are altered by exposure to netrin-1, 
however the specific response varies between studies. Multiple studies in embryonic rat spinal 
commissural and cortical neurons, demonstrate that exposure to netrin-1 increases DCC localization 
to the plasma membrane41 potentiated by, but not requiring, protein kinase A (PKA) activation42,43. A 
single study in dissociated rat embryonic cortical neurons suggests that DCC is ubiquitinated, 
internalized, and then degraded after netrin-1 exposure44. However, whether this affects subsequent 
netrin-1 responses was not shown. Intriguingly KCl-induced depolarization of cortical neurons, but not 
spinal commissural neurons, leads to increased plasma membrane levels of DCC and increases axon 
outgrowth in response to netrin-1. These responses require activity of PKA, PKC, and 
phosphatidylinositol-3-kinases (PI3Ks), as well as exocytosis, but not protein synthesis43. Additional 
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studies are required to define how expression levels, surface localization, and protein stability of DCC 
are modulated by netrin in diverse cell types, and in scenarios in which netrin is perceived by the 
growth cone as attractive or repulsive. 
 
2.1.3 Switch 2: Intracellular secondary messengers 
Intracellular levels of the secondary messenger, cAMP, which promotes the activity of PKA, 
may trigger an attractive-repulsive switch in response to netrin. Inhibition of PKA in Xenopus spinal 
neurons with small molecules KT5720 or Rp-cAMPS causes a typically attractive netrin-1 gradient to 
repulse axons45. The authors conducted a dose-response experiment using Rp-cAMPS, a potent and 
specific competitive inhibitor of cAMP-dependent activation of PKA, to investigate whether the change 
from netrin-1 attraction to repulsion was “switch” or a “dial”. This revealed that the turning response 
transitions abruptly between 1 and 5 µM Rp-cAMPS, rapidly plateauing at higher concentrations: such 
a sigmoidal response suggests a switch-like mechanism45. Later experiments found that PKA 
inhibition with a considerably higher dose of KT5720 reduces attractive responses to netrin-1 in rat 
spinal commissural neurons in a spinal explant, but does not switch the response to repulsion46. The 
differences in experimental conditions make interpretation of these data difficult, however they imply 
that either higher concentration of PKA inhibitor, some non-neuronal component of the spinal explant, 
or differences between rat and frog spinal neurons (such as differing expression of netrin-1 receptor 
isoforms), alters the role of PKA in the netrin-1 attraction/repulsion switch. 
Netrin-1 response is modulated by other secondary messengers in addition to cAMP/PKA. 
Axon guidance experiments in isolated Xenopus spinal commissural neurons revealed that attractive 
netrin-1 response relied on both Ca2+ release from the endoplasmic reticulum and Ca2+ influx through 
the plasma membrane, and that blockade of Ca2+ influx into the cytoplasm converted the attractive 
response to repulsion47. Ca2+-dependent repulsion also requires cGMP. Using cyclic nucleotide 
analogues, Nishiyama et al, found that the ratio of [cAMP]/[cGMP] tunes netrin-dependent turning 
responses; with a high ratio promoting attraction and a low ratio leading to repulsion48. Revisiting 
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these classic experiments on netrin-1 attraction and repulsion with new tools to optogenetically 
manipulate the spatial and temporal distribution of secondary messenger levels is warranted. 
  
2.1.4 Switch 3: Netrin-1 concentration 
Many axon guidance or outgrowth studies reveal bimodal responses of axons occur with 
increasing netrin concentrations5,12,45,46,49, suggesting that the concentration of netrin-1 may 
determine which receptors, and thus intracellular pathways, are recruited. Indeed in a microfluidically 
isolated gradient of netrin-1, embryonic murine cortical axons closer to the source of netrin-1 (higher 
concentration) are repelled, whereas those at the lower end of the concentration gradient are 
attracted22, supporting the notion of a concentration dependent response. Although further work is 
needed to establish this mechanism, biophysical experiments have demonstrated that netrin-1 binds 
with higher affinity to DCC than to UNC529. This could lead to increased UNC5/DCC 
heterodimerization at higher concentrations of netrin-1, inducing repulsive axon guidance 
responses27–29. The attractive and repulsive forces leading to directional axon outgrowth under this 
paradigm are summarized in Figure 4. Structural studies on the interaction between netrin-1, DCC 
and UNC5 suggest that although DCC can bind two sites on netrin-1, only one of these can interact 
with UNC529, which would preclude the formation of UNC5 homodimers. Therefore UNC5-dependent, 
DCC-independent short-range axon repulsion in response to netrin-1 may require dimerization with 
additional receptors such as DSCAM, discussed later in this review. Alternatively, high concentrations 
of netrin-1 may saturate DCC, and prevent DCC homodimerization and attractive responsiveness. 
 
2.1.5 Switch 4: Extracellular environment 
Surprisingly little is known regarding modification of netrin-1 attraction and repulsion by the 
composition of the extracellular environment. One other axon guidance molecule, draxin, has been 
shown to antagonize netrin-1 and is proposed to render netrin-1 a fasciculation cue50,51, however any 
role in mediating netrin-1 attraction or repulsion is unknown. Additionally, netrin-1 is known to bind to 
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glycosaminoglycans (GAGs), a major component of the extracellular matrix, yet once again the role of 
these glycoproteins in axon guidance is unknown. Draxin and GAGs will be discussed in more detail 
later in this review. The integrin ligand laminin-1 is one of the few known extracellular components 
that switches netrin-1 dependent attraction to repulsion. Xenopus retinal growth cones, normally 
attracted to netrin-1, will be repulsed if laminin-1 is present in the extracellular matrix (ECM) or 
substrate52. This response is also likely sensitive to secondary messengers, as in the presence of 
substrate-adhered laminin-1, blockade of Ca2+ release, which is dependent on Ca2+-calmodulin-
dependent protein kinase II (CaMKII), calcineurin (CaN) and protein phosphatase 1 (PP1), switches a 
repulsive netrin-1 response to attraction in Xenopus spinal neurons53. This suggests an intriguing 
modulation of internal signaling by extracellular matrix components; indeed in chick ciliary ganglion 
neurons, treatment with laminin induces an influx of Ca2+54. Whereas a Ca2+ influx blockade can 
switch netrin-1 attraction to repulsion47, a further increase of Ca2+ beyond the attractive netrin-1 
response regime may switch the response once more. The integration of signaling events from a 
complex extracellular environment represents a rich area for future studies into axon guidance. The 
requirement for substrate adhesion of laminin-1 may also indicate that the netrin-1 attractive-repulsive 
switch is in part reliant on mechanotransduction pathways, however this remains to be investigated. 
This is an especially intriguing area for study of mechanical regulation of axon guidance, as many 
mechanotransduction proteins are known to be ion channels, which could modify the intracellular 
environment55–57.  
 
2.2 Chemotaxis and haptotaxis? 
A new axis recently emerged for netrin-1 during haptotactic axon guidance. The dogma of the 
field has long posited that netrin-1 is a diffusible cue, supported by assays in which axons extend 
from explants toward netrin-1 secreted by distant patches of cells5,10,21,58,59 or diffusing from enriched 
agarose blocks58, and by the presence of a gradient of netrin-1 protein in embryonic chick spinal 
cord60. Supporting chemotaxis, fragments of netrin-1 lacking the major ECM-binding domains are 
able to produce axon outgrowth responses61 despite reduced interaction with the substrate, 
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suggesting that there may be adhesion-independent effects of netrin-1 on the axon. However, netrin-
1 also binds the extracellular matrix10 or cell membranes60 and guides axons locally12,62, suggesting a 
potential role for netrin as a haptotactic cue that promotes mechanotransduction. Supporting this 
possibility, when beads covalently linked to netrin-1 are presented to an extending spinal 
commissural axon in vitro, the growth cone exerts force on the bead63. If the bead is immobilized, 
growth cones reorient toward the bead. Adhesion of netrin-1 to the substrate is suggested to be 
necessary for attractive axon guidance in spinal commissural neurons, as inhibiting netrin adhesion 
with heparin blocks this attractive response, and deletion of the highly positively charged C-terminal 
extracellular matrix-binding C domain of netrin-1 reduces axon outgrowth61. This attraction to 
adhesive netrin involves non-muscle myosin II (MyoII)-dependent mechanotransduction, as 
blebbistatin treatment blocked the generation of forces on netrin-1 beads by the growth cone. Indeed, 
netrin-1 signaling through DCC activates MyoII via indirect activation of myosin light-chain kinase 
(MLCK)64.  MyoII also promotes mechanical activation of focal adhesion kinase (FAK), an important 
downstream effector of netrin-1 signaling through DCC61 (covered in more detail in a later section).  
The original studies on the function of netrin-1 in vivo relied on a hypomorphic gene trap 
allele of Ntn1 that maintained low levels of netrin-1 protein65, however recent development of mice 
carrying a floxed Ntn1 allele has allowed for tissue-specific and complete loss of netrin-166,67. Three 
recent papers have galvanized the potential role of netrin-1 as a haptotactic cue in vivo by selectively 
deleting netrin-1 from the floor plate and/or ventricular zone of the spine and hindbrain using floxed 
Ntn1 alleles, and assessing the midline crossing of commissural axons19–21 (for an additional mini-
review on Dominici et al. and Varadarajan et al., see Morales, 2018). All three groups found that 
netrin-1 expression in the floor plate, originally thought to be the source of the attractive gradient of 
netrin-1 responsible for commissural crossing60,69, is not necessary for commissure formation. Rather, 
netrin-1 deposited on the pial surface by ventricular zone neural progenitors forms a path for axons to 
reach the site of the commissure19,20. This deposition of netrin-1 on a surface supports a haptotactic 
guidance role, though it does not invalidate earlier experiments showing a chemotactic function of 
netrin-1. Indeed netrin-1 is deposited on the extending axons in a DCC-dependent manner, 
suggesting that netrin-1 is not substrate-adhered at all times20. These experiments together question 
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whether netrin-1 functions as a chemotactic cue, and potentially suggest that netrin-1 may signal 
differently through chemotactic and haptotactic mechanisms, or perhaps that other modulators of 
netrin-1 guidance are critical in situ. Clearly further experiments are required to determine the role of 
chemotactic and haptotactic netrin-1 responses in vitro and in vivo, however the data accumulated 
over the past 30 years suggest that both mechanisms are important during nervous system 
development. 
 
3 Netrin-1 receptors and their mechanisms 
Netrin-1 acts through a repertoire of membrane-spanning receptors with extracellular 
domains that bind netrin and cytoplasmic domains that interact with effector proteins. These receptors 
include DCC (Frazzled in Drosophila, Unc-40 in C. elegans), its paralog neogenin in vertebrates, the 
UNC5 family (Unc5/Unc-5 in both Drosophila and C. elegans), and DSCAM (DSCAM in Drosophila 
and C. elegans).  
 
3.1 Deleted in Colorectal Cancer (DCC) 
DCC is a transmembrane receptor of the immunoglobulin superfamily highly expressed in 
spinal commissural neurons24, the retina70,71, and many projection neurons of the fore- and midbrain 
during embryonic development72. DCC functions as a receptor for netrin-1 in both growth cone 
attraction and repulsion23–29. The extracellular portion of DCC consists of four Ig-like N-terminal 
domains followed by six fibronectin type-III (FN3) repeats24. Structural studies reveal that netrin-1 
binds in the area of the fifth and sixth FN3 domains, and that attractive axon guidance requires 
binding to two of these sites29,73,74. The binding of a single molecule of netrin-1 to two receptors 
induces DCC homodimerization29. As there are at least three binding sites on DCC for netrin-1, and 
three binding sites on netrin-1 for DCC29,75,76, netrin-1 may link dimers to produce the larger-order 
clustering of DCC observed in vitro41,75,77,78. A similar clustering process increases adhesion avidity in 
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the integrin/laminin receptor/ligand system79,80, and could represent a mechanism for the regulation of 
mechanical forces on the netrin-1/DCC complex. 
The increase in receptor valence due to netrin-1:DCC multimerization likely brings the 
intracellular domains of the receptors into close apposition29. The intracellular region of DCC contains 
three domains termed P1, P2, and P3, which are conserved among DCC family proteins25. When 
multiple DCC molecules coalesce due to netrin-1-dependent clustering, the P3 domains interact81, 
and these binding-site-rich intracellular domains form a scaffold for the recruitment of downstream 
effectors and regulatory proteins82. As the intracellular domains of DCC are required for repulsive 
netrin-1 dependent axon responses as well as attraction, parsing discreet downstream signaling 
pathways is complicated. This section specifically addresses mechanisms associated with either 
attractive axon guidance or increased axon outgrowth in response to netrin-1 downstream of DCC. 
Asymmetrical changes in the shape and rate of extension of the growth cone reorient outgrowth 
during turning; this involves dramatic and regulated remodeling of the plasma membrane1 and 
underlying cytoskeleton83, which is orchestrated by both chemical and mechanical transduction 
downstream of netrin/DCC, summarized in Figure 5. 
 
3.1.1 DCC interactions with the cytoskeleton 
The P3 domain of DCC is a hotspot for interaction with many binding partners of DCC that 
are poised to promote cytoskeletal and membrane remodeling, including the unconventional myosin 
X (MyoX),  the nonreceptor tyrosine kinase FAK, the E3 ubiquitin ligase TRIM9, F-actin binding ezrin-
radixin-moesin (ERM) proteins, and p120RasGAP, which are situated to modulate chemical signaling, 
mechanotransduction, or both. The MyTH4-FERM domain of MyoX binds to the P3 domain of DCC 
and to microtubules, whereas the head/motor domain of MyoX translocates along filamentous actin; 
as such, MyoX translocates DCC to the periphery of cells and tips of filopodia84,85. MyoX is also 
required for netrin-1 dependent axon outgrowth and guidance of spinal commissural neurons84. Now 
that conditional alleles for MyoX exist86, exploring the roles of MyoX in netrin dependent 
mechanotransduction or the formation of specific axon tracts in the brain is possible. DCC also 
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reciprocally regulates MyoX, increasing association with actin filaments and promoting filopodial 
formation87. The modulation of MyoX localization, and potentially function, by DCC represents an 
intriguing direction for future studies into the effect of extracellular ligands on intracellular force 
generation, however future studies need to confirm the netrin dependency of MyoX enhanced actin 
binding.  
Netrin-dependent remodeling of the actin and microtubule cytoskeletons are critical points in 
axon guidance that may also be regulated by mechanotransduction. The formation of filopodia in 
netrin-1 dependent axon guidance relies on the Ena/VASP family of actin polymerases88,89 which, 
along with DCC, localize to the tips of growth cone filopodia90–94. Increases in the length and number 
of filopodia involves PKA phosphorylation of Mena at S236, corresponding to S157 in VASP89,95. 
VASP, but not Mena or the third Ena/VASP family member EVL, is also regulated in netrin-1 
dependent axon guidance by non-degradative TRIM9-dependent ubiquitination91. Ubiquitination of 
VASP is associated with reduced filopodia lifetime and reduced VASP dynamics and localization to 
filopodia tips. The PKA-dependent phosphorylation of Ena/VASP proteins downstream of DCC also 
requires the function of PKA anchoring protein 79 (AKAP79) and ERM actin-binding proteins95,96. In 
addition to regulation of actin-binding proteins, involvement of the microtubule cytoskeleton is also 
implicated in netrin-1/DCC responses: a recent study found that DCC interacted with neuron-specific 
β-III-tubulin in a netrin-1 dependent manner97. By mutating sites on β-III-tubulin necessary for this 
binding, the group found that DCC:β-III-tubulin interactions are required for axon branching of cortical 
neurons and guidance of spinal commissural neurons. 
 
3.1.2 DCC signaling pathways: receptor-linked kinases and GEFs 
Netrin-dependent dimerization of the DCC P3 domains results in clustering of FAK and 
adaptor protein NCK1, which are constitutively bound to DCC58,82,98,99. This leads to activation of FAK 
through autophosphorylation at Y397, subsequent recruitment of Src family kinases (SFK), notably 
Fyn, which then phosphorylate FAK at Y861 and DCC at Y141898–100. The autophosphorylation and 
activation of FAK also requires binding to phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2, PIP2) at the 
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membrane101. Intriguingly, FAK and SFK are maintained in a ready pool when not phosphorylated by 
the membrane-associated scaffolding protein myristoylated alanine-rich C kinase substrate 
(MARCKS)102, which interacts with PIP2 and β-actin and promotes lamellipodium formation103. This 
provides another link between the actin cytoskeleton and the membrane to transduce internal 
mechanical forces to the cell surface for remodeling, through the interaction between FAK and actin.  
Activation of FAK downstream of netrin-1 may be mechanically induced61. The C-terminal 
FAT domain of FAK binds to the P3 domain of DCC, whereas the extracellular region of DCC is 
linked to the extracellular matrix through netrin-1 (Figure 6); FAK also indirectly interacts with the 
actin cytoskeleton through associations between its N-terminal FERM domain and the F-actin binding 
ERM proteins and Arp2/3 complex104,105. These interactions together form a mechanotransductive 
complex centered on FAK. Forces generated by the treadmilling of connected actin filaments or 
contractile forces generated by myosins, expose the FAK kinase domain and allow 
autophosphorylation of FAK106. Further experiments are needed to identify the source of the 
mechanical forces that activate FAK upon netrin-1 binding to DCC. Additionally, atomic force 
microscopy could be conducted on netrin-1/DCC/FAK/actin complexes or FAK under tension in vitro, 
or models made in silico to determine the structure of FAK under tension and in a relaxed state.  
Similar studies are needed to determine the extent to which mechanical forces are required 
for the activation of other proteins linking DCC to cytoskeletal components. For example netrin-
dependent phosphorylation of DCC pY1418 recruits members of the ERM family96,107, linking DCC to 
the actin cytoskeleton. ERM proteins bridge filamentous actin to the plasma membrane through 
interaction with the transmembrane receptors CD44108 and L1 cell adhesion molecule (L1CAM)109, 
each of which have roles in nervous system development110,111. The ERM family member moesin also 
interacts with microtubules112, providing an additional link between the netrin-1/DCC complex, the 
membrane and the cytoskeleton that could transduce mechanical forces either into the cell for 
activation of signaling, or to the cell surface to generate remodeling and movement of the growth 
cone. Inhibition of ERM proteins in rat cortical neurons inhibits netrin-mediated axon outgrowth107. 
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Activation of ERM113–116 and MYOII117,118 enacts reorganization and traction forces, respectively, on 
the actin cytoskeleton.  
Once activated by FAK, the SFKs Src and Fyn recruit to the DCC signaling complex the Rho 
GEFs DOCK180 (DOCK1)119 and triple domain functional protein (Trio)120–125 to promote the 
activation of the Rho GTPase Rac1. Similarly the GEF Tiam-1 is recruited94,126–128 to activate Cdc42. 
In contrast, RhoA activity is decreased throughout the cell after application of netrin-1 in rat spinal 
commissural neurons129. Interestingly, another study shows that netrin-1 treatment can also activate 
RhoA downstream of DCC in rat cortical neurons, leading to activation of Rho kinase (ROCK) and 
subsequent phosphorylation of and activation of ERM proteins107 and myosin II (MYOII)64. Together 
these GTPases regulate the actin cytoskeleton to promote netrin-dependent spreading of lamellipodia 
and formation of filopodia129. Activated Rac1 and Cdc42 form a complex with and activate p21-
activated kinase 1 (PAK1), leading to the activation of the nucleation promotion factor, neuronal 
Wiskott-Aldrich syndrome protein (N-WASP)127. N-WASP then activates the filamentous actin 
nucleation and branching activity of the Arp2/3 complex, a major driver of lamellipodial 
protrusions130,131. This pathway appears to be evolutionarily conserved, as the Rac-like GTPases 
CED-10 and MIG-2, and the GEF UNC-73 (ortholog of mammalian Trio) in C. elegans are also 
required for unc-6 dependent axon guidance88,120. However, mammalian Trio is required for attractive 
axon guidance, whereas the C. elegans ortholog is involved in repellant guidance88,121. While 
GEF/GTPase activation is one of the most thoroughly studied components of netrin-1:DCC signaling, 
there remain unanswered questions to be investigated. For example, how do we reconcile the 
decrease in RhoA activity seen globally129 with the observation that RhoA is activated downstream of 
DCC107? Two potential explanations are that the activation and inhibition of specific GTPases are 
regulated differently depending upon timing after netrin-1 treatment, or that other signals dictate the 
direction of regulation. More work must be done to understand the intricacies of regulatory pathways 
and timelines in the context of DCC, as well as axon guidance receptors in general. 
DCC is also involved in activating members of the mitogen-activated protein kinase (MAPK) 
pathway132. Netrin-1 promotes recruitment, interaction, and activation of MAP kinase kinase 1 
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(MEK1), extracellular signal-related kinases 1 and 2 (ERK1/2), and Jun N-terminal kinase (JNK1) with 
DCC133–135. This is specific, as activation of another MAPK family member, p38 is not triggered by 
netrin-1133. Palmitoylation of the transmembrane domain of DCC, and its association with lipid rafts is 
required for the activation of ERK136. Activation of ERK is necessary for attractive axon guidance and 
leads to activation of transcription factors such as ELK1, suggesting a possible role of netrin-1/DCC 
signaling in transcriptional regulation133. DCC pY1418 is also a binding site for p120RasGAP, which is 
required to tightly control Ras and ERK activities in neurons during attraction of cortical axons toward 
netrin-1137.   
 
3.1.3 DCC signaling pathways: plasma membrane remodeling 
Recent work has elaborated on an important role of membrane reorganization and addition 
during netrin dependent axonal morphogenesis, along with regulation of membrane composition. 
Several groups described addition of DCC to the plasma membrane through exocytosis in response 
to netrin-141–43. The delivery of membrane is critical for axon guidance and outgrowth, which involve 
rapid plasma membrane expansion138–140. Exocytosis frequency increases in response to netrin-1141, 
and may occur downstream of DCC, FAK77,90, SFKs, and ERK1/2142. Early reports suggested that 
syntaxin-1 and vesicle associated membrane protein 7 (VAMP7, TI-VAMP) were required for this 
DCC-dependent increase in exocytosis in spinal commissural neurons, whereas synaptosomal 
associated protein 25 (SNAP25) and vesicle associated membrane protein 2 (VAMP2) were not 
involved143,144. However, later reports show that SNAP25 is required for SNARE complex formation 
and exocytosis in netrin-1 dependent axon branching in embryonic cortical neurons, and that 
SNAP25 is regulated in this context by TRIM9138,141. Studies also show an increase in the exocytosis 
frequency of VAMP2 containing vesicles in response to netrin-1 which, intriguingly, were regulated by 
TRIM9 specifically in neurites77,138. Tension on the cell membrane has been shown to increase the 
efficiency of exocytosis145; this membrane tension can be generated by increased cytoskeletal 
dynamics146, which are induced by netrin-1 activation of the signaling pathways detailed above. The 
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increase in exocytosis in response to netrin-1 provides another avenue to investigate the role of 
intracellular force generation on axon guidance.  
The plasma membrane lipid composition is also modified by netrin-1 signaling. Downstream 
of DCC, phospholipase Cɣ (PLCɣ) is phosphorylated and activated; this activation is required for axon 
outgrowth in response to netrin-1147,148. Activation of PLCɣ leads to hydrolysis of PI(4,5)P2 into 
diacylglycerol (DAG) and inositol 1,4,5-trisphosphate, which among many other functions, lead to the 
activation of PKC and induce endoplasmic reticulum Ca2+ release, respectively149,150. As mentioned, 
PKC activation induces endocytosis of UNC5, which may promote increased DCC-only 
homodimerization and thus attractive outgrowth39,40. Intracellular Ca2+ release is also required for 
netrin-1 dependent attraction47. Interestingly, since PI(4,5)P2 is also required for autophosphorylation 
and activation of FAK by DCC101, this may represent an intrinsic homeostatic negative feedback loop 
that decays the DCC signal, giving it a finite lifetime. In addition to phosphatidylinositol hydrolysis, 
netrin-1 treatment also induces activation of PI3Ks in a DCC-dependent manner, and subsequent 
activation of protein kinase B (PKB/Akt)147,148, which is necessary for nervous system development151. 
 
3.2 Neogenin 
Neogenin is well characterized as a receptor for the repulsive guidance molecule (RGM)152. 
In contrast, although neogenin also binds netrin-1, most information regarding the function of 
neogenin in netrin-1 dependent axon guidance derives from comparisons made to DCC, as they are 
similar proteins with identical domain structures. In the spinal cord of the chicken, an organism in 
which there is no DCC, neogenin may fully replace DCC function153. However, whether this 
comparison is valid in species with both paralogs remains to be seen. Some differences in protein 
functions have been noted. For example, whereas DCC promotes MyoX movement along basal actin 
filaments and induces basal filopodia formation, neogenin promotes MyoX movement toward apical 
filaments, and induces apical filopodia formation84,85. Further studies into the cause of this distinct 
regulation of MyoX may provide insight into the regulation of intracellular force generation by axon 
guidance receptors. DCC and neogenin may share common downstream signaling components, as 
16 
 
neogenin interacts with DOCK1 as DCC does119. Unlike DCC however, neogenin does not promote 
PI(4,5)P2 hydrolysis in response to netrin-1147, and therefore does not recruit an identical repertoire of 
proteins. Neogenin appears to facilitate spinal commissure formation alongside DCC in mice75, as 
well as ventral forebrain axon tracts in Xenopus154. Expression studies of neogenin in the developing 
mouse show a broad expression among many types of maturing neurons, suggesting the receptor 
may act in a variety of processes in addition to netrin-1 axon guidance155. Future studies are needed 
to address the functional outcome of netrin-1 binding to neogenin, as this likely forms an isolated 
dimer as opposed to the clustering observed with DCC75. As neogenin can functionally replace DCC 
in the chicken spinal cord, any differences between the signaling pathways and force transduction 
capacities of these two proteins could provide invaluable insight into which mechanisms are 
necessary for the formation of a spinal commissure. 
 
3.3 The UNC5 family 
The UNC5 family of repulsive netrin receptors consists of one isoform in invertebrates (UNC5 
in Drosophila and Unc-5 in C. elegans) and up to four in vertebrates (UNC5A, UNC5B, UNC5C, 
UNC5D). UNC5 proteins function in repulsive axon guidance in response to netrin-1, through 
heterodimerization with DCC for long-range repulsion27–29, and potentially heterodimerization with 
DSCAM for short-range repulsion30,31. The signaling pathways discussed in this section are 
summarized in Figure 7. The intracellular domain of UNC5 contains a binding site for the P1 domain 
of DCC; association between UNC5 and DCC mediates long-range netrin-1 dependent axon 
repulsion29,32. DCC independent repulsion effects also require the ZU-5 motif of the UNC5 
intracellular domain156 and the adaptor protein required for motor axon guidance 1 (Max-1, human 
homolog PLEKHH1)157, both of which may scaffold downstream proteins into a signaling complex. 
The heterodimer of DCC and UNC5 recruits many of the same effectors for repulsion as DCC 
homodimers recruit for attractive signaling. Notably, Src and FAK are recruited by DCC/UNC5 
heterodimers upon netrin-1 stimulation, leading to phosphorylation of C. elegans Unc-5 at Y482 
(Y568 in murine UNC5C)158. This phosphorylation of Unc-5 is necessary for repulsive netrin-1 axon 
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guidance in vivo156,159. Phosphorylation of UNC5C recruits tyrosine-protein phosphatase non-receptor 
type 11 (PTPN11 / SHP2), which then dephosphorylates UNC5C158. Thus phosphorylation may lead 
to activation of proteins downstream of UNC5, but additionally activates negative feedback through 
phosphatases like SHP2 as possible homeostatic mechanisms. 
Rho family GTPases are also regulated downstream of Unc5 through distinct repertoires of 
GEFs. In neurite outgrowth in mouse neuroblastoma cells, RhoA is activated by netrin-1 binding to 
UNC5A, and to a lesser extent, Rac1 and Cdc42 are activated as well160. In C. elegans, netrin-1 
binding to Unc-5 similarly leads to activation of the Trio ortholog Unc-73, which in repulsive netrin-1 
responses can act as a GEF for the GTPases Ced-10 and Mig-2 (as opposed to Tiam-1, which 
occurs in attractive netrin-1 responses126,128 to inhibit growth cone protrusion120. Downstream of these 
GTPases, the PAK Max-2 is required for netrin-1 dependent repulsion161. Recent work demonstrates 
that additional effectors of these GTPases in netrin-1 repulsion include Unc-33 (ortholog of collapsin 
response mediator proteins (CRMPs)), which regulates remodeling of both the actin and microtubule 
cytoskeletons162, and Unc-44 (ortholog of Ankyrin), an adaptor protein connecting integral membrane 
proteins to the spectrin cytoskeleton120,163. Genetic analysis suggests the flavin monooxygenases 
Fmo-1, Fmo-4, Fmo-5 and Ebhp-1 are required for netrin-dependent repulsion in C. elegans164. The 
C. elegans Rac orthologs activate the flavin monooxygenases, which oxidize a variety of 
substrates165. A similar family of monooxygenases, the molecule interacting with CasL (MICAL) 
protein family, has been shown in Drosophila and in vertebrates to regulate repulsive axon guidance 
to semaphorins by oxidative dismantling of F-actin166–168. However, whether the C. elegans 
monooxygenases similarly oxidize F-actin or other relevant substrates in netrin-1 dependent axon 
guidance has yet to be investigated. In addition to regulation of the actin cytoskeleton, UNC5C also 
interacts with β-III-tubulin, an interaction that may modulate netrin-1 dependent axon repulsion169. 
This represents yet another link between the transmembrane netrin-1 receptors and the cytoskeleton; 





3.4 Down Syndrome Cell Adhesion Molecule (DSCAM) 
DSCAM is a transmembrane cell adhesion molecule which also acts as a receptor for netrin-
1170–172. DSCAM acts with UNC5 as a co-receptor for netrin-1, to mediate short-range repulsive 
responses31. DSCAM is required for midline crossing of spinal commissural neurons in Xenopus, and 
neurons exogenously expressing DSCAM respond to attractive netrin-1 independent of DCC173. 
However, DSCAM is not required for all netrin-1 mediated guidance, such as in mouse spinal 
commissural neurons174. In Drosophila, DSCAM functions as a midline receptor for netrin and 
possibly for an unidentified guidance cue operating in parallel to netrin and the DCC ortholog 
Frazzled175. DSCAM interacts with UNC5C in response to netrin-1, and this pair mediates axonal 
growth cone collapse in mouse cerebellar granule cells by promoting the phosphorylation of FAK, 
Fyn, and PAK131,176. Evidence also suggests that DSCAM may coordinate with DCC to regulate 
interactions with microtubules177 and the activation of JNK1 in response to netrin-1135. Possibly 
independently of either UNC5 or DCC, DSCAM interacts with AMP-activated protein kinase (AMPK), 
which is phosphorylated in response to netrin-1 treatment178. DSCAM promotes axonal fasciculation 
and dendritic tiling through neurite-neurite adhesion179–181. Further studies are required to 
mechanistically define how DSCAM mediates diverse functions during netrin-1 dependent 
morphogenesis. 
 
4 New netrin-1 modifiers 
Recently identified netrin-1 modifiers provide additional complexity to netrin-dependent 
axonal morphogenesis. The protein draxin, secreted from the floor plate, binds soluble netrin-1 and 
acts as an antagonist in the developing spinal cord by binding to netrin50. Structural studies 
demonstrate that a draxin/netrin-1 complex binds two DCC molecules from neighboring axons (in 
trans) simultaneously, promoting fasciculation as opposed to attractive axon guidance or outgrowth51, 
as illustrated in Figure 9. In light of recent studies that revealed floor-plate-derived netrin-1 is 
dispensable for commissural axon guidance19–21, a mechanism in which soluble netrin-1 is converted 
to a fasciculation signal at the location of commissure formation may be an exciting avenue for future 
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study. Studies on draxin in the central nervous system suggest a similar role there as well. Deletion of 
draxin in mice leads to partially penetrant agenesis of the corpus callosum, a major midline brain 
commissure182. Concomitant heterozygous deletion of Dcc and draxin (Dcc+/-draxin+/-) results in a 
much stronger agenesis phenotype than either single heterozygous knockout. 
Structural studies suggest that netrin-1 may require heparin sulfates as co-ligands, as the C-
terminal extracellular matrix domain of netrin-1 interacts with GAGs73,183, and X-ray crystallography of 
netrin-1 in complex with DCC reveals a bound sulfate29. A recent study also shows that the heparin 
sulfate proteoglycan (HSPG) glypican binds to DCC and modulates netrin-1 dependent axon 
guidance in vivo184. Curiously, this interaction with netrin-1/DCC relies on the N-terminal peptide-only 
region of glypican rather than on its C-terminal heparin sulfate binding domain. However, the complex 
structure of a proteoglycan such as glypican, which is membrane-bound by its C-terminus, could 
allow for mechanical attachments between netrin-1, DCC, cell membranes and the extracellular 
matrix. Further studies are needed to assess the extent of proteoglycan regulation of netrin-1 
signaling pathways, and the mechanisms by which glypican and heparin sulfates influence 
chemotactic and haptotactic axon guidance. 
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CHAPTER 1 FIGURES 
 
Figure 1. Axon guidance cues attract or repulse growth cones, and can be presented adhered to the 
extracellular matrix or soluble. The data accumulated over the last 30 years suggest that netrin-1 acts 
both as an attractive and repulsive cue, and may function both as a soluble, chemotactic cue and as 





Figure 2. Diagrams of the known netrin-1 receptor dimers and their signaling functions. Netrin-1 
binding simultaneously to two DCC molecules induces DCC homodimers, which similarly occurs for 
neogenin. If netrin is substrate bound, this could crosslink DCC dimers to the extracellular matrix. 
However, the signaling result of neogenin dimers is not currently known. Whether netrin-1 also links 
neogenin:neogenin, UNC5:DCC, or UNC5:DSCAM dimers to the extracellular matrix is also unknown, 
but represents potential mechanotransductive mechanisms in netrin-1 signaling. Structural studies 
have not been conducted on the UNC5:DSCAM dimer, therefore whether a single netrin-1 molecule 





Figure 3. Summary of known “switches” between attractive and repulsive function of netrin-1. 
Switches span from receptor concentrations at the plasma membrane, cytoplasmic second 





Figure 4. The concentration of netrin-1 may switch attraction to repulsion responses. Attractive and 
repulsive forces generated by DCC and UNC5 dimers are represented as green and red arrows, 
respectively, leading to an axon outgrowth vector (black arrows). As the concentration of netrin-1 
increases, more DCC homodimers are recruited. At higher netrin-1 concentrations, the nonspecific 
receptor binding site begins to recruit UNC5 to dimers, as this binding site has a lower affinity for 
UNC5 than for DCC. At the highest concentrations of netrin-1, saturation of receptors with ligand may 
result in receptors being maintained as monomers as opposed to dimerization, preventing 
downstream signaling that requires a dimer. By virtue of the concentration dependence of attraction 
and repulsion responses, axons are guided into a concentration in which forces are balanced. 
However, this may not be a stable position as receptor trafficking, intracellular secondary messengers 




Figure 5. Model of known signaling pathways and interactions downstream of DCC in netrin-1 
dependent axon guidance. DCC interacts with several enzymes and adaptor proteins and the actin 
and microtubule components of the cytoskeleton in the absence of netrin-1, forming a “primed” 
signaling complex, which can rapidly initiate responses to ligand binding. Netrin-1 increases valency 
through multimerization of DCC homodimers. This clustering brings intracellular domains of the 
receptors into close apposition, forming a scaffold for the recruitment and activation of several 
proteins. Solid green arrows denote direct steps in activation, whereas dashed green arrows are 
known connections that may have intermediates. These pathways together modify the intracellular 
environment to promote directional axon outgrowth in response to netrin-1. Abbreviations: AKAP79, A 
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kinase anchoring protein 79; ARP2/3, actin-related protein 2/3 complex; CDC42, cell division control 
protein 42; DCC, deleted in colorectal cancer; DOCK1, dedicator of cytokinesis 1; ELK1, ETS 
transcription factor; ERK, mitogen activated protein kinase; ERM, ezrin-radixin-moesin; FAK, focal 
adhesion kinase; FN3, fibronectin type 3 domain; Ig, immunoglobulin domain; JNK1, c-Jun N-terminal 
kinase 1; MARCKS, myristoylated alanine-rich C kinase substrate; MEK, mitogen activated protein 
kinase kinase; MENA, mammalian enabled; MYOII, myosin II; MYOX, unconventional myosin X; 
NCK1, NCK adaptor protein 1; N-WASP, neuronal Wiskott-Aldrich syndrome protein; PAK1, protein 
associated kinase 1; PKA, protein kinase A; PKB, protein kinase B; PKC, protein kinase C; PLCɣ, 
phospholipase C gamma; RAC1, Ras-related C3 botulinum toxin substrate 1; RHOA, Ras homolog 
gene family member A; ROCK, Rho associated protein kinase; SFKs, Src family kinases; SNAP25, 
synaptosomal associated protein 25; SYTX1, syntaxin-1; TIAM1, T-lymphoma invasion and 
metastasis protein 1; TRIM9, tripartite motif protein 9; TRIO, triple domain functional protein; VAMP2, 
vesicle associated membrane protein 2; VAMP7, vesicle associated membrane protein 7; VASP, 





Figure 6. Theoretical model of FAK activation by mechanical forces (adapted from Moore et al. 
2012). In the inactive state, the N-terminal FERM domain of FAK interacts with the kinase domain, 
preventing activation. Upon netrin-1 binding, tension on the actin cytoskeleton (through actin 
treadmilling and motor protein function) is transduced through ezrin-radixin-moesin (ERM) proteins to 
the N-terminus of FAK. The immobilization of the C-terminus of FAK through interaction with DCC, 
which is adhered to the extracellular matrix through its interaction with netrin-1, leads to increased 
mechanical force across FAK. This causes a conformational change that exposes the kinase domain, 





Figure 7. Summary of known signaling pathways downstream of UNC5 in repulsive netrin-1 
signaling. Interaction between the intracellular DB domain of UNC5 and the P1 domain of DCC 
produces a scaffold similar to that in DCC homodimers. FAK and Src are phosphorylated and 
activated as in attractive netrin-1 signaling, however the functional outcomes are different. 
Abbreviations: CDC42, cell division control protein 42; CRMP, collapsin response mediating protein; 
DB, DCC-binding domain; DD, death domain; FAK, focal adhesion kinase; FMOs, Flavin 
monooxygenases; Ig, immunoglobulin domain; MAX2, more axillary growth 2; PLEKHH1, pleckstrin 
homology MyTH and FERM domain containing protein H1; RAC1, Ras-related C3 botulinum toxin 
substrate 1; RHOA, Ras homolog gene family member A; SHP2, protein tyrosine phosphatase 2C; 
SRC, proto-oncogene tyrosine-protein kinase Src; TRIO, triple domain functional protein; TSP, 





Figure 8. Summary of known interactions linking the transmembrane receptors DCC and UNC5 to 
the membrane and cytoskeleton. Both receptors are connected to the extracellular matrix through 
interaction with netrin-1. Abbreviations: DCC, deleted in colorectal cancer; ERM, ezrin-radixin-
moesin; ICD, intracellular domain; MARCKS, myristoylated alanine-rich C kinase substrate; MYOX, 
unconventional myosin X; TRIM9, tripartite motif protein 9; UNC5, uncoordinated locomotion 5; 




Figure 9. Model for fasciculation induced by draxin-netrin-1 interaction with DCC (adapted from Liu et 
al. 2018). Interaction between draxin and netrin-1 potentially links together DCC receptors from 
adjacent axons, causing fasciculation. This could additionally lead to higher-order multimers of DCC, 




CHAPTER 2: THE E3 UBIQUITIN LIGASE TRIM9 IS A FILOPODIA OFF SWITCH REQUIRED 
FOR NETRIN DEPENDENT AXON GUIDANCE† 
1 Introduction 
During embryonic development, growth cones at the tips of extending axons respond to 
extracellular cues to direct axon growth185. In the mammalian cortex, the secreted guidance cue 
netrin-1 (netrin) and its receptor DCC (deleted in colorectal cancer) promote attractive axon 
guidance81,186 and deficiency of the murine gene encoding netrin-1 or DCC induces cortical projection 
defects26,65. DCC localizes to the tips of filopodia94, bundled filamentous actin (F-actin) rich 
protrusions that decorate the growth cone periphery and contribute to axon guidance. Furthermore, 
DCC is required for netrin-dependent increases in filopodia density89 . In addition to guidance 
receptors, the filopodia tip complex contains cytoskeletal regulatory proteins that modulate filopodial 
growth and stability90. Cytoskeletal dynamics contribute to the extension and turning of growth cones, 
but how the function of the tip complex is regulated by netrin is not known. 
Ena/VASP actin regulatory proteins localize within the tip complex and are essential in netrin 
response, filopodial formation, neuritogenesis and axon fiber tract formation in the murine 
cortex89,187,188. Mammals have three Ena/VASP orthologs: Mena, VASP, and EVL92,188, which promote 
formation of unbranched F-actin through binding and protecting the barbed end from capping and 
promoting polymerization189–192. This family is characterized by an N-terminal Ena/VASP Homology 1 
(EVH1) domain that binds proteins with the sequence (D/E)FPPPPX(D/E)(D/E) (abbreviated FP4), a 
proline-rich (Pro) domain, and an EVH2 domain that binds monomeric and F-actin and mediates 
tetramerization193. Ena/VASP function is required for netrin-dependent increases in growth cone
                                                          
† This chapter previously appeared as an article in Developmental Cell. The original citation is as follows: 
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“The E3 Ubiquitin Ligase TRIM9 is a Filopodia Off Switch Required for Netrin-dependent Axon Guidance”. 




filopodia89. Ena/VASP proteins are acutely phosphorylated in response to netrin, however this 
phosphorylation is not detected when filopodia density increases, suggesting unidentified 
mechanisms regulate Ena/VASP function. 
We identified murine TRIM9 as a direct binding partner of DCC that regulates cortical axon 
branching in response to netrin141. Like Ena/VASP, TRIM9 localizes to filopodia tips in cortical 
neurons. The interaction between TRIM9 and DCC is conserved in invertebrates, where the TRIM9 
ortholog is required for netrin responses194,195. Their similar localization and requirement in netrin 
responses suggests that TRIM9 and Ena/VASP may cooperate within filopodia in response to netrin. 
TRIM9 is a member of the tripartite motif (TRIM) family of E3 ubiquitin ligases, which mediate 
covalent linkage of ubiquitin to substrates. Ubiquitin addition can trigger proteasomal degradation or 
alternatively modify substrate localization, trafficking or function196–198. Additionally, ubiquitination can 
be reversed by deubiquitinases (DUBs199). Although TRIM9 exhibits ligase activity200, its substrates 
and the consequences of its ligase activity are unknown. 
Here we show that TRIM9, which lacks an FP4 motif, exhibits a distinct mode of direct 
interaction with the EVH1 domain of Ena/VASP proteins. We find that VASP is ubiquitinated in the 
presence of TRIM9, but not Mena or EVL, and that VASP is deubiquitinated upon netrin stimulation. 
Although neither TRIM9 nor netrin treatment altered the stability of VASP protein, they differentially 
altered VASP localization and mobility at filopodia tips. Inhibition of DUB activity or expression of a 
non-ubiquitinatable VASP mutant supports the hypothesis that TRIM9-mediated ubiquitination alters 
VASP localization, filopodial stability, and filopodia density. We show that deletion of TRIM9 disrupts 
attractive axon turning within a netrin gradient, whereas a gradient of DUB inhibition, and thus of 
ubiquitination, was sufficient to repulse axons. We propose that TRIM9 function and a netrin gradient 
create a gradient of VASP ubiquitination across the growth cone, and thus spatial differences in 






2.1 Identification of TRIM9 as a novel Ena/VASP interaction partner 
A yeast two-hybrid screen using an embryonic mouse brain cDNA library and EVL as bait 
identified four independent clones containing sequences corresponding to amino acids 45-532 of 
TRIM9. TRIM proteins share a conserved N-terminal TRIM motif with an E3 ubiquitin ligase RING 
domain, 1-2 BBox domains, and a coiled-coil (CC) domain that mediates homo- and hetero-
multimerization (Fig1A). In TRIM9, the TRIM motif is followed by a COS box, fibronectin type III (FN3) 
and SPRY domains201. Since the SPRY domain of TRIM9 directly interacts with DCC141, the 
interaction between Ena/VASP and TRIM9 may link netrin to filopodia. 
 
2.2 TRIM9 binds and colocalizes with Ena/VASP proteins in cortical neurons 
To confirm the interaction between TRIM9 and Ena/VASP predicted by yeast two hybrid, we 
incubated GST-tagged TRIM9 variants in embryonic mouse brain lysate (Fig1A). A GST-tagged 
protein containing the BBox-CC-COS domains of TRIM9 (BBCCC) bound endogenous Mena and 
VASP, whereas GST did not. GST-TRIM9 and a variant lacking the SPRY domain (ΔSPRY) failed to 
precipitate Mena or VASP. Even though TRIM9 lacks an FP4 motif, GST-EVH1 domains of all three 
Ena/VASP members precipitated endogenous TRIM9 from embryonic brain lysate, but GST-Pro or 
GST-EVH2 did not (Fig1B). This pattern of binding may suggest conformational changes or post-
translational modifications in TRIM9 or Ena/VASP proteins are required to permit binding, or that 
terminal domains of the proteins modulate binding. However, direct binding assays demonstrated that 
GST-BBCCC was able to precipitate His-EVH1 (Fig1C). This interaction was maintained with GST-
BBCC and GST-CC, but not GST-BBox, indicating that the CC domain is the minimal binding region 
of TRIM9. We confirmed this observation with precipitation of Myc-TRIM9 variants expressed in 
HEK293 cells (Fig1D). GST-EVH1 precipitated Myc-TRIM9 and Myc-TRIM9 lacking the RING domain 
(TRIM9ΔRING) but not Myc-TRIM9 lacking the CC motif (TRIM9ΔCC). Tes and Abi are the only 
identified EVH1 interacting proteins that lack an FP4 motif202,203. Unlike Tes and Abi, which exhibit 
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competitive binding with FP4, His-EVH1 continued to interact with GST-CC in the presence of a 10-
fold excess of FP4 (Fig1E). Although these biochemical assays confirm the direct binding predicted 
by the yeast-two hybrid screen, we were unable to co-immunoprecipitate endogenous TRIM9 and 
VASP, suggesting this interaction may be regulated or transient in vivo. 
TRIM9 and Ena/VASP localize to the tips of filopodia, which decorate the periphery of 
neuronal growth cones92,141. TRIM9ΔCC fails to localize to filopodia tips141, suggesting the interaction 
with Ena/VASP proteins may be required for TRIM9 tip localization. Immunocytochemistry of 
endogenous VASP (Fig1F) or Mena (Fig1SA) with Myc-tagged TRIM9 in embryonic mouse cortical 
neurons revealed limited colocalization within filopodia. The observed colocalization coefficient was 
lower than typically reported (Fig1G, Obs ~0.2), but greater than measured following pixel 
randomization (Rand, p<.05), suggesting only a subset of proteins colocalized within filopodia. Live-
cell imaging via total internal reflection fluorescence (TIRF) microscopy revealed transient 
colocalization of mCherry-TRIM9 and GFP-VASP at filopodia tips (Fig1H, MovieS1). Transient 
interaction often occurs between E3 ligases and substrates. Consistent with this, a mutant lacking the 
ligase domain (TRIM9ΔRING) exhibited prominent colocalization with GFP-VASP (MovieS2). GFP-
Mena also colocalized with TRIM9 in dynamic filopodia (FigS1C, MovieS3), although Mena lacked 
distinct tip localization. 
 
2.3 TRIM9 ubiquitinates VASP but not Mena or EVL 
We first used HEK293 cells to determine if Ena/VASP proteins were ubiquitinated in the 
presence of TRIM9; however endogenous TRIM9 complicated these experiments. Therefore we 
generated TRIM9-/- cells via CRISPR/Cas genome editing (Fig2A). Clone 3 contained mutations in 
both TRIM9 alleles and had no detectable TRIM9, whereas clone 1 exhibited partial expression 
(Fig2A). We expressed HA-DCC, GFP-VASP and FLAG-ubiquitin in 293-WT (TRIM9+/+) and clone 3 
(TRIM9-/-) cells. Upon immunoprecipitating GFP-VASP, in addition to the expected 75kDa band, we 
observed a ~25kDa heavier GFP band that co-migrated with ubiquitin in TRIM9+/+ cells, indicative of 
VASP ubiquitination (Fig2B). Either netrin stimulation or deletion of TRIM9 reduced GFP-VASP 
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ubiquitination (p<.05), suggesting TRIM9 ubiquitinated VASP, and this modification was lost in the 
presence of netrin. The netrin-dependent decrease in VASP ubiquitination was not observed in cells 
lacking HA-DCC (Fig S2A), indicating that loss of ubiquitination occurred downstream of DCC. 
Although Ena/VASP proteins are often functionally redundant, we did not detect ubiquitination of 
GFP-Mena or GFP-EVL (Fig S2B-C). To confirm ubiquitination of VASP was relevant to cortical 
neurons, we performed similar experiments by immunoprecipitating endogenous VASP and blotting 
for ubiquitin. A higher molecular weight VASP+ band that co-migrated with ubiquitin was similarly lost 
upon netrin treatment or deletion of Trim9 (Fig2C). Although ubiquitination can decrease substrate 
half-life via proteasomal-degradation, we observed no change in VASP protein in embryonic cortical 
neurons cultured from Trim9+/+ or Trim9-/- mice (Fig2D). Furthermore neither netrin stimulation nor 
proteasome inhibition altered VASP protein levels. Without evidence for degradation of VASP, we 
hypothesized that VASP was deubiquitinated in the presence of netrin. To test this, we inhibited DUB 
activity with PR-619, a cell permeable inhibitor of DUBs that increases levels of ubiquitinated proteins 
with little inhibitory effect on other proteases204,205. DUB inhibition blocked the netrin-dependent 
reduction in VASP ubiquitination in cortical neurons (Fig2E). Based on bioinformatic predictions and 
conservation across VASP orthologs, we mutated single lysines to arginine within VASP to identify 
ubiquitination sites, but this approach failed to reduce VASP ubiquitination (FigS2D). Since E3 ligases 
can promiscuously ubiquitinate lysine residues on substrates206, we combined nine lysine mutations 
based on bioinformatic analysis and mass spectrometry studies207. This mutant (VASP K-R) exhibited 
significantly reduced ubiquitination (Fig2F). Together these results suggest that TRIM9 specifically 
ubiquitinates VASP and that VASP is deubiquitinated upon netrin treatment. E3 ligases and their 
substrates typically interact transiently208; this may account for the low, transient colocalization 
(Fig1G) of these proteins and their inability to co-immunoprecipitate. 
 
2.4 Deletion of Trim9 disrupts growth cone filopodia, netrin response and VASP localization 
To determine if Trim9 regulated filopodia, we compared murine axonal growth cones from 
Trim9+/+ and Trim9-/- embryos (Fig3A). This revealed that Trim9-/- growth cones exhibited increased 
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area, and increased filopodia number, density and length (Fig3B-E, p<.01). Since we previously 
showed that TRIM9 directly interacts with DCC and was important for response to netrin141, we 
investigated growth cone response to netrin stimulation. Following netrin treatment, Trim9+/+ growth 
cones increased filopodia number, density and length (Fig3B-E, p<.01), whereas Trim9-/- growth 
cones (p<.01) were netrin insensitive. Pre-incubation with an antibody that recognizes an epitope 
within the extracellular domain of DCC impeded netrin-dependent increases in filopodia density 
(FigS3A, p=0.93), as previously observed89. This suggests that netrin stimulated increases in filopodia 
are DCC-dependent. However this antibody did not change filopodia density in Trim9-/- growth cones 
(FigS3B), suggesting TRIM9 regulates filopodia density downstream of DCC. To determine if VASP 
localization was sensitive to netrin treatment or TRIM9, we measured VASP intensity relative to 
phalloidin along filopodia. In Trim9+/+ neurons, VASP localized throughout the growth cone and 
accumulated at filopodia tips (Fig3F). Netrin treatment or deletion of Trim9 increased this tip ratio 
more than two fold (p<.01). Expression of MycTRIM9 in Trim9-/- neurons reduced elevated tip 
localization and rescued netrin-dependent increases in VASP tip accumulation (Fig3GH, p<.01). 
MycTRIM9 also accumulated at filopodia tips, but decreased in response to netrin (Fig3I, p<.01). 
Although Mena and EVL accumulated at filopodia tips, both were insensitive to netrin treatment or 
deletion of Trim9 (FigS3C-F). Thus TRIM9 negatively regulates VASP localization to filopodia tips, 
whereas netrin promotes VASP tip localization. 
 
2.5 TRIM9 regulates filopodia density through VASP 
To ensure that excess filopodia in Trim9-/- growth cones required barbed end polymerization 
and thus were conventional, we treated neurons with a low dose of the F-actin capping drug 
cytochalasin D (100 nM CytoD, FigS4A). This blocks filopodia without disrupting growth cone 
extension187,209. As expected, netrin-dependent increases in Trim9+/+ filopodia and excess filopodia in 
Trim9-/- growth cones were blocked by CytoD (FigS4B, p<.005). To further test the specificity of 
TRIM9 function in netrin and DCC-dependent filopodia increases, neurons were treated with 
Fibroblast growth factor 2 (FGF-2), an attractive guidance cue that functions through a distinct 
36 
 
signaling pathway210,211. FGF2 increased filopodia density in both Trim9+/+ and Trim9-/- growth cones 
(p<.05, Fig4AB). Expression of MycTRIM9 in Trim9-/- neurons restored filopodia density and rescued 
netrin sensitivity (Fig4EF, p<.005). Expression of a mutant of TRIM9 that lacks the DCC binding 
domain, Myc-TRIM9ΔSPRY, reduced elevated filopodia, but failed to rescue netrin sensitivity (Fig4F, 
p<.005), although FGF-2 sensitivity remained intact (p<.001, Fig4AB). Together these results suggest 
that TRIM9 functions specifically downstream of netrin, and that the interaction between TRIM9 and 
DCC is required for increases in filopodia density specifically in response to netrin. 
TRIM9ΔRING or TRIM9ΔCC expression did not reduce the excess filopodia of Trim9-/- growth 
cones, suggesting ligase activity and interaction with Ena/VASP proteins were essential to constrain 
filopodia density. Because the CC domain also mediates dimerization of TRIM proteins and the 
interaction between SNAP25 and TRIM9141,212,213, we wanted to confirm that aberrant filopodia in 
Trim9-/- neurons were dependent upon Ena/VASP function. To address whether TRIM9 dimerization 
influenced filopodia density, we attempted to design a TRIM9 variant incapable of dimerization by 
mutating Leu316 within the CC domain to Ala (L316A). However, similar amounts of GFP-TRIM9 co-
immunoprecipitated with MycTRIM9L316A as with MycTRIM9 (Fig4C), indicating this mutation did not 
block dimerization, as a similar mutation does in TRIM25214. However the L316A mutant exhibited 
reduced binding to GST-EVH1 (Fig4D) and did not reduce aberrant filopodia in TRIM9-/- neurons 
(Fig4EF), further supporting the conclusion that TRIM9 interaction with Ena/VASP proteins was 
necessary for constraining filopodia density and TRIM9 dimerization was not sufficient. 
To determine if SNAP25 function was required for the filopodia responses, we used 
Botulinum neurotoxin A (BoNTA) to cleave SNAP25 and block SNAP25-mediated exocytosis215. 
BoNTA treatment had no effect on filopodia density (FigS4CD). In cortical neurons, genetic loss of 
Ena/VASP members blocks filopodia formation, and this is phenocopied by the mis-localization of 
Ena/VASP proteins with a mitochondrial targeting construct attached to an FP4 motif 
(FP4Mito89,187,216). Whereas control EGFP-AP4Mito expressing TRIM9+/+ and TRIM9-/- neurons were 
unaffected, EGFP-FP4Mito expression reduced TRIM9-/- growth cone filopodia (FigS4EF, p<.005), 
indicating the filopodia in TRIM9-/- growth cones required Ena/VASP function. Since this approach 
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sequesters all Ena/VASP proteins, we used siRNA to specifically deplete VASP. Knockdown was 
confirmed by a reduction in VASP immunostaining (Fig4G). VASP siRNA, but not a scrambled control 
(scr) blocked netrin-dependent increases in filopodia density in TRIM9+/+ growth cones and reduced 
elevated filopodia density in TRIM9-/- growth cones (Fig4HI, p<.001). 
 
2.6 Filopodia response to netrin requires VASP ubiquitination and DUB activity 
Based on our observations suggesting that TRIM9-mediated ubiquitination inhibited VASP 
localization and reduced filopodia density, we predicted that the deubiquitination of VASP upon netrin 
treatment would be required for increased filopodia density. Inhibition of DUB activity with PR-619 
blocked netrin-dependent increases in filopodia density in Trim9+/+ growth cones but did not alter 
filopodia density in Trim9-/- growth cones (Fig5AB). Accordingly, although expression of GFP-VASP 
did not alter filopodia density in Trim9+/+ growth cones, expression of GFP-VASP K-R increased 
filopodia density and blocked netrin response (Fig5CD), suggesting non-ubiquitinated VASP was 
sufficient to increase filopodia. In contrast expression of GFP-VASP or GFP-VASP-K-R in Trim9-/- 
neurons did not alter filopodia density (FigS5). TIRF imaging of GFP-VASP K-R and mCherry-VASP 
in Trim9+/+ neurons demonstrated that VASP K-R exhibited significantly increased filopodia tip 
localization compared to wildtype VASP upon PR-619 treatment (Fig5EF). Together, these data 
confirm that TRIM9-mediated ubiquitination inhibits VASP localization to filopodia tips and VASP 
ability to increase filopodia density. 
 
2.7 TRIM9 decreases filopodia stability  
We hypothesized that TRIM9-mediated ubiquitination altered VASP function, which 
modulated filopodia density. To test this hypothesis, we performed kymography of individual filopodia 
(Fig6A) in Trim9+/+ and Trim9-/- neurons expressing mCherry (MovieS4). Although there were minor 
changes in retraction dynamics in the absence of Trim9, filopodial protrusion was unaltered (FigS6A-
C). Netrin treatment increased filopodia lifetimes in Trim9+/+ growth cones (Fig6B, p<.005) and 
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reduced the frequency of filopodia formation and loss (FigS6D, p<.05). Trim9-/- filopodia exhibited 
elevated lifetimes (p<.05) and were insensitive to netrin treatment, supporting the hypothesis that 
TRIM9-mediated ubiquitination altered VASP function. Further, treatment with PR-619 decreased 
filopodial lifetime and blocked netrin response in Trim9+/+ neurons (p<.05) without affecting Trim9-/- 
filopodia. Expression of VASP K-R in the presence of endogenous VASP in Trim9+/+ neurons 
produced an intermediate phenotype not significantly different from control or netrin-treated Trim9+/+ 
neurons or Trim9-/- neurons (Fig6C). Thus filopodial stability and number were decreased by TRIM9-
mediated ubiquitination of VASP. 
 
2.8 TRIM9 and ubiquitination alter VASP dissociation from filopodia tips 
If TRIM9-mediated ubiquitination alters VASP function and localization, VASP dynamics at 
filopodia tips should be affected. The dissociation of GFP-VASP from filopodia tips was measured by 
fluorescence recovery after photobleaching (FRAP, Fig6D, MovieS5) fit to a single exponential 
(Fig6E). Loss of Trim9 accelerated GFP-VASP recovery (smaller t1/2, Fig6F, p<.05), suggesting faster 
VASP dissociation from tips. Following DUB inhibition, VASP recovery slowed in Trim9+/+ filopodia 
(p<.05), but not in Trim9-/- filopodia (p=.61). Netrin accelerated recovery only in Trim9+/+ filopodia 
(p<.05). Fluorescence recovery of VASP K-R was faster than wildtype VASP (p<.05), and not netrin 
sensitive. Thus netrin stimulation, blocking VASP ubiquitination, or loss of Trim9 accelerated VASP 
dissociation from filopodia tips, whereas DUB inhibition in the presence of Trim9 slowed dissociation. 
This suggested that ubiquitination of VASP by TRIM9 slowed VASP dissociation from filopodia tips. 
Differences in recovery rate were likely not due to delayed diffusion within filopodia, as FRAP t1/2 in 
lamellipodia was similar to that of Trim9+/+ untreated filopodia tips, and not significantly different 
between genotypes or treatments (FigS6E). The percent of GFP-VASP FRAP was unchanged 





2.9 TRIM9 is required for axon turning toward netrin 
We hypothesized that increased filopodia stability and density in Trim9-/- neurons might 
disrupt axonal response to netrin, which we first tested in cortical explants (Fig7A). Consistent with 
our previous findings that deletion of Trim9 or longer term netrin treatment did not significantly alter 
the length of cortical axons141, neurite outgrowth was unaltered by loss of Trim9 or the presence of 
netrin (Fig7A). Trim9+/+ explants exhibited biased outgrowth toward netrin, and this response was 
absent in Trim9-/- explants (Fig7A, p<.05). To determine if Trim9 was required for netrin-dependent 
axon turning, we utilized our recently designed micropass gradient device to create and maintain a 
stable netrin gradient (Fig7B217). Axons extended through microgrooves into a fluidically-isolated axon 
viewing area containing a gradient of netrin and fluorescent dextran. Trim9+/+ axons turned toward 
higher netrin concentrations, but did not exhibit turning in a dextran gradient (Fig7CD, p<.01, 
MovieS6). Netrin-dependent turning was absent in Trim9-/- axons (Fig7CE, p<.05). We hypothesized a 
netrin gradient created a gradient of deubiquitinated VASP across the growth cone. To determine if a 
gradient of TRIM9-mediated ubiquitination was sufficient to cause axon turning, we established a 
gradient of PR-619. This repulsed Trim9+/+ axons down the PR-619 gradient (Fig7C,F, p<.005, 
MovieS7), but failed to induce turning of Trim9-/- axons. Netrin-dependent axon turning was also 
absent in Trim9+/+ axons overexpressing VASP K-R mutant (turning angle of -23.94 ± 23.62, n=5 
axons). 
To see if defects in cortical projections occurred in the absence of TRIM9 in vivo, we crossed 
Trim9fl/fl mice to Nex-Cre/TauloxP-STOP-loxPGFP mice to delete Trim9 and express GFP in postmitotic 
cortical neurons249. We compared GFP+ cortical projections in Nex-Cre/TauloxP-STOP-loxPGFP/Trim9+/+ 
and Nex-Cre/TauloxP-STOP-loxPGFP/Trim9fl/fl littermates (Fig7G). Trim9-/- mice exhibit thickening of the 
corpus callosum141. We observed similar thickening in Nex-Cre/Trim9fl/fl mice (green box, 14 ± 3.3%, 
p<0.05). A subset of cortical axons extend to the internal capsule (IC186,218). The length of cortical 
fibers projecting through the IC was increased by deletion of Trim9 (yellow box, 32 ± 2.3%, p<0.005), 
suggesting these axons extended past their target. There was also an increased amount of GFP+ 
fibers within the paraventricular hypothalamic nuclei (PVHTN, red box, 28.5 ± 8%, p<0.05), 
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suggesting that cortical axons219 were misguided to the PVHTN. In contrast there was no alteration in 
the fimbria (FigS7A, p=0.7). Thus deletion of Trim9 induces specific cortical projection defects in vivo. 
Since filopodia are also dendritic spine precursors and VASP affects dendritic spines220,221, we 
investigated cortical spines in Thy1-GFP/Trim9+/+ and Trim9-/- littermates. Consistent with an early 
axonal role for TRIM9 in filopodia, there were no changes in cortical spine density (FigS7B). 
 
3 Discussion 
3.1 TRIM9-mediated ubiquitination modulates VASP function within growth cone filopodia 
during netrin-dependent axon guidance 
The filopodia tip complex contains cytoskeletal regulatory proteins that modulate filopodial 
growth and stability90, but how this complex responds to extracellular cues is unknown. We propose 
that ubiquitination and deubiquitination of cytoskeletal proteins is a rapid, reversible means to alter 
the cytoskeleton. Here we demonstrate that VASP is ubiquitinated in the presence of Trim9, which 
reduces the localization and dynamics of VASP at filopodia tips, as well as reduces filopodia stability, 
suggesting TRIM9 acts as a filopodia “off-switch”. The low stoichiometry of VASP ubiquitination 
indicates a small amount of modified VASP can alter filopodia stability. Tetramers of VASP regulate 
the polymerization and bundling of multiple actin filaments222; an intriguing possibility is that 
ubiquitination of a single VASP protein within a tetramer is sufficient to poison the function of a 
Ena/VASP tetramer and inhibit the elongation of multiple filaments comprising a filopodium. Further, 
the colocalization of TRIM9 and VASP at filopodia tips may increase the local concentration of 
ubiquitinated VASP to produce filopodial-specific consequences. Consistent with this, we observed 
altered VASP mobility at filopodia tips that were dependent upon VASP ubiquitination status and 
associated with the changes in filopodial stability. In contrast, VASP mobility along the lamellipodial 
veil was unchanged by netrin or loss of Trim9. This supports the hypothesis that ubiquitinated VASP 
may localize specifically within filopodia where it alters VASP function and filopodial stability. 
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Whereas ubiquitination often promotes proteasome-mediated degradation, there are 
increasing examples of ubiquitination altering substrate localization and function196,198. The shift in 
VASP molecular weight indicates ~3 ubiquitins were conjugated to VASP. Since mutation of multiple 
lysines was required to reduce VASP ubiquitination, we hypothesize that ubiquitination of VASP can 
occur on a number of lysine residues. However, we found no evidence for VASP degradation, 
suggesting ubiquitins were removed by an unidentified DUB following netrin treatment. This DUB 
therefore acts as a filopodia “on-switch”. Consistent with a model that ubiquitination inhibits filopodial 
stability and density, netrin-dependent increases in filopodia required DUB activity. The requirement 
for Trim9 in netrin-dependent axon guidance along with our findings that a gradient of DUB inhibition 
was sufficient to induce axon turning in the presence of Trim9, suggests that whereas TRIM9 
ubiquitinates VASP, a netrin gradient creates a gradient of VASP deubiquitination across the growth 
cone, which produces a spatial gradient of filopodial stability required for axon turning toward netrin. 
Although netrin-1 is typically described as a soluble axon guidance cue, there is evidence that netrin-
1 functions as a substrate bound guidance cue61,63. Our findings are consistent with a requirement for 
TRIM9 during cortical axon turning in response to netrin, whether netrin is in a soluble or bound state. 
 
3.2 TRIM9 coordinates cytoskeletal dynamics and membrane delivery during axonal 
development 
We recently demonstrated that TRIM9 interacts with the tSNARE SNAP25 and regulates 
exocytosis required for netrin-dependent axon branching141. Neuritogenesis, axon branching and 
guidance involve protrusion and expansion of the plasma membrane, which require cytoskeletal 
dynamics and membrane addition14,140,141,187,216. Loss of Trim9 is associated with elevated filopodia 
stability, exocytosis and axon branching. The interactions with DCC, VASP and SNAP25 poise 
TRIM9 to spatially and temporally coordinate robust netrin-dependent membrane protrusion and 
membrane delivery. This is accomplished by constraining the function of VASP and SNAP25 in the 
absence of netrin: for VASP by ubiquitination, and for SNAP25 by an interaction that competes with 
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SNARE complex assembly and vesicle fusion. It is likely that TRIM9-mediated regulation of both 
exocytosis and filopodia is involved in both netrin-dependent axon branching and guidance. 
 
3.3 Regulation of filopodia and axon guidance by post-translational modification 
The ubiquitination of VASP mediated by TRIM9 is inhibited or reversed following netrin 
treatment. This would result in dis-inhibition of filopodia and localized netrin responses. TRIM9 
performs autoubiquitination in vitro200, and may mediate its own inhibition or removal. Alternatively, 
since TRIM9 interacts with VASP through its dimerization domain, a change in TRIM9 conformation 
that promotes dimerization at the expense of interaction with VASP could occur. Consistent with this, 
the TRIM9 mutant compromised in Ena/VASP binding but not dimerization failed to constrain 
filopodia. Netrin-dependent dimerization of DCC81 may promote TRIM9 dimerization. Alternatively, 
TRIM9 ligase activity may be masked by a competing DUB in the presence of netrin, consistent with 
our findings. Although the DUB is unknown a broad spectrum DUB inhibitor did not alter filopodia 
density and VASP mobility in Trim9-/- neurons, supporting our hypothesis that TRIM9-mediated 
ubiquitination of VASP is a mechanism of filopodia regulation. Although we do not know how 
ubiquitination alters VASP function at the barbed end, our finding that filopodia lifetimes but not 
protrusion dynamics were altered by deletion of Trim9 suggests that VASP ubiquitination may alter 
the anti-capping function of VASP or block the processive polymerase activity of VASP, effectively 
turning VASP into a capping protein. 
VASP is also phosphorylated by cAMP-dependent protein kinase downstream of netrin and 
DCC89. Phosphorylation and ubiquitination often collaborate to alter protein function223, which may be 
the case for VASP, or these modifications may be mutually exclusive. A relationship between 
ubiquitination and phosphorylation may explain our result that VASP mobility showed a trend toward 
decreasing in Trim9-/- filopodia tips treated with netrin. If this response were phosphorylation-
dependent, it may have been masked in Trim9+/+ filopodia by VASP deubiquitination. The pairing of 
ubiquitination and phosphorylation to alter VASP localization and function may promote VASP 
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function in a narrow spatiotemporal window constrained by the presence of netrin, and may explain 
why loss of Trim9 or loss of VASP ubiquitination did not completely phenocopy netrin stimulation. 
In many instances, a single Ena/VASP member compensates for loss of Ena/VASP 
function187,224. Although TRIM9 interacts with the EVH1 domain of all three Ena/VASP proteins in 
vitro, we detected ubiquitination of VASP, not Mena or EVL, in the presence of Trim9. Since VASP 
exhibits unbiased tetramerization with itself, Mena and EVL225, ubiquitination and inhibition of VASP 
may indirectly impact Mena or EVL function, however we saw no evidence of changes in Mena or 
EVL localization. The phenotypes caused by expression of VASP K-R support this possibility and 
may explain why modulation of VASP was sufficient to alter filopodia and axon guidance. In light of 
increasing examples of unique functions and interactions for Mena and VASP221,226,227, TRIM9-
mediated regulation of VASP alone may be sufficient to induce the observed changes in filopodia. 
However, since ubiquitin ligases often have multiple substrates, TRIM9 may have additional 
substrates involved in modulating neuronal morphology, possibly also localized at filopodia tips. 
 
3.4 Conservation and divergence of the netrin pathway in axon guidance 
The invertebrate paralogs of netrin, DCC, VASP and TRIM9 all function in axon 
guidance5,25,88,194,195,228. Given this and conserved domain organization of TRIM9 and VASP 
orthologs, the mechanism uncovered here may link invertebrate TRIM9 and VASP orthologs. The 
phenotypes associated with loss of TRIM9 however are not conserved. Loss of madd2 in C. elegans 
phenocopied loss of unc-6 (netrin) or unc-40 (DCC194). Similar commissural phenotypes were 
observed in D. Melanogaster with loss of function mutations in dTRIM9, netrin or frazzled (DCC195). In 
contrast, the corpus callosum agenesis caused by deletion of Nnt1 or Dcc26,65 or lack of the IC and 
corpus callosum associated with deletion of Ena/VASP genes188 are in contrast to the thickened 
corpus callosum and longer IC associated with deletion of Trim9. Despite Trim9 having the highest 
sequence homology with the single invertebrate class I TRIM195, the contrasting phenotypes indicate 
divergence of TRIM9 function. Whether another class I TRIM is the functional mammalian ortholog 
remains to be seen. 
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CHAPTER 2 FIGURES 
 
Figure 1: TRIM9 is a brain-enriched Ena/VASP interaction partner: A-B) Binding assays with 
purified GST fusion proteins incubated in E15.5 brain lysate. Coomassie stained gels of recombinant 
proteins shown in lower panels. A) GST-BBox-coiled-coil-COS (BBCCC) of TRIM9 precipitates 
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endogenous Mena and VASP. B) The GST-EVH1 domain of Mena, VASP and EVL interacts with 
endogenous TRIM9. C) In vitro binding assay showing that GST-Coiled Coil (CC) domain of TRIM9 
directly binds His-EVH1 domain of VASP. D) Binding assay showing that GST-EVH1 precipitates 
Myc-TRIM9 and Myc-TRIM9ΔRING from cell lysate, but not Myc-TRIM9ΔCC. E) A 10-fold excess of 
FP4 containing peptide does not block the CC-EVH1 interaction. F) Axonal growth cones of control 
and netrin-treated cortical neurons stained for VASP (green), MycTRIM9 (red) and phalloidin (blue). 
G) Quantification of Pearson’s correlation coefficient within filopodia (Obs=Observed measurements, 
Rand=pixels from one image randomized). Squares represent means +/- 95% CI. H) Montage of 
TIRF images of GFP-VASP (red) and mCherry-TRIM9 (green). Arrowheads denote filopodia tips in 






Figure 2: VASP ubiquitination occurs in the presence of TRIM9 and is lost following netrin 
treatment: A) Immunoblot for TRIM9 and GAPDH in E15.5 brain lysates, HEK293 lysates: TRIM9+/+ 
(WT), TRIM9+/- (clone 1) and TRIM9-/- (clone 3). B) Input and GFP-VASP immunoprecipitation (IP) 
from ubiquitination assay immunoblotted (IB) for GFP, ubiquitin and GAPDH. Shown are GFP-VASP 
(75kDa) in TRIM9+/+ and TRIM9-/- cell lysates and ~25kDa heavier VASP band present in TRIM9+/+ 
lysate that co-migrates with ubiquitin (red arrowheads). Plot shows quantification of VASP 
ubiquitination. C) Endogenous VASP ubiquitination in Trim9+/+ and Trim9-/- neurons at 2DIV. A higher 
molecular weight VASP+ band (red arrowhead) that co-migrates with ubiquitin is seen in Trim9+/+ 
cortical neurons. D) Endogenous VASP in Trim9+/+ and Trim9-/- control neurons or neurons treated 
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with MG132 and/or 600 ng/ml netrin. IB for VASP (50kDa) and GAPDH. No difference in VASP 
protein levels detected between genotypes or treatment conditions. E) Endogenous VASP 
ubiquitination in Trim9+/+ cortical neurons treated with netrin or netrin and 4 µM PR-619. Elevated 
ubiquitination is observed upon PR-619 treatment. F) Ubiquitination assay and quantification of 
wildtype VASP and VASP K-R mutant. The VASP K-R mutant exhibits a reduction in the ~25kDa 
heavier VASP band that co-migrates with ubiquitin (red arrowheads). All error bars represent SEM. 




Figure 3: Deletion of TRIM9 increases growth cone size and filopodia density and alters VASP 
localization to filopodia tips: A-F) Images and quantification of axonal growth cones from control 
and netrin-treated Trim9+/+ and Trim9-/- neurons, stained for phalloidin (red, left), VASP (green, 
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middle) and βIII tubulin (blue, merge). Quantification of B) growth cone area +/-SEM, C) growth cone 
filopodia number +/-SEM, D) density of growth cone filopodia +/-SEM, E) filopodia length +/-SEM, and 
F) VASP fluorescence intensity relative to phalloidin +/- 95% CI from the tip of filopodia into growth 
cone. G-I) Images and quantification of Trim9-/- growth cones stained for VASP (red), phalloidin 
(blue), and Myc (green, Myc or MycTRIM9). H) VASP fluorescence intensity normalized to phalloidin 
+/- 95% CI from filopodia tip into growth cone. Expression of TRIM9 rescues VASP localization. I) 
MycTRIM9 fluorescence intensity normalized to phalloidin +/- 95% CI from filopodia tip into growth 




Figure 4: TRIM9 constrains filopodia density through VASP: A-B) Images and quantification of 
filopodia +/-SEM in axonal growth cones from control and FGF2-treated Trim9+/+ and Trim9-/- cortical 
neurons expressing Myc or MycTRIM9ΔSPRY, stained for Myc (green), βIII tubulin (blue) and 
phalloidin (red). C) TRIM9 dimerization assay IB for GFP-TRIM9 (IB:GFP) co-IP with Myc-TRIM9 
variants (IP:Myc, IB:Myc). GAPDH is loading control. Numbers indicate levels of coIP GFP-TRIM9 +/-
SEM. D) Binding assay immunoblot showing MycTRIM9 and TRIM9-L316A interaction with GST-
EVH1. Numbers denote relative levels of MycTRIM9 variant precipitated by GST-EVH1 beads +/-
SEM. E-F) Images and quantification of filopodia +/-SEM in axonal growth cones from control and 
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netrin-treated Trim9+/+ and Trim9-/- neurons stained for Myc (blue: Myc, Myc-TRIM9 or TRIM9 
mutants), βIII tubulin (green) and phalloidin (red). *denotes significance compared to Trim9+/+ and 
*denotes significance compared to Trim9-/-. G) Representative images of Trim9-/- neurons transfected 
with scrambled (scr) or VASP siRNA, along with GFP to identify transfected cells. GFP (blue), VASP 
immunostaining (green), phalloiding (red). H-I) Images and quantification of axonal growth cone 
filopodia +/-SEM from control and netrin-treated Trim9+/+ and Trim9-/- cortical neurons transfected with 





Figure 5: VASP deubiquitination is required for netrin-dependent increases in filopodia 
density. A-B) Images and quantification of filopodia +/-SEM in axonal growth cones from control, PR-
619 netrin or PR-619/netrin treated Trim9+/+ and Trim9-/- neurons, stained for VASP (green), III 
tubulin (blue) and phalloidin (red). C-D) Images and quantification of filopodia +/-SEM in Trim9+/+ 
growth cones expressing GFP, GFP-VASP or GFP-VASP K-R, stained for GFP (blue), βIII tubulin 
(green) and phalloidin (red). E) Trim9+/+ filopodia containing GFP-VASP K-R (green) and mCherry-
VASP (red) before and after PR-619 treatment. F) Ratio of fluorescence intensity at filopodial 
tip:filopodial base of GFP-VASP K-R or mCherry-VASP +/-SEM in PR-619 treated Trim9+/+ neurons. 




Figure 6: Ubiquitination of VASP reduces filopodia lifetime and the rate of VASP dissociation 
from filopodia tips: A) Example kymographs of axonal growth cone filopodia from TRIM9+/+ and 
TRIM9-/- neurons expressing mCherry. B) Filopodial lifetimes +/-SEM in control, netrin, and PR-619 
treated TRIM9+/+ and TRIM9-/- neurons and TRIM9+/+ neurons expressing GFP-VASP K-R. C) 
Cumulative fraction plot of filopodial lifetime demonstrating intermediate phenotype of VASP K-R 
expressing neurons. D) Image montage of GFP-VASP FRAP at a filopodium tip. Bleach denoted by 
dashed region, time before and after bleaching in seconds. E) Example of fluorescence intensity data 
fit to a single exponential (red line), depicting percent fluorescence recovery and t1/2 of fluorescence 
recovery. F) Fluorescence recovery halftime (t1/2) +/-SEM and G) mean % fluorescence recovery +/-
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SEM for indicated conditions. (See also Movies S4, S5, FigS6). VASP K-R was expressed in 






Figure 7: Deletion of TRIM9 disrupts axon guidance: A) Trim9+/+ but not Trim9-/- cortical explants 
exhibit biased neurite outgrowth (βIII tubulin staining) towards netrin (arrowhead). B) Schematic 
representation of a micropass gradient device with zoomed view of the axon viewing area depicting 
the dextran gradient and axon growth into the viewing area, arrows indicate direction of fluid flow. C) 
Turning angles for Trim9+/+ axons in a dextran gradient, dextran/netrin or dextran/PR-619 gradient 
and Trim9-/- axons in a dextran/netrin gradient or dextran/PR-619 gradient. D) DIC images (top) 
showing a Trim9+/+ axon turning towards a higher netrin concentration, as seen by the gradient in 
epifluorescence images (bottom). The red arrowhead denotes the front of the growth cone, the red 
box denotes the area for which epifluorescence is shown. Time in hours:minutes. Quantification of 
dextran fluorescence intensity across the region within each epifluorescence image (red), x and y 
axes are kept constant to demonstrate the stability of the gradient over time. E) Trim9-/- axon 
(arrowhead) failing to turn toward the higher netrin concentrations, gradient displayed as in D. F) 
Trim9+/+ axon (arrowhead) turning down a PR-619 gradient, displayed as in D. G) Regions of interest 
(ROI) from coronal sections of Nex-Cre/TauloxP-stop-loxPGFP/Trim9fl/fl and Trim9+/+ littermates reveal 
aberrant cortical axon projections patterns in the corpus callosum (green dashed box), the 
paraventricular hypothalamic nuclei (red), and the internal capsule (yellow). Green is GFP, red and 
blue demarcate GFAP in separate littermate pairs. The locations of ROIs and associated defects are 
denoted in the coronal schematic, n=3 littermate pairs. (See also Movies S6-7, FigS7) 
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CHAPTER 2 SUPPLEMENTAL FIGURES 
 
Figure S1, related to Figure 1: TRIM9 and Mena exhibit minimal colocalization: A) Axonal 
growth cones of control and netrin-treated cortical neurons stained for Mena (red), MycTRIM9 (green) 
and phalloidin (blue). B) Quantification of Pearson’s Correlation Coefficient within filopodial regions 
(Obs = Observed measurements, Rand = pixels from one image randomized). Squares represent 
means +/- 95 % CI. C) Montage of TIRF images of GFP-Mena and mcherry-TRIM9, time in seconds. 




Figure S2, related to Figure 2: Mena and EVL are not ubiquitinated by TRIM9 and VASP 
ubiquitination is not lost in the absence of DCC and is not reduced in single, double or triple 
VASP lysine mutants: A) GFP-VASP ubiquitination and quantification +/- SEM in the absence of 
DCC overexpression. No change in ubiquitination is detected upon netrin treatment. B) Mena 
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ubiquitination assay and quantification +/- SEM in TRIM9+/+ and TRIM9-/- HEK cells, GFP-Mena (~150 
kDa). C) EVL ubiquitination assay and quantification +/- SEM in TRIM9+/+ and TRIM9-/- HEK cells, 
GFP-EVL (~75 kDa). D) VASP ubiquitination assay with wildtype VASP and VASP K252R, 
K283,286R, K321R, K283,286,321R mutants. These mutants do not exhibit a reduction in the 






Figure S3, related to Figure 3: TRIM9 regulation of growth cone filopodia occurs downstream 
of DCC: A-B) Images and quantification of filopodial density +/- SEM in Trim9+/+ and Trim9-/- cortical 
growth cones treated with netrin, a DCC function blocking antibody (DCC Ab) or both. (+N/U: netrin-
treated vs. untreated; Ab+N/Ab U: same comparison after pretreatment with DCC function blocking 
antibody; Ab/U: untreated vs. untreated after pretreatment with DCC antibody). C) Axonal growth 
cones from control and netrin-treated Trim9+/+ and Trim9-/- cortical neurons, stained for Mena (green), 
βIII tubulin (blue) and phalloidin (red). D) Mena fluorescence intensity normalized to phalloidin +/- 
95% CI from the tips of filopodia into the growth cone. E) Axonal growth cones from control and 
netrin-treated Trim9+/+ and Trim9-/- cortical neurons, stained for GFP-EVL (green), βIII tubulin (blue) 
and phalloidin (red). F) GFP-EVL fluorescence intensity normalized to phalloidin +/- 95% CI from the 






Figure S4, related to Figure 4: TRIM9-dependent filopodia density regulation is cytoskeletal 
and specific to netrin-1: A-B) Images and quantification of filopodia density +/- SEM in axonal 
growth cones from control (DMSO), CytoD, netrin or CytoD/netrin treated Trim9+/+ and Trim9-/- 
neurons, stained for βIII tubulin (green) and phalloidin (red), n=2. C-D) Images and quantification of 
axonal growth cone filopodia density +/- SEM in control and netrin-treated Trim9+/+ and Trim9-/- 
cortical neurons pre-treated with either media or botulinum toxin A (BoNTA), stained for phalloidin. E-
F) Images and quantification +/- SEM of axonal growth cone filopodia density from control and netrin-
treated Trim9+/+ and Trim9-/- cortical neurons transfected with GFP-AP4Mito or GFP-FP4Mito, stained 





Figure S5, related to Figure 5: Filopodia density is not increased by VASP overexpression in 
the absence of Trim9: A) Axonal growth cones from control and netrin-treated Trim9-/- cortical 
neurons expressing GFP, GFP-VASP or GFP-VASP K-R. B) Growth cone filopodia density +/- SEM 






Figure S6, related to Figure 6: Filopodial protrusion dynamics are not regulated by TRIM9: A) 
The rate of filopodial tip protrusion and retraction +/- SEM, the B) duration of time +/- SEM and C) 
percentage of time +/- SEM spent protruding, retracting or pausing measured from kymographs of 
growth cone filopodia, as shown in Figure 6. D) Frequency of filopodial formation and loss +/- SEM in 
Trim9+/+ and Trim9-/- neurons before and after treatment with netrin. E) FRAP t1/2 +/- SEM of GFP-





Figure S7, related to Figure 7: The fimbria and density of dendritic spines are not altered by 
deletion of Trim9: A) Coronal sections from 5 week old Nex-Cre/TauloxP-stop-loxPGFP/Trim9fl/fl and 
Trim9+/+ littermates, demonstrating that the width of the fimbria does not significantly change between 
littermates, n=3 pairs of littermates, p=0.7. B) Example images of spines along a dendrite of GFP+ 
pyramidal cortical neurons from coronal sections of Thy1-GFP Trim9+/+ and Trim9-/- P21 mice brains. 
Mean spine density +/- SEM is reported. 
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CHAPTER 3: MAMMALIAN TRIM67 FUNCTIONS IN BRAIN DEVELOPMENT AND BEHAVIOR‡ 
1 Introduction 
E3 ubiquitin ligases mediate covalent attachment of ubiquitin to specific substrates. This 
posttranslational modification targets substrates for degradation or affects substrate localization, 
interactions, or function 229,230. In developing neurons we have found that specific non-degradative 
ubiquitination events alter cytoskeletal dynamics and signaling pathways during axonal 
morphogenesis 77,91. Although the expression patterns and functions of many ubiquitin ligases are not 
known, many are brain-enriched 231 and implicated in neurodevelopmental and neurodegenerative 
diseases 232,233. Specific members of the tripartite motif (TRIM) family of E3 ligases are brain-enriched 
and regulate neuronal development and function 234–237, however the functions and expression 
patterns of many TRIM proteins are unknown. 
TRIM proteins are subdivided into classes based on their carboxy-terminal domains 201. The 
mouse and human genomes contain six class I TRIMs, comprising three pairs of paralogs. Mutations 
in the TRIM1 and TRIM18 pair are associated with X-linked Opitz syndrome 238–240, characterized by 
midline birth defects, and frequently intellectual and motor disabilities. TRIM46 is required for 
formation of the axon initial segment 241, and mutations in its closest paralog TRIM36 are associated 
with anencephaly 242. TRIM9 and TRIM67 were previously described as the most evolutionarily 
conserved pair of class I TRIMs 201. TRIM9 localizes to Parkinsonian Lewy bodies 200, may be linked 
to atypical psychosis243, and regulates netrin-dependent axon guidance and branching through the 
receptor DCC 77,91,141,194. Trim9 deletion is also associated with aberrant migration, morphogenesis, 
and synapse organization of adult-born neurons in the murine dentate gyrus, and severe deficits in 
spatial learning and memory 244. A single study has demonstrated that TRIM67 is expressed in the 
                                                          
‡ This chapter previously appeared as an article in eNeuro. The original citation is as follows: Boyer NP, 
Monkiwicz C, Menon S, Moy SS, Gupton SL. “Mammalian TRIM67 Functions in Brain Development and 
Behavior”. eNeuro. June 14, 2018. v.5, i.3. 
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mouse and human brain and regulates neuritogenesis in a mouse neuroblastoma cell line 245, 
although its role in neurons and in vivo is unknown. In D. melanogaster and C. elegans there is a 
single class I Trim 201. Loss of this TRIM in either organism phenocopies the axon guidance and 
branching defects that occur upon loss-of-function of invertebrate orthologs of the axon guidance cue 
netrin or its receptor DCC 194,195,246. Sequence comparison of the D. melanogaster to human class I 
TRIMs suggested that TRIM9 was the closest mammalian ortholog 201,195. In mice, loss of Ntn1 or Dcc 
causes agenesis of the corpus callosum and hippocampal commissure, as well as other axon 
guidance and branching defects 26,65,67. In contrast to invertebrates, we have shown that deletion of 
murine Trim9 does not phenocopy loss of Ntn1 or Dcc and in some cases exhibits an opposite, gain-
of-function phenotype, including increased axon branching and thickening of the corpus callosum 
91,141. This suggested TRIM9 was not the functional ortholog of the invertebrate class I TRIM.  
 Here we show that TRIM67 interacts with its paralog TRIM9 and the netrin receptor DCC. We 
found that deletion of murine Trim67 results in impairments in spatial memory, cognitive flexibility, 
social novelty preference, muscle function, and sensorimotor gating. Histological analysis 
demonstrated decreases in the size of a specific subset of brain regions in Trim67-/- mice, including 
the hippocampus, caudate putamen, thalamus, and amygdala. Additionally, there were decreases in 
the size of the internal capsule and the dorsal commissures, including the corpus callosum and 
hippocampal commissure. The consequences of Trim67 deletion on brain anatomy and behavior 
indicate that TRIM67 plays critical, yet undefined roles in brain development and function. 
 
2 RESULTS 
2.1 Phylogenetic analysis of class I TRIMs reveals evolutionary conservation of TRIM67  
Comparisons of human class I TRIMs to D. melanogaster trim9 suggested that human TRIM9 
was the most evolutionarily conserved 201,195. In light of the divergence in phenotypes associated with 
the loss-of-function mutations in invertebrate trim9 compared to deletion of murine Trim9 91,141,194,195, 
we compared the sequences of class I TRIMs from a variety animal phyla, which revealed interesting 
features of this family. Based on current genome annotations, no class I TRIMs were found in more 
simple animal clades such as Choanoflagellata, Porifera, or Ctenophora, but were present in 
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Placozoa, Cnidaria, and phyla within the Bilateria. TRIM67 and TRIM9 were the most conserved 
vertebrate class I TRIMs, as determined by branch length from the sole class I TRIM in Placozoa to 
each vertebrate ortholog pair (Fig.1A, TRIM9/67: 0.4866; TRIM46/36: 0.5213; TRIM1/18: 0.6253 
substitutions per site [sps]). Cnidaria and several Bilaterian clades including Mollusca, 
Echinodermata, Hemichordata, and Platyhelminthe had more than one class I TRIM, indicating a 
gene gain event. One of these was closest to TRIM9/67 (Fig.1A, average distance to TRIM9/67 pair = 
0.4098 sps; average distance to TRIM1/18 and TRIM46/36 pairs = 0.5368 sps), the other was closer 
to the chordata TRIM46/36 and TRIM1/18 pairs (Fig.1A, average distance to TRIM9/67 pair = 0.5964 
sps; average distance to TRIM1/18 and TRIM46/36 pairs = 0.58127 sps). Interestingly, this second 
class I TRIM was absent from a subset of Bilaterian clades, including Arthropoda, Nematoda, and 
Annelida, suggesting a subsequent gene loss event. This broader phylogenetic analysis indicated 
that Chordata TRIM67 homologs exhibited higher sequence similarity to ancestral class I TRIMs, and 
the single class I TRIM present in Drosophila and C. elegans, suggesting vertebrate TRIM67 
homologs were more evolutionarily conserved than vertebrate TRIM9 homologs (Fig.1B, TRIM67: 
0.1155; TRIM9: 0.1478 sps, from nearest non-vertebrate branch). 
 
2.2 Generation of Trim67-/- Mice 
Based on the evolutionary conservation of class I TRIM proteins, and the established, 
independent roles of the other five class I TRIMs in the developing nervous system, we sought to 
investigate how loss of TRIM67 affected brain development. We generated a conditional murine 
Trim67 allele (Fig.2A, Trim67fl). Mice carrying the Trim67fl allele were crossed with CMV-Cre mice to 
delete Trim67 in the germline and generate Trim67-/- mice, confirmed by multiplexed PCR genotyping 
(Fig.2B). Trim67-/- mice were viable, and heterozygous adults produced the expected Mendelian ratio 
of offspring (+/+ 102/87; +/- 157/174; -/- 89/87; χ2 = 0.117). We developed specific polyclonal antibodies 
to TRIM9 and TRIM67 using unique regions within their respective N-termini (Fig.2C). Western 
blotting of lysate from embryonic whole-brain and dissociated cortical neuron culture at two days in 
vitro using the TRIM67 antibody confirmed loss of TRIM67 protein (Fig.2D). TRIM67 was detected in 
most sampled regions of the adult and embryonic nervous systems, including dorsal root ganglion in 
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the adult peripheral nervous system, but it was not detected in the tested non-neuronal tissues 
(Fig.2E-G). Of brain regions tested, TRIM67 protein was most enriched in the embryonic cortex and 
the adult cerebellum. Immunohistochemical staining of sagittal sections of embryonic brains (Fig.3A) 
demonstrated high TRIM67 expression throughout the developing hippocampus (Fig.3B), the cortex 
(Fig.3C), and most structures of the nascent diencephalon (Fig.3D). This staining was absent in 
Trim67-/- embryonic brains (Fig.3). Unfortunately, our TRIM67 antibody exhibited nonspecific staining 
in adult tissue by IHC, hindering examination of TRIM67 localization in the mature brain. 
 
2.3 TRIM67 interacts with TRIM9 and DCC 
Using our newly developed TRIM67 and TRIM9 antibodies, we investigated protein levels of 
TRIM9 and TRIM67 in the developing cortex. We found that both proteins were present in the murine 
cortex at a range of ages. TRIM67 protein levels peaked late embryonically and perinatally, whereas 
levels of TRIM9 peaked later in development (Fig.4A). TRIM proteins often heterodimerize, including 
class I members TRIM1 and TRIM18 247. We exploited co-immunoprecipitation assays to determine if 
TRIM9 and TRIM67 could potentially heterodimerize. Using the TRIM67 antibody, endogenous 
TRIM9 was co-immunoprecipitated from wildtype embryonic cortical lysate, but not from Trim67-/- 
lysate (Fig.4B). In the reciprocal assay, the TRIM9 antibody co-immunoprecipitated endogenous 
TRIM67 from wildtype embryonic cortical lysate, but not from Trim9-/- lysate (Fig.4C). These data 
indicate TRIM9 and TRIM67 interact and may heterodimerize.  
Mammalian TRIM9 and the class I TRIM in D. melanogaster and C. elegans interact with the 
netrin-1 receptor DCC (or its invertebrate ortholog) and regulate netrin-dependent axonal responses 
141,194,195. In light of the enriched expression of TRIM67 in the developing cortex, the diverse 
phenotypes associated with loss of mammalian TRIM9 and the invertebrate trim, and the evolutionary 
conservation of TRIM67, we hypothesized that TRIM67 may also interact with DCC and represent a 
more functional homolog to the invertebrate class I TRIM. Co-immunoprecipitation of HA-tagged DCC 
occurred with either myc-tagged TRIM67 RING or myc-TRIM9 RING from HEK293T lysates, 
demonstrating that both mammalian TRIM9 and TRIM67 were capable of interacting with DCC 
(Fig.4D). These constructs were used as deletion of the RING domain ( RING) stabilizes transient 
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interactions between TRIMs and their interacting partners 208. Endogenous DCC was also enriched 
over background in endogenous TRIM67 immunoprecipitates from embryonic brain lysate (Fig.4E). 
Immunocytochemistry also revealed that TRIM67 and DCC were present simultaneously in 
dissociated embryonic cortical neurons (Fig.4F). Together these data indicate that TRIM67 interacts 
with both TRIM9 and DCC. 
 
2.4 Cortical Commissural Fiber Tracts  
All these findings prompted us to investigate netrin-dependent fiber tracts in Trim67-/- mice. 
Loss of murine Ntn1 or Dcc leads to a narrower anterior commissure and agenesis of the corpus 
callosum and hippocampal commissure 26,65. We measured the size of these axon tracts in 5 adult 
Trim67+/+ (1 female, 4 males) and 4 adult Trim67-/- (2 females, 2 males) littermate-paired brains, 
sectioned and stained for myelin (Fig.5A). Deletion of Trim67 had no effect on the size of the anterior 
commissure (Trim67+/+: 0.495 ± 0.023 mm; Trim67-/-: 0.493 ± 0.013 mm; p = 0.944, Mann-Whitney), 
but did decrease the thickness of the corpus callosum (Fig.5B). Additionally, the hippocampal 
commissure, measured as the combined dorsal fornix and dorsal hippocampal commissure, was 
thinner in Trim67-/- mice (Fig.5B, inset). Taken together, these data suggest that loss of Trim67 
decreases the size of cortical and hippocampal axon tracts, but not all commissures. To better 
determine if differences in the corpus callosum were due to loss of Trim67 from cortical neurons, we 
crossed Trim67fl/fl with mice expressing Cre under the Nex promoter 248 and Tau-lox-STOP-lox-GFP mice 
249, resulting in Trim67 deletion and GFP expression in the neocortex and hippocampus. The corpus 
callosum thickness of NexCre/Trim67fl/fl/Tau-lox-STOP-lox-GFP mice (2 females, 2 males) was also reduced 
when compared to NexCre/Trim67+/+/Tau-lox-STOP-lox-GFP littermates (2 females, 2 males) (Fig.5C, p = 
0.0304, Mann-Whitney). The intensity of GFP in the hippocampal commissure of these mice was 
insufficient to permit quantification of the thickness of this tract. 
 
2.5 Altered Subcortical Anatomy in Trim67-/- Brains 
In investigating the effect of Trim67 deletion on fiber tracts, we noted that Trim67-/- brains 
appeared smaller than Trim67+/+ counterparts; postfixation weight of Trim67-/- brains was indeed 
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~10% less than littermate counterparts (Fig.6A). In light of this decrease, we hypothesized that fiber 
tract thinning may be due to general hypotrophy of the cortex and hippocampus, and therefore 
measured the sizes of these brain regions in the same sections (Fig.6B). However, there was no 
difference in the thickness of the cortex between Trim67+/+ and Trim67-/- brains (Fig.6C), but the 
hippocampus was smaller in the absence of Trim67 (Fig.6D). Further, the anterior aspect of the 
hippocampal gray matter began approximately 100 µm posterior in Trim67-/- mice compared to 
Trim67+/+ mice, when aligned anatomically (Fig.6D, Bregma -1.0 and -0.9, respectively). We also 
observed that the amygdala (Fig.6E) and lateral ventricles (Fig.6F) were smaller in Trim67-/- brains. 
 
2.6 Behavioral Phenotyping of Trim67-/- Mice 
With the neuroanatomical defects in Trim67-/- mice and a wide range of functions of class I 
TRIMs in neurons, we employed a comprehensive battery of behavioral assays to determine the 
ramifications of loss of Trim67 in vivo. The behavioral testing regimen (Table 1) has been 
standardized across multiple mouse strains (Moy et al., 2007, 2008, 2012; Huang et al., 2013; Nagy 
et al., 2017). For these studies, subjects were 15 Trim67+/+ mice (7 males and 8 females) and 13 
Trim67-/- mice (7 males and 6 females) aged 6 weeks at the start of behavioral testing. Over the 
course of the behavioral testing, there was no significant effect of loss of Trim67 on body weight or 
overall growth in either male or female mice (Fig.7A). There were also no effects of genotype on 
anxiety-like behavior in an elevated plus maze, exploratory and perseverative digging in a marble-
bury assay, olfactory ability in finding buried food, or thermal sensitivity (Fig.7B). In an open field 
assay, loss of Trim67 had no effect on locomotor activity or rearing movements (Fig.7C) or in time 
spent in the center region of the field (Trim67+/+ = 234 ± 47s, Trim67-/- = 213 ± 32s), a measure of 
anxiety. Normal behaviors in these tests indicate loss of Trim67 does not detectably impact sensory 
abilities, general locomotion, or anxiety behaviors. 
 
2.7 Impaired Spatial Memory and Cognitive Flexibility 
Changes in the size of the hippocampus and lateral ventricles, as observed in Trim67-/- 
brains, have been associated with spatial learning and memory deficits 256–258. The Morris water maze 
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was used to assess spatial and reversal learning, swimming ability, and visual function. The 
procedure was divided into three phases: a visible platform test, acquisition with a hidden platform, 
and reversal learning. In the visible platform trials both groups showed similar times to escape, as 
well as similar swimming speeds (Table S2), indicating visual function was not affected by loss of 
Trim67.  
Following the visible platform task, mice were evaluated for their ability to find a hidden 
escape platform submerged in opaque water. On the first day of hidden platform acquisition both 
groups again had similar swimming speeds, however Trim67-/- mice swam more slowly on the first 
day of the reversal learning test [genotype x testing phase interaction, p = 0.0256]. Trim67-/- mice took 
significantly longer to find the hidden platform, and never reached the criterion for learning (Fig.8A 
dashed line, 15s) by day nine of testing. On trial day nine, two Trim67-/- mice failed to locate the 
platform on more than one trial, and were not tested further. In the subsequent probe trial, percent 
time spent in the quadrant that previously held the platform was significantly higher than the opposite 
quadrant in Trim67+/+ mice, however Trim67-/- mice failed to show quadrant selectivity and had lower 
percent time than Trim67+/+ in the target quadrant [genotype x quadrant interaction, p = 0.0343] 
(Fig.8B). Trim67-/- mice also demonstrated impairment in the number of crossings over the platform’s 
previous location [main effect of genotype, p = 0.0101, genotype x quadrant interaction, p = 0.0281]. 
During this reversal phase of testing to assess cognitive flexibility, Trim67-/- mice showed 
significant deficits in learning the new location of the escape platform [main effect of genotype, p = 
0.0388] (Fig.8C). During the subsequent probe trial, only the Trim67+/+ mice showed a preference for 
spending more time in the quadrant previously containing the platform in the reversal trials, while 
neither genotype displayed a significant difference in target crossings (Fig.8D). Normal behaviors 
during the visible platform test and other sensory tests indicate TRIM67 is specifically required for 
appropriate spatial learning and memory and cognitive flexibility.  
 
2.8 Deficits in Social Novelty Preference, but not Sociability 
Mice were evaluated for the effects of Trim67 deficiency on social preference using a 3-
chamber choice test. This behavior has been associated with the hippocampus and parts of the 
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amygdala 259,260, both of which were decreased in size in Trim67-/- brains. In the initial habituation 
phase, both Trim67+/+ and Trim67-/- mice made similar numbers of entries into each side chamber 
(Trim67+/+; 10.3 ± 1 right, 9.3 ± 0.7 left: Trim67-/-; 8.5 ± 0.9 right, 8.3 ± 0.8 left). In the test for 
sociability (Fig.9A), both genotypes showed a preference for spending time in proximity to the cage 
containing stranger mouse 1 versus an empty cage. However, in the subsequent social novelty phase 
(Fig.9B), Trim67-/- mice showed no preference for a novel stranger mouse, whereas Trim67+/+ mice 
did. In both sociability and novelty phases, both groups of mice showed a similar number of entries 
into each side chamber, indicating that the lack of social novelty preference in the Trim67-/- group was 
not due to alterations in activity during the test. These data suggest that TRIM67 is required for a 
preference for social novelty, but not for overall sociability. 
 
2.9 Impairments in Sensorimotor Gating 
We hypothesized that the reduction in amygdala size in Trim67-/- mice may affect specific 
behaviors. Lesions of the amygdala have been associated with impairments in sensorimotor gating, 
specifically the basolateral region 261,262. Mice were tested both at 10-11 weeks and at 17-19 weeks of 
age for prepulse inhibition of acoustic startle responses. At the first test, Trim67-/- mice showed no 
difference in either initial startle amplitude or in the % inhibition by prepulses of any intensity 
(Fig.10A). However, in the retest at 17-19 weeks, Trim67-/- mice exhibited a mild decrease in startle 
response, and significant deficits in prepulse inhibition (Fig.10B). This suggests impairments in 
sensorimotor gating emerged by the age of four months, and that TRIM67 may function in the adult 
animal as well. 
 
2.10 Trim67-/- Mice Have Impaired Muscle Function 
Mice carrying a spontaneous mutation in Dcc display overt impairments in motor function, 
including hopping behavior instead of a typical gait pattern 263,264. Thirteen Trim67+/+ (5 female, 8 
male) and thirteen Trim67-/- (8 female, 5 male) mice were assayed for gait and muscle function. 
Assessment of footprints on a linear track (Fig.11A) indicated there were no differences between 
stride length or in either front or rear base width for Trim67+/+ and Trim67-/- mice, suggesting no effect 
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on gait (Fig.11B). Subjects were tested for motor coordination and learning on an accelerating 
rotarod. In the initial day of testing (trials 1-3) Trim67-/- mice exhibited deficits in acquisition of motor 
learning (Fig.11C), as indicated by a decreased latency to fall from the top of the rotating barrel. This 
difference was not observed on the second day of testing 48 h later (trials 4,5). This suggests that 
deletion of Trim67 leads to impairment of the initial performance, but not eventual learning, of a motor 
task. Since motor learning was not impaired, we suspected that decreased initial latency to fall may 
be due to impaired muscle function, and assayed muscle strength in a four-paw rolling-wire hang 265. 
The maximum and average hang impulse of three trials were significantly lower in Trim67-/- mice 
(Fig.11D), suggesting an overall decrease in muscle tone. 
 
2.11 Altered Striatal and Thalamic Anatomy in Trim67-/- Mice 
In addition to circuits in the hippocampus and cortex, striatal circuits are implicated in spatial 
learning and memory and motor activity, particularly in the caudate putamen (CPu) 266–268. Since loss 
of Trim67 disrupted these behaviors, we performed black gold staining of serial coronal sections 
through the CPu of five-week-old male and female littermates (Fig.12A) to determine if there were 
malformations of this region. This revealed that the CPu was smaller in Trim67-/- brains (Fig.12B), 
which appeared to be largely in more anterior portions. We generated a binary mask of the myelin-
stained CPu at Bregma to determine if the change in CPu was due to a loss of white and/or gray 
matter (Fig.12C). Although there was no difference in total area of white matter between genotypes 
(Trim67+/+ = 2.28 ± 0.12 mm2, Trim67-/- = 2.47 ± 0.12 mm2, p = 0.322, Mann-Whitney), when 
normalized to CPu area, white matter was increased in Trim67-/- brains (Trim67+/+ = 38.15% ± 1.81%, 
Trim67-/- = 46% ± 2.23%, p = 0.030, Mann-Whitney), indicating a reduction in gray matter in Trim67-/- 
brains. Despite equal white matter in the striatum, the cross-sectional area of the internal capsule, 
where these fibers fasciculate, was smaller in Trim67-/- brains (Fig.12D).  
Deficits in sensorimotor gating have been associated with abnormalities in the sensory nuclei 
of the thalamus 269–271. In light of the sensorimotor gating disruption in Trim67-/- mice (Fig.10) and 
TRIM67 expression the embryonic thalamus (Fig.3C), we measured the size of the thalamus in five-
week-old male and female littermates (Fig.13A). Thalamic size was decreased in Trim67-/- mice 
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(Fig.13B). However, the neighboring nucleus of the habenula was the same size compared to 
Trim67+/+ brains (Fig.13C), indicating there was not hypotrophy of all diencephalic structures. Since 
the TRIM67 interaction partner DCC (Fig.4D,E) is present in the thalamic and habenular associated 
fibers tracts of the stria medullaris and stria terminalis, respectively 72, we compared their cross-
sectional area in serial coronal sections, to investigate whether these fiber tracts were malformed as 
was the cortical commissure of the corpus callosum. This revealed that the stria medullaris and stria 
terminalis were both smaller in cross-sectional area in Trim67-/- brains (Fig.13D). These anatomical 
measurements demonstrate that deletion of Trim67 results in decreases in the size of some, but not 
all, brain regions and fiber tracts in the adult. 
 
3 DISCUSSION 
Here we generated a novel knockout mouse and specific antibody to investigate the largely 
unstudied, yet evolutionarily conserved E3 ubiquitin ligase, TRIM67. We show that TRIM67 is 
enriched in the cerebellum and, to a lesser extent, other brain regions in the adult mouse. 
Furthermore, in the embryo, TRIM67 is enriched in the developing cortex, diencephalon, and 
midbrain. We found that Trim67 deletion results in a complex set of behavioral deficits and 
malformation of several brain regions and axonal fiber tracts in adult mice. In humans, the TRIM67 
gene, which thus far has not been linked to any human disorders, is within the q42.2 band of 
chromosome 1, a region highly associated with heritable neurological conditions 272–274. The proximity 
of TRIM67 to other genes linked to Alzheimer’s disease and schizophrenia (DISC1) 275,276, 
Parkinson’s disease (SIPA1L2) 277, and cognitive function (DISC2, C1orf131, GALNT2) 278 by 
genome-wide association studies (GWAS), and the behavioral deficits revealed here associated with 
deletion of murine Trim67 are intriguing, potentially suggesting possible involvement of TRIM67 in 
human disorders or behaviors. Indeed, a small GWAS of patients with neuroticism, a personality trait 
that often occurs with major depression and anxiety disorders, identified variations in several genes, 
including TRIM67 279. However, none of these variations reached genome wide significance levels, 




3.1 A role for TRIM67 in brain development and maintenance 
The change in TRIM67 protein levels from embryonic to adult brains suggests that TRIM67 
could function both in developing neurons, for example the embryonic cortex, as well as mature 
neurons, such as cells of the adult cerebellum. Indeed, despite Trim67 being deleted globally, 
sensorimotor gating deficits in prepulse inhibition of acoustic startle were not present at 10-11 weeks, 
but appeared by 17-19 weeks. This suggests that TRIM67 may also be necessary for maintenance of 
brain function in mature animals. The spatial and motor learning impairments also suggest a role for 
TRIM67 in remodeling of the hippocampus, classically associated with the Morris water maze task 280. 
This study may support an intriguing possibility that the lack of TRIM67 may result in the onset of 
neurological dysfunction with age, a common feature of many human disorders including 
schizophrenia, bipolar disorder, and neurodegenerative diseases 281–283.  
There is apparent hypotrophy of the hippocampus, striatum, thalamus, and amygdala in 
Trim67-/- brains which, based on black-gold staining, is due to decreased non-myelinated tissue. 
Given the normal size of the cortex and some portions of the affected nuclei, this may be due to 
abnormal maturation and development of specific types of neurons, as opposed to overall 
proliferation. This distinction will require additional studies to determine which neuron types express 
TRIM67, and at what points during development or maturity TRIM67 is expressed. The pattern of 
TRIM67 expression in the embryonic brain however supports a role for TRIM67 in neuronal 
development after proliferation, as TRIM67 protein levels are highest in regions of the developing 
cortex and hippocampus containing migrating and maturing, postmitotic neurons. This may offer an 
explanation for the reduction in adult gray matter, as a large portion of this tissue consists of neurites 
as opposed to cell bodies. A previous study on TRIM67 suggested a role in the formation and 
elongation of neurites 245, and the similar protein TRIM9 regulates dendritic arborization in the 
hippocampus 244, both of which support this possibility. The decreased gray matter observed in 
Trim67-/- mice alternatively may originate from decreases in branching of axons in the affected brain 
regions, whereas the cell bodies of the affected neurons reside in distant nuclei. As TRIM67 interacts 
with the axon guidance receptor DCC, which can promote axon branching 14,141, this is an intriguing 
hypothesis, particularly since several DCC-expressing, netrin sensitive axon tracts are malformed in 
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the brains of Trim67-/- mice, including the callosal and hippocampal commissures, and the stria 
terminalis and stria medullaris. 
These experiments have laid a foundation for investigating the role of TRIM67 in 
development and function of the brain. The role of TRIM67 ubiquitin ligase activity, its substrates, and 
the consequences of their ubiquitination remain to be identified. Further studies will be required to 
elucidate not only this molecular function of TRIM67 in developing and adult neurons, but also 
whether TRIM67 plays a role in DCC-dependent responses, the underlying cause of brain hypotrophy 
resulting from Trim67 deletion, the changes in cellular structure that lead to fiber tract malformation, 
the time course of and underlying cause of behavioral abnormalities in Trim67-/- mice, and the 
contribution of TRIM67 variations to human neurological disorders. Furthermore, although TRIM67 is 
the most evolutionarily conserved vertebrate class I TRIM, unlike the invertebrate TRIM ortholog, loss 
of Trim67 does not fully phenocopy the axon tract defects seen in mice lacking Dcc. Future studies 
will need to examine whether this is due to compensation from other class I TRIM proteins such as 
TRIM9, which interacts with both DCC and TRIM67, or TRIM1 and TRIM18, whose mutation in 








Fig. 1: TRIM67 is evolutionarily conserved. A Phylogeny of class 1 TRIM proteins across animal 
phyla based on protein sequences, showing the six members in vertebrate species (cyan, TRIM9; 
red, TRIM67; green, TRIM1/MID2; pink, TRIM18/MID1; purple, TRIM36; orange, TRIM46) and the 1-2 
members in nonvertebrate animal phyla (blue, TRIM1/18/36/46-like; brown, TRIM9/67-like). Dashed 
red line separates TRIM9/67-like proteins from TRIM1/18/36/46-like proteins. Bootstrap values are 
shown at major group branches. B Phylogenetic tree of invertebrate TRIM9/67-like proteins alongside 
several vertebrate TRIM9 and TRIM67 homologs (all proteins above dashed red line in A). Vertebrate 
TRIM67 exhibits higher sequence similarity than TRIM9 to invertebrate class 1 TRIMs. Numbers 





Fig. 2: Generation of Trim67-/- mouse and TRIM67 brain localization. A Diagram of targeting 
strategy for the Trim67 gene showing Cre-lox mediated excision of exon 1. This excision leads to the 
next 16 intronic and 4 exonic ATG codons being out of frame. LoxP sites are yellow, FLIP sites are 
orange, and neomycin resistance gene (NeoR) is purple. B Agarose gel separation of genotyping 
PCR products, demonstrating deletion of both copies of the first exon of Trim67 (-/-) or one copy in a 
heterozygote (+/-). Diagrams show PCR products from wildtype and knockout alleles. C Duplicate 
western blots of lysate from HEK293T cells expressing both myc-TRIM9 and myc-TRIM67, were 
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probed with both the indicated TRIM antibody (left, red) and myc (right, green), and spectrally distinct 
secondary antibodies. The newly generated TRIM67 polyclonal antibody recognizes TRIM67 but not 
TRIM9; the polyclonal TRIM9 antibody recognizes TRIM9, but not TRIM67, as can be seen in the 
merged images below. D Western blot of whole-brain or two day in vitro dissociated cortical neuron 
lysate from Trim67+/+ and Trim67-/- E15.5 embryos probed for TRIM67 and βIII-tubulin as a loading 
control. E,F,G Western blot detects TRIM67 expression in various adult (E) and embryonic (F) neural 
tissues, but not in the examined tissues outside the nervous system (G). GAPDH is a loading control. 





Fig. 3: TRIM67 is present in multiple murine brain regions. A Low magnification sagittal sections 
of Trim67+/+ and Trim67-/- E15.5 brains stained for TRIM67 (green), β-III-tubulin (magenta), and nuclei 
(DAPI, blue). B TRIM67 is present in cell bodies in the developing hippocampus and C cortex at 
E15.5. D TRIM67 expression is evident in the peduncular hypothalamus (5), diencephalon (1), and 






Fig. 4: TRIM67 is expressed in developing cortex and interacts with TRIM9 and DCC. A Western 
blots of cortical lysate from indicated embryonic (E) and postnatal (P) ages reveal expression patterns 
of TRIM67 and the three isoforms of TRIM9. B Western blot of TRIM67 immunoprecipitates from 
Trim67+/+ and Trim67-/- mouse cortical neuronal lysate probed for TRIM9 and TRIM67. Co-
immunoprecipitation of TRIM9 occurred in the presence of TRIM67. C A similar immunoprecipitation 
of TRIM9 from embryonic brain lysates co-immunoprecipitates TRIM67 in wild-type cortical lysate, but 
not in the absence of TRIM9. D HEK293T cells were co-transfected with HA-tagged DCC and either 
myc-tagged TRIM9 or TRIM67 lacking the RING domain ( RING). Immunoprecipitation of either myc-
TRIM RING co-precipitated HA-DCC. E The top of the blot shown in panel B, probed for DCC, 
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showing that endogenous DCC is enriched over background levels in TRIM67 immunoprecipitates 
from wildtype embryonic brain lysate. The TRIM67 IP is the same as in panel B. F Photomicrographs 
of neurites and growth cones from Trim67+/+ and Trim67-/- cultured embryonic cortical neurons show 
DCC immunostaining in the same cells as TRIM67. Residual TRIM67 staining in Trim67-/- is due to 





Fig. 5: Trim67 deletion reduces the thickness of certain fiber tracts. A Photomicrographs of 
black-gold stained coronal brain sections, the fiber tracts measured are indicated. B The corpus 
callosum was thinner in Trim67-/- mice (p = 0.00000909), with most significant individual measures 
towards the caudal end of the tract. The hippocampal commissure, including both the fornix and 
dorsal hippocampal commissure, was reduced in thickness in Trim67-/- mice (p = 0.000215). C GFP 
staining in the corpus callosum of Nex-Cre:Taulox-STOP-lox-GFP:Trim67+/+ and Nex-Cre:Taulox-STOP-lox-





Fig 6: Reduction in total brain weight and hypotrophy of multiple brain areas occurs with loss 
of Trim67. A Photograph of representative Trim67+/+ (left) and Trim67-/- (right) brains from five-week-
88 
 
old mice. Total weight of Trim67-/- brains was reduced by approximately 10% when compared to 
littermate controls (p = 0.0108, Wilcoxon Signed Rank test). B Photomicrographs of black-gold 
stained coronal sections of Trim67+/+ and Trim67-/- brains at 1.3 mm posterior to Bregma. Outlines 
delineate regions used for measures in this figure. C Deletion of Trim67 had no effect on the 
thickness of the cortex (p = 0.069), measured from the cingulum to the cortical surface (average 
distance between the dashed black lines in panel B). D Area of the hippocampal gray matter 
(including both the dentate gyrus and Ammon’s horn), reported as the average of both individual 
hemispheres from its first emergence through the fimbriae to 2.7 mm posterior to Bregma. The 
hippocampus was smaller in Trim67-/- brains (p = 0.00000889), with significant individual measures 
toward the rostral portion. E Area of the amygdala, reported as the average of both individual 
hemispheres. The amygdala was significantly smaller in Trim67-/- brains (p = 0.000110). F Area of the 
lateral ventricles reported as the average of both individual hemispheres, from the first section 
posterior to the anterior commissure to the last section with visible ventricle. Trim67-/- lateral ventricles 




Fig. 7: Mouse growth, sensory ability and general locomotion are not affected by Trim67 
deletion. A Weights of mice over the course of behavioral assays, showing no effect of Trim67 loss 
on overall growth. B Results of elevated plus maze and several sensory assays. Units are indicated. 





Fig. 8: Loss of Trim67 leads to impairments in spatial learning and memory. 
A Time (s) for mice to find a hidden platform in the Morris water maze, with a threshold for learning 
set at a group average of 15 s (dashed line). Trim67-/- mice fail to reach this threshold out to the 
maximum of 9 days of training, and have overall significantly higher latencies to find the platform (* 
p<.05, all trials p = 0.0225). B Time spent in target and opposite quadrants and number of times 
crossing the previous platform position in a probe trial following acquisition day 9. Whereas Trim67+/+ 
mice spent a higher amount of time in the quadrant previously occupied by the platform (* p = 
0.0003), Trim67-/- mice failed to show this preference and spent a lower time in the target quadrant 
than Trim67+/+ mice (# p = 0.0343). C Subsequent reversal trials demonstrated an increased latency 
to find the platform in the Trim67-/- cohort compared to Trim67+/+ littermates (* p < 0.05, all trials p = 
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0.0149). D In a probe trial following reversal day 7, only Trim67+/+ mice spent more time in the new 




Fig. 9: Trim67-/- mice display normal sociability, but impaired social novelty preference. A 
Measures of total time spent in (top) and entries into (bottom) side chambers of a  three chamber 
socialization assay, showing mice of both genotypes exhibited a significant preference for proximity to 
stranger mouse 1 (*** p < 0.0001). B Total time spent in and entries into side chambers in 
subsequent three chamber social novelty assay. Trim67-/- mice show a lack of preference for the 




Fig. 10: Prepulse inhibition of acoustic startle is impaired by loss of Trim67. A Startle amplitude 
(in arbitrary units) in response to no stimulus (NoS) or 120 dB stimulus (AS), with varying prepulse 
levels 100 ms before stimulus. B Prepulse inhibition is reported as % inhibition compared to AS. Test 
1 took place at 10-11 weeks of age, and Test 2 at 17-19 weeks. Trim67-/- mice showed a decrease in 




Fig. 11: Muscle function, but not motor learning, is impaired in Trim67-/- mice. A Mouse gait was 
measured by footprint analysis on a straight track, with forepaws in red and hindpaws in blue. B 
There was no significant difference in base width (forepaws, p = 0.775; hindpaws, p = 0.229) or stride 
length (p = 0.252) during normal walking between Trim67-/- and Trim67+/+ mice. C Latency to fall from 
an accelerating rotarod in three trials separated by 45 seconds (1, 2, 3), followed by two additional 
trials 48 hours later separated by 45 seconds (4, 5). Deletion of Trim67 led to a decrease in fall 
latency during the first day of trials (p = 0.0074), however there was no difference during the retest 
trials. D Muscle tone measured during a four-paw rolling wire hang assay, reported as maximum and 
average impulse (weight * time) over 3 trials. Trim67-/- mice have lower maximum (p = 0.0387) and 




Fig. 12: Malformation of caudate putamen in Trim67-/- mice. A Photomicrographs of black-gold 
stained coronal brain sections showing the area used for quantification of CPu parameters. B The 
area of the CPu, reported as the average of both individual hemispheres. Yellow box denotes position 
of white matter measurements. The CPu was smaller in Trim67-/- brains (p = 0.00000876), with most 
significantly different individual positions towards the anterior. C Binary masks of white matter (black 
regions) in the CPu after semi-automated segmentation. D Deletion of Trim67 resulted in a decrease 
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in the area of the internal capsule, reported as the average of both hemispheres (p = 0.000138). (* - p 




Fig. 13: Deletion of Trim67 is associated with a reduction in thalamus size. A Coronal brain 
sections with the thalamus, habenula, stria terminalis and stria medullaris regions outlined as used for 
measurements. B Trim67 deletion resulted in a decrease in the area of the thalamus in the region 
under the anterior hippocampus (p = 0.000174). C The area of the habenula was not affected by 
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deletion of Trim67 (p = 0.299). D Both the stria terminalis and stria medullaris were reduced in cross-
sectional area in Trim67-/- brains (p = 0.0222 and 0.00152, respectively). (* - p < 0.05 at this position). 
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CHAPTER 3 TABLES 
 




Table 2: Swim speeds of mice during Morris water maze trials. 
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CHAPTER 4: A PAIR OF E3 UBIQUITIN LIGASES COMPETE TO REGULATE FILOPODIAL 
DYNAMICS AND AXON GUIDANCE 
1 Introduction 
 Appropriate axon guidance is necessary to form accurate neuronal connections. Guidance 
cues stimulate reorganization of the cytoskeleton within the distal growth cone at the tip of the 
extending axon. Filopodia at the periphery of the growth cone have long been considered sensors for 
axon guidance cues, yet how they perceive and respond to extracellular cues remains ill-defined. Our 
previous work found that the filopodial actin polymerase VASP is regulated via TRIM9-dependent 
nondegradative ubiquitination, and that appropriate VASP ubiquitination and deubiquitination are 
required for axon turning in response to the guidance cue netrin-1. Here we show that the TRIM9-
related protein TRIM67 antagonizes VASP ubiquitination by outcompeting the TRIM9:VASP 
interaction. This antagonistic role is required for netrin-1 dependent filopodial responses, axon turning 
and branching, and fiber tract formation. We suggest a novel model that coordinated regulation of 
nondegradative VASP ubiquitination by a pair of ligases is a critical element of axon guidance. 
Axon guidance toward appropriate synaptic partners is critical to the formation of the intricate 
neuronal networks found in mature organisms. Extracellular guidance cues direct axon navigation 
and are sensed and integrated by transmembrane receptor signaling pathways185. Such receptors 
often localize to the tips of actin rich filopodial protrusions in the axonal growth cone, a dynamic, 
cytoskeleton-rich structures at the distal end of extending axons94. Directionally biased remodeling 
and movement of growth cones, coupled with progressive elongation and condensation of the axons, 
produces turning behavior in axon guidance284. The localization of signals within the growth cone to 
allow for this directional bias requires tight regulation of effectors, such as cytoskeletal remodeling 
proteins83. However, the mechanisms allowing for highly localized regulation in the growth cone are 
not fully understood, especially those which maintain intracellular conditions in a non-signaling state 
primed for response to extracellular cues.
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 The guidance cue netrin-1 and its receptor DCC are required for midline-crossing behavior of 
many CNS axons26,65–67, especially the corpus callosum in the mammalian brain285.  There is a large 
body of work demonstrating the function of proteins that are activated and produce responses 
following netrin-1 binding to DCC286. Recent work has shown that negative regulation of downstream 
effectors prior to signaling is also required for appropriate cue response77,91. Specifically in the 
absence of netrin, the actin polymerase vasodilator stimulated phosphoprotein (VASP) is 
ubiquitinated in a manner dependent upon the E3 ligase tripartite motif protein 9 (TRIM9), which 
negatively impacts filopodia lifetime91. Changes in filopodial dynamics are an important element of 
growth cone response to extracellular cues, especially netrin-190,187. Regulation of VASP is a crucial 
factor in modifying filopodial dynamics in axon outgrowth and guidance, and is required for netrin-1 
signaling downstream of DCC89,188. Loss of VASP ubiquitination is necessary for growth cone 
filopodial response to netrin-191, however the factors that prohibit ubiquitination of VASP or increase 
deubiquitination, in the presence of netrin are unknown, and regulators of TRIM9 are not known. 
 Tripartite motif protein 67 (TRIM67) is a class 1 TRIM protein along with TRIM9 and, as such, 
shares the same domain organization and 63.3% sequence identity201. Our recent work described a 
line of mice lacking Trim67 and showed that TRIM67 is required for development of the brain and, 
specifically, several axons tracts including the corpus callosum287. Additionally, TRIM67 was shown to 
interact with both TRIM9 and the netrin-1 receptor DCC. Little is known about the function of TRIM67 
in the cell, though a previous paper reported TRIM67-dependent ubiquitination of 80K-H, a negative 
regulator of a Ras protein, in a neuroblastoma cell line245. However, no role has been described for 
TRIM67 in the regulation of axon guidance. 
 Here we describe a surprising antagonistic role for TRIM67 in the ubiquitination of VASP in 
murine embryonic cortical neurons, and demonstrate that appropriate regulation of VASP 
ubiquitination is required for filopodial and axonal responses to netrin-1. We demonstrate that 
TRIM67 interacts with the actin polymerase VASP and negatively regulates its TRIM9-dependent 
ubiquitination. We provide evidence that this antagonism occurs via TRIM67 competitively inhibiting 
the interaction between TRIM9 and VASP. Using a combination of cell biological and biochemical 
approaches, we show that genetic deletion of Trim67 results in increased VASP ubiquitination and 
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basal defects in filopodia dynamics, as well as a loss of acute filopodial and growth cone responses 
to netrin. Additionally, netrin-dependent axon turning and branching responses are impaired by loss 
of Trim67. We extend these in vitro findings into the animal, where we find a perinatal delay in the 
developmental completion of the netrin-sensitive corpus callosum. These experiments suggest a 
model: a pair of closely related TRIM proteins generate a “yin and yang” like modulation of VASP 
function in axonal growth cones that allows filopodia to effectively search their environment, providing 
fidelity in netrin-1 dependent axon guidance. 
 
2 Results 
2.1 TRIM67 is involved in netrin-dependent axon guidance 
We recently generated mice carrying a Trim67 allele flanked by loxP sites (Trim67Fl/Fl). 
Germline deletion of Trim67 resulted in a thinner and smaller corpus callosum in the adult murine 
brain287. In light of this phenotype, we examined the perinatal development of this axon tract in 
newborn (P0) and 4-day old (P4) Trim67+/+:Nex-Cre:Tau-Lox-STOP-Lox-GFP and Trim67Fl/Fl:Nex-
Cre:Tau-Lox-STOP-Lox-GFP littermates.  The Nex promoter drives Cre expression and 
recombination in postmitotic cortical and hippocampal neurons starting at embryonic day (E) 11.5248. 
We analyzed corpus callosum development in serial sections (Fig.1A) at P0. Deletion of Trim67 
widened the interhemispheric distance between leading callosal fibers (Fig.1A, white arrows) 80, 160 
and 240 µm posterior to the last midline-crossing section of the corpus callosum (Fig.1B, p = 0.0055; 
p = 0.008; p = 0.045, respectively), suggesting a delay in axon extension toward the midline in 
Trim67Fl/Fl brains. Concordantly, corpus callosum growth was delayed toward the posterior of the 
brain at P0 (Trim67+/+ 453±22um posterior to fornix, Trim67Fl/Fl 360±25um posterior to fornix; p = 
0.0342). By P4, when the callosum has completed midline crossing288, the callosum extended a 
shorter distance caudally in Trim67Fl/Fl littermates (Fig.1D, p = 0.0403), and that the posterior portion 
of the callosum was thinner (Fig.1E, p = 0.0081).   These data suggest that TRIM67 is required for 
the midline-directed outgrowth and/or guidance of cortical axons, which form the corpus callosum.  
Since loss of Dcc or the gene encoding netrin (Ntn1) result in agenesis of the corpus 
callosum26,65–67, and our previous work revealed that TRIM67 interacts with DCC287, we hypothesized 
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TRIM67-dependent defects in the corpus callosum could arise from axon guidance failure. To 
investigate a role of TRIM67 in netrin-dependent axon guidance, we employed microfluidic axon 
guidance chambers to establish a stable, long-term gradient of netrin-122 and measured axon turning 
angles of cortical neurons cultured from Trim67+/+ and Trim67-/- embryos (Fig.1F-H). As previously 
reported, we observed positive turning angles indicative of attractive turning in a low concentration 
range of the netrin-1 gradient (approximately 40-220ng/mL), but not in a dextran-only gradient in 
Trim67+/+ cells (Fig. 1I). At the higher end of the gradient (approximately 550-600ng/mL), Trim67+/+ 
axons exhibited a negative turning angle, indicative of repulsion by netrin-1. However axons of 
Trim67-/- neurons did not show a turning response to netrin-1 in either range, similar to Trim67+/+ cells 
in the dextran gradient (Fig.1I). These results demonstrate a requirement for TRIM67 in netrin-1 
dependent axon turning in vitro, consistent with in vivo defects in the formation of the netrin sensitive 
corpus callosum. 
 
2.2 Netrin increases TRIM67 localization to filopodia tips 
TRIM67 shows a punctate localization in the growth cone and its expression is enriched in 
the developing cortex and decreases after synaptogenesis287, which together with the axon turning 
phenotypes associated with deletion of Trim67, suggest that TRIM67 is poised to modulates 
developmental responses to netrin. We next characterized the localization of TRIM67 in the growth 
cone, and how this was modulated by netrin. Endogenous TRIM67 exhibited a punctate pattern of 
localization in growth cones of developing axons, specifically in the core region, the edge of the 
lamellipodium, and the tips of filopodia (Fig.2A). This localization was recapitulated in Trim67-/- cells 
transfected with myc-TRIM67 and imaged by structured illumination microscopy (SIM) (Fig.S1A). 
TRIM67 staining was not apparent in Trim67-/- growth cones. We quantified the enrichment of 
endogenous TRIM67 along the length of filopodia protruding from axonal growth cones of wild-type 
embryonic neurons and found that TRIM67 is enriched in puncta at the tips of filopodia, a pattern 
which was not observed in Trim67-/- filopodia. This is reminiscent of the localization of proteins which 
are members of the filopodial tip complex, such as the related tripartite motif protein 9 (TRIM9)91, 
vasodilator stimulated phosphoprotein (VASP)89, and deleted in colorectal carcinoma (DCC)94. In light 
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of the requirement for TRIM67 for netrin-dependent axon guidance, and the involvement of filopodia 
in axon guidance responses90,187, we examined the effect of netrin-1 treatment on filopodial tip 
localization of TRIM67. The proximity of TRIM67 puncta to the filopodial tip was quantified as the ratio 
of fluorescence ½ an Airy unit from the edge of detectable signal (the center of a punctum at the tip of 
the filopodium) to the fluorescence at 1 Airy unit (Fig.3C). Following netrin treatment this ratio 
increased (Fig.2C-E, p = 0.0354) suggesting that TRIM67 is located closer to the tip of filopodia, 
supporting our hypothesis that TRIM67 is poised to modulate netrin-1 dependent axonal responses.  
 
2.3 Axonal netrin-1 responses require TRIM67 
We exploited scanning electron microscopy of cultured neurons to achieve a three 
dimensional (3D) gross overview of growth cone responses to netrin, and potential defects in Trim67-/- 
neurons (Fig.3A). We hierarchically categorized the 3D morphology of the growth cones as either flat 
(fully apposed to coverslip), curled (peripheral structures away from coverslip), dorsal (possessing 
lamellipodial ruffles or filopodia on the dorsal surface), or nonadherent (growth cone fully separated 
from coverslip) (Fig.S1B). We found that netrin-1 treatment promoted non-flat growth cone 
morphologies in Trim67+/+ neurons, (Fig.S1C, p = 0.040 by Fisher’s exact test). The growth cones of 
Trim67-/- axons were basally shifted towards these non-flat morphologies (p = 0.011), and this 
distribution was not affected by treatment with netrin-1 in the absence of Trim67 (p = 0.310).  
The non-responsiveness of Trim67-/-growth cone morphology to netrin-1 prompted us to 
perform a thorough assessment of growth cone responses to netrin, including size, filopodial number 
and filopodial length of axonal growth cones (Fig.3B-C). As reported91, netrin-1 treatment increased 
the growth cone area (p = 5.34E-4), filopodia number (p = 1.64E-7), filopodia density (p = 7.08E-7), 
and filopodial length (p = 7.97E-12) in Trim67+/+ growth cones (Fig.3C). However, netrin-1 treatment 
had no effect on these parameters in Trim67-/- growth cones (growth cone area, p = 0.896; filopodial 
number, p = 0.2176; filopodial density, p = 0.434; filopodial length, p = 0.808), indicating that TRIM67 
is required for the response of growth cones to netrin-1. Basally, the filopodia of Trim67-/- growth 
cones were longer (p = 4.27E-23), and growth cones were larger (p = 0.00695), than wild-type 
counterparts. We investigated whether TRIM67 was similarly required for responses to other 
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guidance cues (Fig S1D). As reported previously289, treatment with FGF increased the size of and the 
number of filopodia on growth cones in Trim67+/+ (area, p = 8.13E-5; filopodia, p = 2.38E-7); these 
effects were also observed with Trim67-/- (area, p = 0.007; filopodia, p = 0.00722) growth cones 
(Fig.S1E). Slit2N treatment caused a collapse of growth cones290,291, as indicated by a decrease in 
the growth cone size in both Trim67+/+ (p = 0.00291) and Trim67-/- (p = 0.00101) neurons (Fig.S1E). 
These results suggest that TRIM67 is not required for growth cone responses to all guidance cues, 
and may be specific to netrin-1. 
Netrin also promotes axon branching in cortical neurons14,141, therefore we assessed whether 
TRIM67 was required for axon branching responses to netrin-1 after a 24 hour addition of netrin 
(Fig.3D,E). As reported14,141, 24h netrin-1 treatment increased the density of branches along 
Trim67+/+ axons (p = 9.43E-7). In Trim67-/- axons this branching response was absent (p = 0.543), 
and there was no change in the branch density of untreated axons (p = 0.423). Basally Trim67-/- 
axons were shorter than their wild-type counterparts (p = 0.0133), though there was no effect on axon 
length from netrin-1 treatment in either genotype (Fig.3F, Trim67+/+, p = 0.711; Trim67-/-, p = 0.858). 
To determine whether the regulation of axon branching by TRIM67 was specific to netrin-1, we 
treated neuron cultures for 24 h with FGF or Slit2N (Fig.S1F). As reported289,292, treatment with either 
of guidance cue increased axon branching in Trim67+/+ cortical neurons (Fig.S1G; FGF, p = 2.78E-4; 
Slit2N, p = 0.00175). Axons of Trim67-/- neurons were also more branched following treatment with 
either FGF (p = 7.43E-4) or Slit2N (p = 0.00173), suggesting that TRIM67 is not required for all axon 
branching responses to guidance cues, but specifically netrin. 
 
2.4 Functional analysis of TRIM67 protein domains 
After establishing the necessity for TRIM67 in axonal responses to netrin-1, we performed 
rescue experiments using either full length TRIM67 or several N-terminally myc-tagged mutants of 
TRIM67 (Fig.S2A). The localization of most constructs was qualitatively similar to the full-length 
protein (Fig.S2B); however, qualitatively the ligase-dead mutant showed enhanced peripheral 
localization in many cells, while both the ΔCC and Nterm constructs appeared more diffuse. We 
quantified the growth cone area, filopodia number, filopodia density, and filopodial length in Trim67-/- 
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neurons expressing each of these TRIM67 constructs or myc alone. Only full-length myc-TRIM67 
rescued the increase in growth cone area in response to netrin-1 treatment (Fig.S2C, p = 2.40E-5). 
The full-length construct also rescued the increase in filopodial density following netrin-1 treatment 
(Fig.S2D, p = 5.36E-7). However, all constructs possessing both the COS and FN3 domains rescued 
the basal growth cone area, except for the ligase dead variant (Fig.S2E). Intriguingly, the only other 
construct which rescued filopodial density was the Nterm (p = 2.65E-5), suggesting that the N-
terminus is sufficient for filopodia-associated functions of TRIM67 but that a partial C-terminus may 
inhibit these functions. Most constructs were, however, able to reduce the basal filopodial length but 
not necessarily the netrin-dependent increase in length (Fig.S2E). These data suggest that all 
domains of TRIM67, as well as ligase activity, are necessary for growth cone responses to netrin-1. 
Additionally, the COS and FN3 domains are required for TRIM67 to constrain the size of the growth 
cone in the absence of netrin.  
Following the growth cone structure-function analysis, we explored the function of these 
same TRIM67 domains in netrin-1 dependent axon branching (Fig.S3A).  Axon branching in 
response to netrin-1 was only rescued by full-length TRIM67 (Fig.S3B, p = 9.93E-7). Intriguingly, 
expression of TRIM67ΔCOS introduced a novel suppression of branching by treatment with netrin-1 
(p = 0.00713). The results of this experiment suggest that, like growth cone regulation, all domains of 
TRIM67 are necessary for proper axon branching in response to netrin-1. Together these results 
indicate the axonal defects in response to netrin are caused by loss of Trim67, but that TRIM67-
dependent regulation of netrin responses is likely complex, as it requires each of the domains, and 
thus many functions of the protein. 
 
2.5 Filopodia growth dynamics are regulated by TRIM67 
We next assayed the dynamics of axonal growth cone filopodia using live-cell microscopy 
(Fig.4A). In agreement with a previous study91, we found that 40 min treatment with netrin-1 
increased the lifetime of filopodia in Trim67+/+ neurons (Fig.4B). In Trim67-/- growth cones, however, 
filopodial lifetime was longer than Trim67+/+ basally, and was reduced by netrin-1. This decrease in 
lifetime could be attributed in part to an increase in the lateral buckling (collapse at the middle) or 
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folding (collapse at the base) of filopodia following netrin-1 treatment in Trim67-/-, but not in Trim67+/+ 
(Fig.4C). We found that both the protrusion and retraction speed of the tips of filopodia were higher in 
Trim67-/- growth cones than in their wild-type counterparts, but that there was no effect on these rates 
with netrin-1 in either genotype (Fig.4D). However, the duration of individual filopodial and retraction 
events was shorter in Trim67+/+ growth cones following netrin-1 treatment, and this effect was absent 
in Trim67-/- filopodia (Fig.4E). Together, these data suggest that TRIM67 is required for filopodial 
growth dynamics to respond properly to netrin-1, resulting in the snapshot filopodial phenotypes seen 
in fixed cultures. 
 
2.6 TRIM67 interacts and localizes with the filopodial actin polymerase VASP 
Previous work has shown that the actin polymerase VASP is required for filopodial responses 
to netrin-189, and that VASP is regulated by TRIM9-dependent ubiquitination91. Since TRIM9 and 
TRIM67 are highly similar and interact287, we hypothesized that TRIM67 may also interact with VASP. 
Indeed, immunoprecipitation of Myc-TRIM67 or a mutant lacking the RING domain 
(MycTRIM67ΔRING) from HEK293 cells co-precipitated GFP-VASP (Fig.5A). The TRIM67:VASP 
complex was maintained in TRIM9-/- HEK293 cells, indicating the TRIM67:VASP interaction occurs 
independent of TRIM9 (Fig.5A). To map the domains of TRIM67 necessary for VASP interaction, we 
generated a HEK293 cell line in which TRIM67 was deleted via CRISPR/Cas9 genome editing 
(TRIM67-/- HEK293) (Fig.S4) and performed co-immunoprecipitation assays using domain-deletion 
constructs of TRIM67. The coiled-coil domain of TRIM67 was required for co-immunoprecipitation of 
VASP, while ligase function was not (Fig.5B). Since interacting proteins often colocalize, we 
investigated whether tagRFPt-tagged TRIM67 and GFP-VASP colocalized in neurons by live TIRF 
microscopy (Fig.5C). Colocalization was quantified at growth cone filopodia tips and was higher than 
Fay-randomized controls (Fig.5D), indicating TRIM67 and VASP colocalize at filopodia tips. 
Consistent with co-immunoprecipitation results suggesting that the coiled-coil domain of TRIM67 is 
required for interaction with VASP, tagRFPt-TRIM67ΔCC showed decreased colocalization with GFP-
VASP at filopodial tips. By coimmunoprecipitation we also found an interaction between TRIM67 and 
Ena/VASP family members Mena (Fig.S4F) and EVL (Fig.S4G). 
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2.7 TRIM67 antagonizes VASP ubiquitination 
We previously reported TRIM9-dependent non-degradative ubiquitination of VASP that 
negatively impacted VASP dynamics and filopodial stability, all of which were reversed by netrin91.  
This previous work detected no ubiquitination of the other Ena/VASP family members Mena and Evl, 
and similar results were found here with Mena (Fig.S4H). Due to the structural similarities between 
TRIM9 and TRIM67 and their conserved coiled-coil mediated interaction with VASP, we investigated 
how TRIM67 modulated VASP ubiquitination. Consistent with previous work, we found a basal level 
of VASP ubiquitination in Trim67+/+ neurons, which was decreased in response to netrin-1 treatment 
(Fig.5E,F, p = 0.00805). Further we confirmed previous results that VASP ubiquitination was 
decreased in the absence of Trim9 (p = 0.00220). Surprisingly, in Trim67-/- neurons there was a 
contrasting increase in basal levels of VASP ubiquitination and a trend towards decreased VASP 
ubiquitination following netrin-1 treatment (Trim67+/+ vs Trim67-/- p = 0.018, netrin effect p = 0.0573). 
Again, we conclude this ubiquitination is likely not associated with degradation of VASP, as changes 
in levels of VASP protein were not detected in Trim67-/- or Trim9-/- brain lysates (Fig.S4I-J). We 
performed similar ubiquitination assays of GFP-VASP in TRIM67-/- HEK293 cells and found high 
levels of VASP ubiquitination in the absence of TRIM67 (Fig.5G,H). Introduction of myc-tagged 
TRIM67 decreased VASP ubiquitination (p = 0.0300), consistent with endogenous VASP 
ubiquitination in neurons. The TRIM67-dependent inhibition of VASP ubiquitination required the 
coiled-coil domain of TRIM67 as well as ligase function, as neither mutant decreased ubiquitination 
compared to myc-transfected TRIM67-/- HEK cells (Fig.5G,H, ΔCC, p = 0.0874; LD, p = 0.656). This 
suggests that the interaction of TRIM67 with VASP or another protein, as well as TRIM67 E3 ligase 
function, are necessary for inhibiting VASP ubiquitination. To confirm the molecular weight shift of 
VASP and co-migration of ubiquitin were indicative of increased ubiquitination in the absence of 
TRIM67, we exploited a construct of GFP-VASP harboring nine lysine residues mutated to arginine 
(VASPK-R). These mutations were previously shown to decrease VASP ubiquitination91. Similarly here 





2.8 VASP ubiquitination slows VASP dynamics at filopodia tips 
Using fluorescence recovery after photobleaching (FRAP) of GFP-VASP, we previously 
found that the dynamics of VASP at filopodia tips correlated with the ubiquitination state of VASP91. 
For example, when VASP was ubiquitinated (in the absence of netrin or presence of the 
deubiquitinase inhibitor PR-619, which we have previously shown to increase the amount of 
ubiquitinated VASP in neurons91) the fluorescence recovery halftime (t1/2) was slow, whereas when 
VASP was not ubiquitinated (in the presence of netrin, in the absence of TRIM9, or the VASPK-R 
mutant) the FRAP t1/2 was fast. We therefore performed FRAP assays in embryonic cortical neurons 
transfected with GFP-VASP (Fig.5I) to determine if loss of Trim67 also altered VASP dynamics. 
Consistent with our previous work, treatment with netrin-1 caused a reduction in the t1/2 of filopodial 
GFP-VASP (Fig.5J), indicating more rapid dynamics of VASP at filopodial tips when VASP 
ubiquitination was reduced91. In Trim67-/- neurons there was no change in t1/2 with netrin treatment, 
matching the pattern found in our in vitro ubiquitination assays. To test whether this effect on FRAP 
t1/2 was due to ubiquitination as has been shown previously91, we performed these FRAP experiments 
using GFP-VASPKR. In both Trim67+/+ and Trim67-/- neurons the FRAP t1/2 of GFP-VASPK-R was lower 
than that of GFP-VASP, and there was no effect of netrin on the t1/2 of GFP-VASPK-R FRAP in either 
genotype. To assay effects of increased VASP ubiquitination on FRAP t1/2 we treated neurons with 
the PR-619; in Trim67+/+ neurons PR-619 treatment increased GFP-VASP FRAP t1/2, consistent with 
an increase in ubiquitination (Fig.5J). However, the VASP t1/2 was not affected in Trim67-/- neurons 
treated with PR-619. We see no difference in the percent of VASP which recovers after 
photobleaching (% recovery) between genotypes or treatment conditions (Fig.S5A). Together these 
data suggest that VASP ubiquitination correlates with the rate of FRAP recovery, as previous work 
suggested91, and that TRIM67 is required for the proper netrin-1 dependent increase in VASP mobility 
at filopodia tips. 
 
2.9 TRIM67 negatively regulates TRIM9 through competition for binding with substrates 
These data suggest that TRIM67 antagonizes the TRIM9-dependent ubiquitination of VASP. 
Like TRIM67, TRIM9 also localizes to filopodia tips; we therefore investigated whether TRIM67 and 
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TRIM9 colocalize, such that TRIM67 may inhibit TRIM9-dependent ubiquitination of VASP. In Trim9-/-
:Trim67-/- embryonic cortical neurons GFP-TRIM9 and tagRFPt-TRIM67 colocalized significantly 
across whole cells when compared to Fay-randomized controls (Fig.6A,B). Netrin treatment did not 
detectably alter the colocalization of these two proteins. 
We hypothesized that TRIM67 might compete with TRIM9 for an interaction with VASP, as 
deletion of Trim67 did not affect overall TRIM9 protein levels (Fig.S4K,L). Coimmunoprecipitation 
assays suggested a stronger interaction between TRIM67 and VASP than between TRIM9 and VASP 
(Fig.6D,E, p = 0.0211). The Ena/VASP homology domain 1 (EVH1) of VASP, which interacts with 
TRIM991, precipitated both TRIM67 and TRIM9 from cortical lysate when tagged with glutathione S-
transferase (GST), indicating both proteins interact with the same domain of VASP (Fig.6F). GST-
EVH1 enriched indistinguishable amounts of endogenous TRIM67 from wildtype and Trim9-/- cortical 
lysate (Fig.6F,G, p = 0.878), indicating TRIM9 did not impair the TRIM67:EVH1 interaction. However, 
GST-EVH1 precipitated approximately two-fold more TRIM9 in the absence of Trim67 (Fig.6F,G, p = 
0.0211), suggesting that TRIM67 competes with the interaction between TRIM9 and VASP. 
In light of this competitive interaction, we hypothesized that TRIM67 functioned upstream of 
TRIM9, and that would predict that VASP ubiquitination and filopodial responses to netrin-1 in Trim9-/-
:Trim67-/- cortical neurons would resemble those of Trim9-/- neurons91. Indeed in Trim9-/-:Trim67-/- 
neurons we observed a decrease in VASP ubiquitination (Fig.7A,B, p = 0.00210), similar to Trim9 -/- 
neurons. Consistent with the hypothesis that ubiquitination of VASP slows its dynamics at filopodia 
tips, the FRAP t1/2 of GFP-VASP expressed in Trim9-/-:Trim67-/-  embryonic cortical neurons was 
lower than in untreated wild-type neurons, and displayed an increase following netrin treatment 
(Fig.7C). As with previous FRAP assays we saw no differences in % recovery with any condition 
(Fig.S5B) Analysis of Trim9-/-:Trim67-/- axonal growth cones (Fig.7D) showed that similar to those of 
Trim9-/- neurons, basal filopodial number and filopodial density increased in the absence of both TRIM 







In this study we demonstrate that TRIM67 antagonizes the TRIM9-dependent ubiquitination 
of VASP and is crucial for axonal responses to netrin-1. This leads to our working model shown in 
Fig.7F, in which VASP is ubiquitinated by TRIM9, resulting in decreased stability of filopodia on 
axonal growth cones. This ubiquitination is antagonized by TRIM67, potentially via competition with 
TRIM9 for interaction with the EVH1 domain of VASP. We found that the ubiquitination and dynamics 
of VASP, the filopodial morphology, and netrin responses in a Trim67:Trim9 double knockout neuron 
resemble that of a Trim9-/- neuron. This suggests that TRIM9 acts downstream of TRIM67. We 
hypothesize that VASP ubiquitination and the resultant short lived filopodia allow for efficient filopodial 
exploration of the extracellular environment. Consequently, when a filopodia encounters netrin, 
TRIM67 is recruited to filopodia tips, where it antagonizes VASP ubiquitination and increases 
filopodial lifetime, prior to axon turning.  
 
3.1 TRIM67 regulates brain development 
These experiments support the hypothesis that TRIM67 is critical for aspects of brain 
development, especially in the midline-crossing axons of the corpus callosum. In agreement with our 
previous work showing that genetic deletion of Trim67 results in thinning of the corpus callosum in the 
adult brain, we found here that there is a reduction in the midline-directed outgrowth of callosal fibers 
during development of this fiber tract. This may be due to a diminished attraction of Trim67-/- axons to 
the midline, as netrin-1 is a large component of this signaling and axons are insensitive to netrin-1 
dependent attraction in the absence of Trim67. The reduced axon length observed in our cultured 
neurons could also contribute to the midline-crossing deficiency in knockout brains. Similar deficits in 
axon outgrowth and guidance in response to netrin-1 could contribute to other neuroanatomical 
defects seen in the brains of Trim67-/- mice. Additionally, our observation that TRIM67 is required for 
axon branching in response to netrin-1 suggests that there could be a reduction in innervation by 
netrin-1 sensitive neurons due to decreased axon arbor elaboration, and thereby a decrease in 
network complexity. These possibilities present an intriguing path of future study, as several of the 
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brain region hypotrophies seen in Trim67-/- mice are in areas with evidence of netrin-1 
secretion13,26,65,66,296. 
 
3.2 TRIM67 and TRIM9, but possibly neither alone, are evolutionarily conserved 
 Initial studies into the function of TRIM9 in mammalian neurons discovered a surprising 
phenotype; when Trim9 was knocked out, axons displayed exuberant branching141. This contrasted 
strikingly with studies knocking out the invertebrate orthologs madd2 and trim9, which resulted in 
insensitivity to netrin-1 but no increase in branching194,195. Our new findings suggest that Trim67 may 
be more functionally similar to the single arthropod and nematode class I TRIM protein, which aligns 
with phylogenetic analysis on the diversification of class I TRIM proteins287. However, our data also 
suggest that TRIM9 is required for VASP ubiquitination whereas TRIM67 acts upstream, a situation 
which would not be conserved with a single TRIM67-like protein; however it is yet unknown if VASP 
ubiquitination is conserved in invertebrate netrin-1 signaling. If VASP ubiquitination is indeed present 
in invertebrate neurons, one conclusion could be that the invertebrate ortholog in fact represents a 
single protein which incorporates functions of both TRIM9 and TRIM67, which were then specified to 
each protein after gene duplication and divergence. Alternatively, this may represent an exciting 
outcome of gene duplication: a protein capable of homodimerization which is duplicated could 
eventually produce a functional copy and an inhibitory copy, which would then be regulated 
differentially at the gene level as well as posttranslationally. Considering the frequency of whole-
genome duplication events293,294, especially in the chordate lineage295, this mechanism of generating 
inhibitory proteins could be relatively common. 
 
3.3 TRIM67 is a protein with diverse functions 
The results of our structure-function rescue assays with TRIM67 suggest that the protein may 
have more functions than those published on previously245 and what we have found for regulation of 
VASP. In particular, the rescue of growth cone area was dependent upon the COS and FN3 domains 
of TRIM67, which did not appear to be necessary for the regulation of filopodia. Indeed, the peculiar 
gain-of-function in neurons transfected with TRIM67ΔCOS, resulting in a suppression of branching by 
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netrin-1 rather than the typical increase suggests a more complex protein than meets the eye. Other 
members of the class 1 TRIM proteins have been shown to interact with microtubules by way of the 
COS domain, and regulation of microtubules could be associated with both the branching phenotype 
and lamellipodial reorganization. This suggests another intriguing avenue for future research, and 
could facilitate the identification of substrates of TRIM67. 
 
3.4 The puzzle of VASP ubiquitination 
Our findings here reinforce the idea that nondegradative ubiquitination of VASP alters or 
inhibits the functionality of the polymerase in growth cones, and that changes in the degree of 
ubiquitination of VASP are associated with netrin-1 dependent axon responses. This brings up the 
possibility of many avenues of inquiry, both as to how ubiquitination modifies VASP function or 
localization as well as what other signaling pathways could be regulated in this manner. The relatively 
small amount of VASP which is ubiquitinated even in the disinhibited Trim67-/- neurons suggests that 
only a small portion of the total pool of VASP is regulated in this way at any given time; however the 
effect of even such a relatively small amount of regulation can result in a complete inability of the 
neurons to respond to netrin-1. As VASP functions as a tetramer at actin barbed ends, this could be 
the result of one modified VASP monomer altering the function of the tetramer as a whole. Further 
studies will need to be performed to investigate how ubiquitination of VASP alters its function on the 
molecular level or changes the state of the tetramer. Such work could have intriguing implications for 
the regulation of other actin associated proteins which function as multimers, such as formins, which 
recent work has also suggested are regulated by nondegradative ubiquitination297. 
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Fig. 1: Trim67 is required for axonal development and guidance in vivo and in vitro. A) 
Confocal micrographs of GFP in the corpus callosum of brains fixed immediately at postnatal day 0 
(P0) from Trim67+/+:Tau-Lox-STOP-Lox-GFP:Nex-Cre and Trim67Fl/Fl:Tau-Lox-STOP-Lox-GFP:Nex-
Cre mice littermates. Arrows demarcate leading fibers of the corpus callosum in sections 80, 160 and 
240 µm posterior to the final connection of the callosum. B) Individual data points and box and 
whisker plots of the distance between leading fibers of the corpus callosum at P0. C) Confocal 
micrographs of the corpus callosum at four days of age (P4) 160 µm anterior to the final connection of 
the callosum. Quantification of the extent of callosal development expressed as D) distance from the 
fornix to the separation of the callosal leading fibers and E) callosal width at the midline eight sections 
posterior to the fornix at P4. F) Schematic of microfluidic axon guidance chambers. G) Example axon 
extending from a microgroove into the axon guidance chamber, and fluorescent dextran used to 
visualize the gradient. H) Diagram depicting axon turning angle measured between a line bisecting 
the axonal growth cone and a line overlapping and parallel to the axon as it exits microgroove. I) 
Rose plots of embryonic cortical neuron axon turning angles in a gradient of fluorescent dextran or 
dextran + netrin-1. Low concentration denotes the four microgrooves furthest from the gradient 
source while the four microgrooves closest to the source are denoted high concentration217. Positive 
turning angles represent axon turning toward the netrin-1 source; negative angles represent axon 





Fig. 2: TRIM67 localizes to filopodia tips, and this localization is enhanced by netrin-1. A) ICC 
of actin, β-III-tubulin and TRIM67 in axonal growth cones of primary neurons isolated from Trim67+/+ 
and Trim67-/- embryonic cortices. B) TRIM67 fluorescence in the first 0.5µm from the tip of the 
filopodium to the next 0.5µm. C) Diagram showing the Airy disk of a fluorescent protein at the tip of a 
filopodium (green) and fluorescence of a protein along the filopodium (orange). D) Tip proximity of 
TRIM67 in filopodia, quantified as the fluorescence ratio of the center to the edge of the first Airy unit 




Fig. 3: TRIM67 is required for axon and growth cone responses to netrin-1. A) Scanning electron 
micrographs of axonal growth cones from embryonic Trim67+/+ and Trim67-/- cortices treated with 
media or media containing netrin-1. B) Growth cones from primary neuronal cultures stained for actin, 
β-III-tubulin and TRIM67. C) Quantification of growth cone responses to netrin-1, including increase in 
growth cone area, filopodial density, filopodia number, and filopodia length. D) Micrographs of 
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neurons cultured for 3 days in vitro including a final 24 hours with addition of media or netrin-1, shown 
as the combined fluorescence of staining for both actin and β-III-tubulin. E) Quantification of axon 






Fig. 4: TRIM67 regulates filopodial growth and dynamics. A) Kymographs of filopodia from 
cultured primary embryonic cortical neurons expressing mcherry. B) Quantification of filopodial 
lifetime and C) both filopodial buckling and folding events during the course of 10-minute time-lapse 
image sets of axonal growth cones. D) Rate of filopodial tip movement and E) length of individual 
filopodial protrusion and retraction periods following media sham or netrin treatment. * - p < 0.05, ** - 





Fig. 5: TRIM67 inhibits the ubiquitination of the actin polymerase VASP. A) 
Coimmunoprecipitation assays from TRIM9+/+ or TRIM9-/- HEK293 cells transfected with GFP-VASP 
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and myc or myc-tagged TRIM67 constructs demonstrate an interaction between TRIM67 and VASP 
that is independent of TRIM9. B) Coimmunoprecipitation assays from HEK293 cells transfected with 
the shown TRIM67 and VASP constructs, showing requirement for the TRIM67 coiled-coil domain for 
the TRIM67:VASP interaction. C) Colocalization between GFP-VASP and tagRFPt-tagged constructs 
of TRIM67 in murine embryonic cortical neurons. D) Quantification of the colocalization (ϰ) between 
VASP and TRIM67 (R(obs)) in filopodia compared to Fay-randomized controls (R(rand)). E) Western blot 
of VASP immunoprecipitated from denatured cultured embryonic cortical lysate showing a band 
which co-migrates and co-labels with ubiquitin (VASP-Ub, red arrowhead), roughly 24kDa heavier 
than unmodified VASP, and a phosphorylated VASP (pVASP) band roughly 2 kDa heavier than 
unmodified (purple arrowhead). F) Quantification of VASP-Ub relative to total VASP levels, 
normalized to untreated wild-type of each experiment. Bars are averages of 5-7 experiments ± SEM. 
G) Similar ubiquitination-precipitation assays of GFP-VASP expressed in HEK293T cells lacking 
TRIM67 expressing indicated myc-TRIM67 constructs, along with FLAG-ubiquitin. A VASP band that 
comigrates with FLAG-Ub appears approximately 24kDa heavier than unmodified VASP (red 
arrowhead). H) Quantification of VASP-Ub, quantified from FLAG signal relative to total GFP-VASP, 
normalized to the myc control condition. I) Diagram of a fluorescence recovery curve following 
photobleaching of GFP-VASP at the tip of a filopodium with a representation of the halftime of 
recovery (t1/2), alongside an image montage of the FRAP of GFP-VASP in a transfected embryonic 
cortical neuron. J) Quantification of the FRAP t1/2 of GFP-VASP or GFP-VASPK-R in embryonic cortical 
neurons treated with netrin-1 or the deubiquitinase inhibitor PR-619. Statistical comparisons in red 
are with respect to the GFP-VASP FRAP t1/2 in untreated cells of the same genotype. * - p < 0.05, ** - 




Fig. 6: TRIM67 competitively inhibits the TRIM9 interaction with VASP. A) Colocalization of GFP-
TRIM9 and tagRFPt-tagged TRIM67 in embryonic cortical neurons. B) Quantification of colocalization 
(ϰ) between TRIM9 and TRIM67 (R(obs)) compared to Fay-randomized controls (R(rand)). C) 
Coimmunoprecipitations of myc-tagged TRIM9 or TRIM67 from HEK293 cells showing precipitated 
GFP-VASP. D) Quantification of co-precipitated GFP-VASP relative to myc-tagged TRIM protein 
normalized to the VASP/TRIM67 ratio of each experiment. E) Pulldowns from embryonic mouse 
cortical lysate using either GST or GST-EVH1 domain of VASP, probed for endogenous TRIM67 and 
TRIM9. F) Quantification of TRIM proteins precipitated by GST-EVH1 from lysates of indicated 




Fig. 7: TRIM67 functions upstream of TRIM9 in the regulation of VASP and filopodia. A) VASP 
ubiquitination immunoprecipitation from Trim9-/-:Trim67-/- embryonic cortical neurons. B) 
Quantification of VASP ubiquitination; bars are averages of 4-7 experiments ± SEM. C) FRAP 
halftime  (t1/2) of GFP-VASP at filopodia tips in Trim9-/-:Trim67-/- embryonic cortical neurons treated 
with netrin-1 or PR-619. D) Growth cones of cortical neurons cultured from Trim67+/+:Trim9+/+ or 
Trim67-/-:Trim9-/- embryos, treated with either netrin-1 or a media sham. E) Filopodia number per 
growth cone and numerical density in embryonic cortical neurons isolated from Trim9-/-:Trim67-/- 
brains. F) Model of TRIM67 in the regulation of VASP ubiquitination, and the role of VASP-Ub in the 
cell. * - p < 0.05, *** - p < 0.005, n.s. – p > 0.05. 
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CHAPTER 4 SUPPLEMENTAL FIGURES 
 
Fig. S1: TRIM67 growth cone response to morphogens. A) Structured illumination microscopy 
image of myc-TRIM67 in an axonal growth cone, localizing to the tip of a filopodium (inset, same area 
as dashed box). B) Examples of growth cone morphological categories as identified by scanning 
electron microscopy. C) Quantification of growth cone morphology distributions of Trim67+/+ and 
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Trim67-/- cortical neurons treated with media or netrin-1. Distributions are compared by chi-square 
test. * - p < 0.05. D) Examples of cortical embryonic axonal growth cones treated with media, Slit2N, 
or FGF2. E) Quantification of growth cone area and filopodia per growth cone following 40 minutes of 
treatment with the indicated guidance cues. F) Inverted images of neurons combining staining of both 
filamentous actin (phalloidin) and β-III-tubulin, treated for 24 hours with media, Slit2N, or FGF2. G) 






Fig. S2: All domains of TRIM67 are required to fully rescue growth cone response to netrin-1. 
A) Domain makeup of each TRIM67 construct used in rescue experiments. RING domains of TRIM 
proteins contain zinc binding pockets necessary for E3 ubiquitin ligation activity, and can also mediate 
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oligomerization of the TRIM proteins themselves298,299; we therefore made both a RING-deletion 
construct (TRIM67ΔRING) and one containing mutations at cysteines 7 and 10 to abolish zinc binding 
in the RING domain and thus any ligase activity (TRIM67-LD). Many studies have shown that the 
coiled-coil (CC) domains of TRIM proteins mediate homo- and heterodimerization with other 
members of the same TRIM class214,213. In our previous investigation of TRIM9, the CC domain also 
interacted with the filopodial tip-localized actin polymerase VASP91; therefore, we generated a 
construct of TRIM67 lacking the coiled-coil domain (TRIM67ΔCC). The C-terminal B30.2/SPRY 
domain of other TRIM proteins has been shown to mediate interactions with binding partners300,301, 
and in the case of TRIM9, interacts directly with the netrin-1 receptor DCC141, thus we made a 
construct of TRIM67 lacking this domain (TRIM67ΔSPRY). Binding to the microtubule cytoskeleton 
has been shown between the COS domain of the class 1 TRIM MID1 (TRIM18), and colocalization 
with tubulin has been shown with other class 1 members239,302,303. The binding motif in the COS 
domain of MID1 is conserved throughout class 1 TRIMs302, therefore we made a construct of TRIM67 
lacking the COS domain (TRIM67ΔCOS). It has been suggested that the adjacent fibronectin type III 
(FN3) domain facilitates the interaction with microtubules303–305, and as such we made a construct of 
TRIM67 in which the FN3 domain was absent (TRIM67ΔFN3). Finally, we generated a construct 
possessing only the three N-terminal tripartite motif domains (TRIM67-N). All constructs possessed 
an N-terminal myc tag. B) ICC of growth cones stained for actin, β-III-tubulin and myc showing 
expression and distribution of each rescue construct. C) Quantification of growth cone area, D) 
filopodial density, and E) filopodia length in cells expressing each rescue construct. All statistical 
comparisons in red are to myc-expressing, untreated growth cones. * - p < 0.05, ** - p < 0.01, *** - p < 




Fig. S3: All domains of TRIM67 are required to rescue axon branching in response to netrin-1. 
A) ICC of cells expressing each rescue construct, stained for myc, actin and β-III-tubulin. B) branches 
per 100µm axon length and percent of axons unbranched in cells expressing each rescue construct. 







Fig. S4: TRIM67 interacts with all members of the Ena/VASP family, and does not regulate 
VASP or TRIM9 protein levels. A-E) Generation of TRIM67-/- HEK293 cells lines. A) CRISPR gRNA 
were designed to target the first exon in all known isoforms of TRIM67. Red vertical lines indicate the 
regions targeted by the gRNAs. B) A set of three designed gRNAs (blue) targeting Exon 1 of TRIM67. 
Two complementary gRNAs per set were used with nickase-Cas9 to reduce off target effect potential. 
The NGG sequence is highlighted in red. C) PCR of genomic DNA of CRISPR clones indicates a 
deletion of ~ 100bp in CRISPR clone 3. D) Sequencing of HEK293 CRISPR clone 3 (top strand) 
shows a deletion of 94 base pairs in exon 1 of TRIM67. E) Immunoblot for TRIM67 and GAPDH in 
E15.5 murine brain lysate, Trim67-/- murine brain lysate, HEK293 lysates, and CRISPR-Cas9 clone 3 
TRIM67-/- HEK293 lysates. F) Coimmunoprecipitation assay from TRIM67-/- HEK293T cells 
transfected with GFP-Mena and myc or myc-TRIM67. G) Similar coimmunoprecipitation with GFP-
EVL. H) Immunoprecipitation of GFP-tagged Mena from denatured TRIM67-/- HEK293T cell lysate 
coexpressing FLAG-Ub and indicated myc or myc-TRIM67. I) Representative western blot of VASP in 
embryonic cortical lysate. J) VASP expression measured by Western blotting of embryonic cortical 
lysates, normalized to GAPDH. K) Representative western blot of TRIM9 in embryonic cortical lysate. 






Fig. S5: Percent recovery of fluorescence in FRAP assays. A) % recovery of fluorescence (mobile 
fraction) in FRAP assays reported in figure 8. B) % recovery of fluorescence in FRAP assays reported 
in figure 10. 
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CHAPTER 4 TABLES 
Table 4.1: Summary of data. Number of measurements, mean, standard error of the mean, and 
reported p-values from all figures.  
Figure 
Panel measurement condition # of n mean SEM
p value (to 
genotype 
control)
p value (to 
treatment 
control)
1B distance between 80µm Trim67 +/+ 8 191.04 27.92
callosal leading fibers 80µm Trim67 Fl/Fl 6 399.44 34.57 0.00551
(µm) 160µm Trim67 +/+ 8 452.3 32.29
160µm Trim67 Fl/Fl 6 640.8 33.03 0.00806
240µm Trim67 +/+ 8 663.35 18.58
240µm Trim67 Fl/Fl 6 775.7 55.03 0.0454
1D callosum development Trim67 +/+ 5 960 50.6
from fornix (µm) Trim67 Fl/Fl 6 786.67 29.31 0.0081
1E corpus callosum Trim67 +/+ 5 378.12 6.34
width (µm) Trim67 Fl/Fl 6 312 9.09 0.0403
1I axon turning angle (°) Trim67 +/+  dextran [low] 20 -4.915 7.793
Trim67 +/+  netrin-1 [low] 23 47.162 5.86 0.0000882
Trim67 -/-  netrin-1 [low] 15 -0.827 7.76 1
Trim67 +/+  dextran [high] 17 -3.976 8.65
Trim67 +/+  netrin-1 [high] 43 -46.495 7.321 0.00699
Trim67 -/-  netrin-1 [high] 17 -2.076 7.423 0.957
2B first 0.5 µm / second Trim67 +/+ 462 1.76 0.26
0.5 µm fluorescence Trim67 -/- 439 1.17 0.26 0.0014
2E tip localization ratio + media 444 2.43 0.39
+ netrin-1 535 2.89 0.57 0.0354
3C growth cone area Trim67 +/+  + media 127 85.29 11
(µm2) Trim67 +/+  + netrin-1 103 128.14 12.7 0.000534
Trim67 -/-  + media 98 127.06 13.73 0.00695
Trim67 -/-  + netrin-1 83 143.69 15.11 0.896
filopodia / 10µm Trim67 +/+  + media 127 3.18 0.09
perimeter Trim67 +/+  + netrin-1 103 3.84 0.1 7.08E-07
Trim67 -/-  + media 98 3.13 0.08 0.834
Trim67 -/-  + netrin-1 83 3.24 0.1 0.434
filopodia / growth Trim67 +/+  + media 127 12.24 0.8
cone Trim67 +/+  + netrin-1 103 19.47 1.09 1.64E-07
Trim67 -/-  + media 98 15.8 1.04 0.0207
Trim67 -/-  + netrin-1 83 19.07 1.25 0.218
filopodia length (µm) Trim67 +/+  + media 729 1.78 0.06
Trim67 +/+  + netrin-1 956 2.21 0.06 7.97E-12
Trim67 -/-  + media 786 2.58 0.07 4.27E-23
Trim67 -/-  + netrin-1 1076 2.68 0.07 0.808
3E branches / 100µm axon Trim67 +/+  + media 188 0.613 0.047
Trim67 +/+  + netrin-1 186 1.074 0.066 9.43E-07
Trim67 -/-  + media 178 0.607 0.058 0.423
Trim67 -/-  + netrin-1 156 0.51 0.051 0.724
3F axon length (µm) Trim67 +/+  + media 188 173.48 6.24
Trim67 +/+  + netrin-1 186 166.33 5.85 0.948
Trim67 -/-  + media 178 148.72 5.63 0.0133
Trim67 -/-  + netrin-1 156 150.62 6.7 0.858
4B filopodia lifetime (s) Trim67 +/+  + media 293 49.51 3.31
Trim67 +/+  + netrin-1 278 67.50 4.26 0.000311
Trim67 -/-  + media 257 73.04 4.89 4.118E-06




Panel measurement condition # of n mean SEM
p value (to 
genotype 
control)
p value (to 
treatment 
control)
4C buckling events per Trim67 +/+  + media 9 2.44 0.57
growth cone (/10 min) Trim67 +/+  + netrin-1 5 2.20 0.77 1
Trim67 -/-  + media 7 3.00 0.78 1
Trim67 -/-  + netrin-1 7 6.86 1.28 0.0462
folding events per Trim67 +/+  + media 9 10.89 2.42
growth cone (/10 min) Trim67 +/+  + netrin-1 7 10.86 2.03 1
Trim67 -/-  + media 7 10.29 1.67 0.874
Trim67 -/-  + netrin-1 7 20.57 1.78 0.00851
4D filopodia tip movement Trim67 +/+  + media 142 69.96 3.47
rate (nm/s) (protrusion) Trim67 +/+  + netrin-1 193 70.79 2.45 0.318
Trim67 -/-  + media 171 76.64 2.58 0.00854
Trim67 -/-  + netrin-1 136 71.42 2.99 0.0942
filopodia tip movement Trim67 +/+  + media 151 64.25 2.48
rate (nm/s) (retraction) Trim67 +/+  + netrin-1 226 64.49 2.12 0.882
Trim67 -/-  + media 174 75.69 2.70 0.00292
Trim67 -/-  + netrin-1 151 75.55 3.15 1
4E protrusion time (s) Trim67 +/+  + media 142 22.07 1.83
Trim67 +/+  + netrin-1 135 15.38 0.72 0.52
Trim67 -/-  + media 143 19.09 0.85 0.167
Trim67 -/-  + netrin-1 136 20.65 0.97 0.303
retraction time (s) Trim67 +/+  + media 151 25.57 1.69
Trim67 +/+  + netrin-1 157 19.11 1.12 0.0148
Trim67 -/-  + media 150 20.55 0.78 1
Trim67 -/-  + netrin-1 151 20.38 0.82 0.8842
5D Pearson's R (GFP-VASP TRIM67 R(obs) 281 0.26 0.014
ϰ tagRFPt-TRIM67) TRIM67 R(rand) 281 0.055 0.004 9.28E-30
TRIM67ΔCC R(obs) 270 0.179 0.011 0.000065
TRIM67ΔCC R(rand) 270 0.059 0.005 9.46E-19
5F VASP-Ub/VASP wild-type + media 9 1 0
wild-type + netrin-1 9 0.775 0.079 0.00805
Trim9 -/-  + media 5 0.65 0.106 0.0022
Trim9 -/-  + netrin-1 5 1.074 0.164 0.245
Trim67 -/-  + media 7 1.401 0.169 0.018
Trim67 -/-  + netrin-1 7 0.904 0.103 0.0573
5H VASP-Ub/VASP GFP-VASP + myc 5 1 0
GFP-VASP + myc-TRIM67 5 0.651 0.064 0.03
GFP-VASP + myc-TRIM67ΔCC 5 1.007 0.271 0.874
GFP-VASP + myc-TRIM67-LD 5 1.251 0.191 0.656
GFP-VASP(K-R) + myc 5 0.64 0.103 0.015
5J halftime of recovery (s) (GFP-VASP) Trim67 +/+  + media 27 9.47 1.19
(GFP-VASP) Trim67 +/+  + netrin-1 16 3.86 0.47 0.00716
(GFP-VASP) Trim67 +/+  + PR-619 10 26.20 5.87 0.0244
(GFP-VASP) Trim67 -/-  + media 28 17.76 3.51 0.262
(GFP-VASP) Trim67 -/-  + netrin-1 26 14.24 2.82 0.594
(GFP-VASP) Trim67 -/-  + PR-619 20 19.59 4.56 0.925
(GFP-VASP(K-R)) Trim67 +/+  + media 14 4.57 0.72 0.0359
(GFP-VASP(K-R)) Trim67 +/+  + netrin-1 15 4.74 0.67 0.95
(GFP-VASP(K-R)) Trim67 -/-  + media 28 6.96 0.84 0.0256
(GFP-VASP(K-R)) Trim67 -/-  + netrin-1 19 7.29 1.73 0.682
6B Pearson's R (GFP-TRIM9 + media R(obs) 22 0.324 0.026
ϰ tagRFPt-TRIM67) + media R(rand) 22 0.131 0.028 0.0000119
+ netrin-1 R(obs) 11 0.267 0.019 0.0892
+ netrin-1 R(rand) 11 0.102 0.021 0.00127
6D VASP/TRIM protein TRIM67 4 1 0




Panel measurement condition # of n mean SEM
p value (to 
genotype 
control)
p value (to 
treatment 
control)
6F TRIM67/GST-EVH1 Trim9 +/+ 4 1 0
Trim9 -/- 4 1.024 0.092 0.878
TRIM9/GST-EVH1 Trim67 +/+ 4 1 0
Trim67 -/- 4 2.22 0.307 0.0211
7B VASP-Ub/VASP Trim67 +/+ :Trim9 +/+  + media 9 1 0
Trim67 +/+ :Trim9 +/+  + netrin-1 9 0.775 0.079 0.00805
Trim67 -/- :Trim9 -/-  + media 7 0.554 0.099 0.0021
Trim67 -/- :Trim9 -/-  + netrin-1 5 0.744 0.213 0.626
7C halftime of recovery (s) Trim67 +/+ :Trim9 +/+  + media 8 7.65 0.82
Trim67 +/+ :Trim9 +/+  + netrin-1 8 2.86 0.69 0.00388
Trim67 -/- :Trim9 -/-  + media 10 1.83 0.33 0.0018
Trim67 -/- :Trim9 -/-  + netrin-1 14 5.74 0.81 0.00152
Trim67 -/- :Trim9 -/-  + PR-619 8 7.35 0.86 0.00158
7E filopodia / growth cone Trim67 +/+ :Trim9 +/+  + media 82 12.72 0.99
Trim67 +/+ :Trim9 +/+  + netrin-1 88 22.39 1.23 0.00306
Trim67 -/- :Trim9 -/-  + media 93 18.94 1.49 0.025
Trim67 -/- :Trim9 -/-  + netrin-1 92 16.7 1.38 0.895
filopodia / 10µm Trim67 +/+ :Trim9 +/+  + media 82 2.99 0.12
perimeter Trim67 +/+ :Trim9 +/+  + netrin-1 88 3.45 0.12 7.6E-09
Trim67 -/- :Trim9 -/-  + media 93 3.26 0.08 0.000226
Trim67 -/- :Trim9 -/-  + netrin-1 92 3.29 0.11 0.032
S1C % of growth cones Trim67 +/+  + media 37
per category Trim67 +/+  + netrin-1 38 0.04
Trim67 -/-  + media 33 0.0105
Trim67 -/-  + netrin-1 36 0.31
S1E growth cone area (µm2) Trim67 +/+  + media 76 97.62 11.8
Trim67 +/+  + Slit2N 56 64.43 10.43 0.00655
Trim67 +/+  + FGF2 56 174.43 15.96 0.0000265
Trim67 -/-  + media 76 116.76 12.84
Trim67 -/-  + Slit2N 57 80.29 14.16 0.0101
Trim67 -/-  + FGF2 57 176.24 23.14 0.034
filopodia per Trim67 +/+  + media 76 12.21 0.79
growth cone Trim67 +/+  + FGF2 56 22.63 1.61 3.04E-08
Trim67 -/-  + media 76 13.41 0.95
Trim67 -/-  + FGF2 57 19.37 1.73 0.0148
S1G branches / 100µm axon Trim67 +/+  + media 78 0.484 0.087
Trim67 +/+  + Slit2N 79 0.907 0.109 0.00389
Trim67 +/+  + FGF2 71 0.891 0.093 0.00206
Trim67 -/-  + media 73 0.58 0.084 0.31
Trim67 -/-  + Slit2N 76 1.038 0.109 0.00418
Trim67 -/-  + FGF2 76 1.168 0.128 0.00211
S2C growth cone area (µm2) myc + media 96 90.48 8.9
myc + netrin-1 88 79.03 8.87 0.602
myc-TRIM67 + media 121 41.11 4.12 9.89E-07
myc-TRIM67 + netrin-1 114 64.69 5.49 0.0000816
myc-TRIM67-LD + media 65 72.3 12.2 0.0974
myc-TRIM67-LD + netrin-1 52 44.21 4.84 0.841
myc-TRIM67ΔRING + media 68 45.94 8.89 0.000023
myc-TRIM67ΔRING + netrin-1 68 33.56 4.73 0.61
myc-TRIM67ΔSPRY + media 70 34.02 4.43 7.48E-07
myc-TRIM67ΔSPRY + netrin-1 65 45.71 11.87 0.927
myc-TRIM67ΔCC + media 45 29.16 4.39 0.000001
myc-TRIM67ΔCC + netrin-1 52 26.83 3.04 0.703
myc-TRIM67ΔCOS + media 57 88.05 12.19 0.909
myc-TRIM67ΔCOS + netrin-1 71 70.65 11.97 0.461
myc-TRIM67ΔFN3 + media 70 88.67 13.31 0.283
myc-TRIM67ΔFN3 + netrin-1 67 62.78 6.62 0.933
myc-TRIM67-Nterm + media 52 61.36 5.32 0.437
myc-TRIM67-Nterm + netrin-1 65 66.32 8.89 0.78
38%, 38%, 16%, 8%
10%, 61%, 21%, 8%
15%, 21%, 46%, 18%





Panel measurement condition # of n mean SEM
p value (to 
genotype 
control)
p value (to 
treatment 
control)
S2D filopodia / 10µm myc + media 96 2.4 0.09
perimeter myc + netrin-1 88 2.37 0.11 0.828
myc-TRIM67 + media 121 2.34 0.09
myc-TRIM67 + netrin-1 114 2.96 0.08 9.11E-06
myc-TRIM67-LD + media 65 2.33 0.14
myc-TRIM67-LD + netrin-1 52 2.17 0.13 0.763
myc-TRIM67ΔRING + media 68 2.59 0.13
myc-TRIM67ΔRING + netrin-1 68 3.02 0.11 0.051
myc-TRIM67ΔSPRY + media 70 3.02 0.17
myc-TRIM67ΔSPRY + netrin-1 65 3.12 0.14 0.635
myc-TRIM67ΔCC + media 45 3.13 0.23
myc-TRIM67ΔCC + netrin-1 52 2.96 0.18 0.72
myc-TRIM67ΔCOS + media 57 2.31 0.11
myc-TRIM67ΔCOS + netrin-1 71 2.35 0.1 0.775
myc-TRIM67ΔFN3 + media 70 2.48 0.11
myc-TRIM67ΔFN3 + netrin-1 67 2.74 0.13 0.263
myc-TRIM67-Nterm + media 52 1.98 0.11
myc-TRIM67-Nterm + netrin-1 65 2.66 0.11 0.000225
S2E filopodia length (µm) myc + media 128 2.67 0.1
myc + netrin-1 118 2.96 0.1 0.0168
myc-TRIM67 + media 121 2.3 0.11 0.00618
myc-TRIM67 + netrin-1 119 2.63 0.09 0.00438
myc-TRIM67-LD + media 64 2.14 0.14 0.146
myc-TRIM67-LD + netrin-1 50 2.49 0.18 0.146
myc-TRIM67ΔRING + media 68 3.22 0.17 0.00392
myc-TRIM67ΔRING + netrin-1 68 3.67 0.17 0.0906
myc-TRIM67ΔSPRY + media 69 3.02 0.19 0.2
myc-TRIM67ΔSPRY + netrin-1 65 3.16 0.2 0.732
myc-TRIM67ΔCC + media 45 3.31 0.21 0.204
myc-TRIM67ΔCC + netrin-1 50 2.92 0.17 0.204
myc-TRIM67ΔCOS + media 56 2.3 0.13 0.0246
myc-TRIM67ΔCOS + netrin-1 68 2.67 0.11 0.0264
myc-TRIM67ΔFN3 + media 70 2.18 0.1 0.0041
myc-TRIM67ΔFN3 + netrin-1 67 2.28 0.11 0.504
myc-TRIM67-Nterm + media 52 2.72 0.18 0.906
myc-TRIM67-Nterm + netrin-1 64 2.94 0.16 0.473
S3B branches / 100µm axon myc + media 169 0.488 0.053
myc + netrin-1 177 0.461 0.05 0.942
myc-TRIM67 + media 173 0.38 0.056
myc-TRIM67 + netrin-1 166 0.815 0.082 8.94E-06
myc-TRIM67-LD + media 80 0.497 0.081
myc-TRIM67-LD + netrin-1 77 0.476 0.081 0.998
myc-TRIM67ΔRING + media 108 0.538 0.063
myc-TRIM67ΔRING + netrin-1 111 0.648 0.09 1
myc-TRIM67ΔSPRY + media 120 0.518 0.068
myc-TRIM67ΔSPRY + netrin-1 119 0.631 0.82 1
myc-TRIM67ΔCC + media 113 0.417 0.065
myc-TRIM67ΔCC + netrin-1 116 0.303 0.079 0.081
myc-TRIM67ΔCOS + media 81 0.651 0.097
myc-TRIM67ΔCOS + netrin-1 79 0.281 0.051 0.0321
myc-TRIM67ΔFN3 + media 87 0.354 0.056
myc-TRIM67ΔFN3 + netrin-1 83 0.514 0.094 0.9927
myc-TRIM67-Nterm + media 76 0.505 0.085
myc-TRIM67-Nterm + netrin-1 51 0.456 0.102 0.895
S4J VASP/GAPDH wild-type 16 1 0.06
Trim67 -/- 14 1.2 0.13 0.253
S4L TRIM9/GAPDH wild-type 15 1 0.07




Panel measurement condition # of n mean SEM
p value (to 
genotype 
control)
p value (to 
treatment 
control)
S5A % fluorescence (GFP-VASP) Trim67 +/+  + media 27 25.87% 2.76%
recovery (GFP-VASP) Trim67 +/+  + netrin-1 16 24.29% 4.39% 1
(GFP-VASP) Trim67 +/+  + PR-619 10 33.83% 6.19% 1
(GFP-VASP) Trim67 -/-  + media 28 35.36% 4.31% 1
(GFP-VASP) Trim67 -/-  + netrin-1 26 35.93% 4.38% 0.952
(GFP-VASP) Trim67 -/-  + PR-619 20 36.97% 6.98% 0.879
(GFP-VASP(K-R)) Trim67 +/+  + media 14 30.77% 5.96% 0.917
(GFP-VASP(K-R)) Trim67 +/+  + netrin-1 15 35.48% 6.67% 1
(GFP-VASP(K-R)) Trim67 -/-  + media 28 30.86% 4.46% 0.982
(GFP-VASP(K-R)) Trim67 -/-  + netrin-1 19 33.65% 4.34% 1
S5B % fluorescence Trim67 +/+ :Trim9 +/+  + media 9 22.95% 5.16%
recovery Trim67 +/+ :Trim9 +/+  + netrin-1 8 40.80% 9.22% 0.652
Trim67 -/- :Trim9 -/-  + media 12 26.91% 6.28% 0.999
Trim67 -/- :Trim9 -/-  + netrin-1 15 31.15% 7.13% 0.864





All mouse lines were on a C57BL/6J background and bred at UNC with approval from the 
Institutional Animal Care and Use Committee. Timed pregnant females were obtained by placing 
male and female mice together overnight; the following day was designated as E0.5 if the female had 
a vaginal plug. We previously generated mice in which the first exon of Trim9, which encodes the 
RING and two BBox domains, was flanked by LoxP sites 141. Exon 1 was removed from the germline 
with cytomegalovirus (CMV)-Cre, and all TRIM9 protein was lost. Since Trim9 and Trim67 have 
similar gene architectures, we generated a conditional Trim67 allele using a similar strategy of 
flanking exon one and ~200 bp upstream of the ATG start site by LoxP sites via homologous 
recombination. Mice carrying the Trim67fl allele were crossed with CMV-Cre mice to delete Trim67 in 
the germline and generate Trim67-/- mice. After Cre-mediated excision of exon 1 of Trim67, the 
subsequent 16 ATGs encode out-of-frame transcripts. This excision was confirmed by PCR 
genotyping. Mice expressing Cre under the Nex promoter and mice carrying a TauloxP-STOP-loxP-GFP 
allele306 were generous gifts from Dr. Klaus-Armin Nave (Max-Planck Institute, Goettingen, Germany), 
and Dr. Eva Anton (University of North Carolina at Chapel Hill, USA) respectively. Trim9-/-, Trim9Fl/Fl, 
Thy1-GFP and Nex-Cre mice were described 141,248,307. Double TRIM knockout mice were generated 
by crossing Trim9-/- and Trim67-/- mice, and then crossing resultant heterozygotes.  
 
2 Yeast Two Hybrid 
LexA two-hybrid system selection with mouse Matchmaker cDNA library and beta-
galactosidase assays were performed according to the manufacturer's protocol (Clontech). DCC was 




3 Cortical Neuron Culture 
E15.5 dissociated cortical neuron cultures were prepared as described188. Briefly, cortices 
were micro-dissected and neurons were dissociated with trypsin and plated on Poly-D-lysine (Sigma)-
coated coverglass or tissue culture plastic in Neurobasal media supplemented with B27 (Invitrogen). 
To assay growth cones and filopodia, 600 ng/ml recombinant netrin-1 (+/- 4µM PR-619 or +/- 100nM 
CytoD), 24 ng/ml recombinant FGF-2 (MBL International) or 400 ng/mL Slit2N (PeproTech) was bath 
applied after 48 hrs in vitro for 40 min, or 250ng/mL netrin-1, 10 ng/mL FGF-2, or 100 ng/mL Slit2N 
was bath applied for 24 hours after 48 hours in vitro, followed by fixation with 4% paraformaldehyde in 
PHEM buffer and immunostaining. Widefield epifluorescence images of pyramidal-shaped neurons 
were analyzed. Growth cone perimeter and area were measured using ImageJ. Filopodium length 
was measured from the filopodium tip to lamellipodial veil. Number of filopodia was counted per 
growth cone, and density is reported per 10 µm of growth cone perimeter. To assay filopodia 
dynamics, dynamic colocalization and FRAP, time-lapse imaging was performed with a stage top 
incubator that maintained humidity, 37°C and 5% CO2 (Tokai Hit). Cortical explants were prepared 
and cultured and analyzed as described (Fothergill et al., 2014). Briefly ~500 μm cortical explants 
from TRIM9+/+ and TRIM9−/− embryos (E13- E15) were embedded in collagen matrices. Agarose 
cubes soaked in netrin-1 (10 μg/ml) were asymmetrically placed ~500 μm from the explant. After 48 
hrs explants were fixed, stained for βIII tubulin. 
 
4 Plasmids, Antibodies and Reagents 
Plasmids encoding human TRIM9 cDNA, TRIM9ΔRING (aa139-781), and TRIM9ΔCC 
(removed aa220-394) were described previously141. TRIM9L316A was made using QuikChange site-
directed mutagenesis of Leu316 to Ala. GFP-VASP individual, double or triple lysine mutants (K252R, 
K321R, K283,286R, K283,286,321R) were made using QuikChange site-directed mutagenesis. 
Simultaneous mutation of 9 lysine residues to arginine (K240,252,283,286,321,348,357,358,363R) in 
GFPVASP (VASP K-R) was synthesized by gBlocks® Gene Fragment (IDT). The following plasmids 
were acquired: mCherry (Clonetech), FLAG-Ub (Dr. Ben Philpot, UNC-Chapel Hill) pCAXeGFP-
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FPPPP-Mito, pCAX-eGFP-APPPP-Mito, pmscv-eGFP-Mena, pCaxeGFP-Mena+, pmscv-eGFP-EVL, 
pGEX-6P-1-CC, pGEX-6P-1-BBoxCCCos, pGEX-6P-1-BBoxCC, pGEX-6P-1-BBox, pGEX-6P-1-
ΔSPRY, pGEX-6P-1-EVH1, pGEX-6P-1-EVH2, pQE-EVH1, pGEX-6P-1-Pro (Dr. Frank Gertler, MIT), 
peGFP-N1-VASP (Dr. Richard Cheney, UNC). TRIM9 FN3 domain sequence and TRIM67 CC 
domain sequence (aa332-369 of murine TRIM67) were cloned into the pGEX-6P-1plasmid. 
Antibodies include: TRIM9 rabbit polyclonal (generated using murine TRIM9 recombinant protein 
aa158-271), rabbit polyclonal against TRIM67 generated using TRIM67 recombinant protein aa45-73, 
rabbit polyclonal antibodies against VASP and Mena (Dr. Frank Gertler, MIT), rabbit polyclonal 
against VASP (sc-13975, SCBT), mouse monoclonal c-Myc (9E10 SCBT),  rabbit polyclonal GST 
(G1417 Sigma), mouse monoclonal against human βIII Tubulin (TujI SCBT), rabbit polyclonal against 
GFP (A11122 Invitrogen), mouse monoclonal against GFP (75-131 UC Davis Neuromab), chicken 
polyclonal against GFP (GFP-1010, aves LABS, inc.), goat polyclonal against GFAP (sc-6170 SCBT) 
mouse monoclonal against HA (05-904 Millipore), Penta His antibody (34660, Qiagen), ubiquitin (sc-
8017, SCBT) and GAPDH (sc-166545, SCBT). Fluorescent secondary antibodies and fluorescent 
phalloidin labeled with AlexaFluor 488, AlexaFluor 568, or AlexaFluor647 were from Invitrogen.  
Recombinant netrin-1 was concentrated from HEK293 cells (Lebrand et al., 2004; Serafini et al., 
1994). PR-619 ((2,6-diaminopyridine-3,5-bis(thiocyanate), abcam), MG132 (81-5-15, American 
Peptide Company), Rhodamine B isothiocyanate–Dextran (Sigma-Aldrich, R9379). siGENOME 
mouse VASP siRNA SMARTpool and siGENOME non-targeting siRNA pool #2 were purchased from 
Dharmacon. 
 
5 Selection of Knockout HEK293 Cells Generated by CRISPR/Cas9 Technology 
The generation of HEK 293 TRIM9−/− cells was done by CRISPR/Cas9 gene editing using a 
guide RNA targeting the sequence 5-GCGGCTATGGCTCCTACGGGGGG-3’ (hg19 chr14: 
+51561408 - 51561431) in exon 1 of the TRIM9 gene in 293 cells. 5 x 105 HEK293 cells were 
transfected in 6-well plates with an expression plasmid (3 µg DNA/9 µl TranIT transfection reagent 
(Mirus Bio, Madison, WI) coding for a CMV promoter-driven CAS9-2A-RFP cassette and the U6-
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driven guide RNA. After 24 h RFP-positive cells were sorted by flow cytometry and limiting dilution 
cloning was performed by plating 0,5 RFP-positive cells in each well of 96-well plates. Growing 
clones were expanded. Genomic DNA was extracted using QuickExtract™ DNA extraction solution 
(Epicentre) and the target region of interest in was amplified by PCR (forward primer 5’-
CACAGAGCTAGCGCCTCTC-3’; reverse primer 5’-TACGCGATTCTTGGGGAAGC-3’). After a pre-
screening using the mismatch-sensitive T7 endonuclease I (T7EI) assay (Kim et al., 2009) positive 
clones in the T7 assay were sequenced. Knock-out cell clones were identified as cell clones 
harboring mono-allelic (clone 1) or all-allelic (clone 2) frameshift mutations. Similar procedures were 
used to generate the TRIM67-/- HEK293T cells, using guide RNAs with the sequences 5’-
CCGTCCACGACGAGTGGCAG-3’, 5’-GATCCCCGGGAAAGCAGGAG-3’, 5’-
GTCCACGACGAGTGGCAGGC-3’, 5’-ATCCCCGGGAAAGCAGGAGC-3’, 5’-
CGATCCCCGGGAAAGCAGGA-3’, and 5’-CCGTCCACGACGAGTGGCAG-3’. Genotypes of the 
respective knockout cell lines are available upon request.  
 
6 Transfection Procedures 
For transfection of plasmids and VASP or control Scramble siRNA (1 µM), neurons were 
resuspended after dissociation in Lonza Nucleofector solution (VPG1001) and electroporated with an 
Amaxa Nucleofector according to manufacturer protocol. Since expression of FP4Mito blocks 
filopodia formation and neuritogenesis (Gupton and Gertler, 2010), pCAX-eGFP-AP4Mito or pCAX-
eGFP-FP4Mito were transfected after neurons were cultured for 24 hours in vitro (once neurites had 
formed) using CalPhos™ Mammalian Transfection Kit (Clontech Laboratories, Inc.) according to 
manufacturer protocol with slight modifications. Briefly, 2µg of DNA was incubated with Solution A 
and B for 20 min. This mixture was added to neurons after the culture medium was replaced with 
neurobasal medium and allowed to incubate for 45 min. Following incubation, fresh neurobasal 
medium was added to the cells, allowed to incubate for another hour following which neurobasal 
media was replaced with fresh culture media. HEK cells were transfected using Lipofectamine 2000 
(Invitrogen) as per manufacturer protocol. 
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7 Immunoblotting, Co-immunoprecipitation, Binding Assays, Ubiquitination Assays 
For ubiquitination assay MG132 and netrin-1 or netrin-1 and PR-619 treated cells were lysed 
in IP buffer (20 mM Tris-Cl, 250 mM NaCl, 3 mM EDTA, 3 mM EGTA, 0.5% NP-40, 1% SDS, 2 mM 
DTT, 5 mM NEM (N-ethylmaleimide), 3 mM iodoacetamide, protease and phosphatase inhibitors 
pH=7.3-7.4). For 5- 6 million cells 270 ul of ubiquitin IP buffer was added and incubated on ice for 
10min. Cells were removed from the dish and transferred into tubes. 30 µl of 1X PBS was added and 
gently vortexed. Samples were boiled immediately for 20 minutes, until clear, then centrifuged at 
14,000 rpm for 10 minutes. The boiled samples were diluted using IP Buffer without SDS to reduce 
the SDS concentration to 0.1%. For TRIM9 dimerization assay, HEK 293 cells transfected with Myc-
tagged TRIM9 or TRIM9 variants and GFP tagged TRIM9 were lysed with RIPA buffer (50 mM Tris-
HCl, ph 7.5, 150 mM NaCl, 1% NP40, 0.5% Sodium deoxycholate, 0.1% SDS with phosphatase and 
protease inhibitors). 
 
For binding assays, all recombinant GST-tagged proteins were purified on sepharose-
immobilized glutathione beads (ThermoScientific). For binding to endogenous TRIM67 or Ena/VASP, 
E15.5 mouse cortices were lysed in 0.5% NP40 lysis buffer (50 mM Tris pH7.5, 200 mM NaCl, 0.5% 
NP-40 with phosphatase and protease inhibitors). Lysates were pre-cleared with GST-glutathione-
sepharose beads for 1 hour at 4°C with agitation and incubated with 5-10 µg of GST fusion protein or 
GST immobilized onto glutathione-sepharose beads at 4°C overnight. For EVH1 direct binding assay, 
His-EVH1 was expressed in E. Coli strain BL21 (DE3) Codon Plus (Agilent), bound to Ni-NTA beads 
and then eluted (Elution buffer: 50 mM Na3PO4 pH 8.0, 500 mM NaCl, 10 mM β-mercaptoethanol, 
0.1% Tween-20, 10 mM Imidazole) and dialyzed. 100 nM concentrations of His-EVH1 and 100 nM of 
GST fusion TRIM67 and TRIM9 domains or GST immobilized onto glutathione-sepharose beads 
were incubated in PBS buffer (140 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8mM KH2PO4, pH 7.4 
plus protease inhibitors) as described in 212 at 4°C overnight. For binding of Myc-tagged TRIM67 
variants, HEK293 cells were transfected and 24 hours later lysed in 1% NP40 lysis buffer and 
incubated overnight at 4°C with 100 nM GST or GST-EVH1. For all binding assays, precipitated 
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beads were washed three times with lysis buffer or PBS buffer and bound proteins were resolved by 
SDS-PAGE and analyzed by immunoblotting.  
For co-immunoprecipitation assays, IgG-conjugated A/G beads (SCBT) were utilized to 
preclear lysates for 1.5 hours at 4°C with agitation. Myc antibody-conjugated A/G beads (SCBT) or 
Protein A/G beads (SCBT) coupled with a mouse anti-GFP Ab (Neuromab) or rabbit anti-VASP Ab 
(SCBT) were agitated within pre-cleared lysates overnight at 4°C to precipitate target proteins. Beads 
were washed three times with lysis buffer and bound proteins were resolved by SDS-PAGE and 
analyzed by immunoblotting. 
 
8 Microscope Descriptions  
All live cell images and immunofluorescence images were collected on an Olympus IX81-
ZDC2 inverted microscope equipped with the following objective lenses: a UPLFLN 40x/1.39NA DIC 
objective (Olympus), UAPON 100x/1.49NA DIC TIRF objective (Olympus), a 20x/0.85NA UPlanSApo 
DIC objective lens (Olympus), and a 4x/0.13NA Plan Apochromat objective (Nikon), an automated 
XYZ stage (Prior) and an Andor iXon EM-CCD. Images were procured using the Metamorph 
acquisition software. Neuroanatomical images were acquired on inverted laser scanning confocal 
microscopes (FluoView FV1200, Olympus; Zeiss LSM 780, Zeiss) equipped with a 10X/0.4NA Plan 
Apochromat objective lens, a 20X/0.75NA Plan-Apochromat objective lens, and 488-nm and 561-nm 
argon lasers. SIM images were obtained using a DeltaVision OMX SR imaging system (GE 
Healthcare) with a 60x 1.42 NA oil immersion objective in 2D-SIM super-resolution mode. SEM 
images were acquired using a Zeiss Supra 25 FESEM using a backscatter detector.  
 
9 Elevated Plus Maze 
Mice were given one five-minute trial on the plus maze, which had two walled arms (closed 
arms, 20 cm in height) and two open arms. The maze was elevated 50 cm from the floor, and the 
arms were 30 cm long. Animals were placed on the center section (8 cm x 8 cm) and allowed to freely 
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explore the maze. Measures were taken of time in, and number of entries into, the open and closed 
arms. 
 
10 Marble-bury Test 
Mice were tested in a Plexiglas cage located in a sound-attenuating chamber with ceiling light 
and fan. The cage contained 5 cm of corncob bedding, with 20 black glass marbles (14 mm diameter) 
arranged in an equidistant 5X4 grid on top of the bedding. Subjects were given access to the marbles 
for 30 min. Measures were taken of the number of buried marbles (two thirds of the marble covered 
by the bedding). 
 
11 Olfactory Test 
Several days before the olfactory test, an unfamiliar food (Froot Loops, Kellogg’s) was placed 
overnight in the home cages of the mice. Observations of consumption were taken to ensure that the 
novel food was palatable. Sixteen to twenty hours before the test, all food was removed from the 
home cage. On the day of the test, each mouse was placed in a large, clean tub cage (46 cm L x 23.5 
cm W x 20 cm H), containing paper chip bedding (3 cm deep), and allowed to explore for five 
minutes. The animals was removed from the cage, and one Froot Loop was buried in the cage 
bedding. The animal was then returned to the cage and given fifteen minutes to locate the buried 
food. Measures were taken of latency to find the food reward. 
 
12 Hotplate Test 
Individual mice were placed in a tall plastic cylinder located on a hotplate, with a surface 
heated to 55°C (IITC Life Science, Inc.). Reactions to the heated surface, including hindpaw lick, 
vocalization, or jumping, led to immediate removal from the hotplate. Measures were taken of latency 
to respond, with a maximum test length of 30sec. 
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13 Open Field Assay 
Mice were given a one-hour trial in an open field chamber (41 cm x 41 cm x 30 cm) crossed 
by a grid of photobeams (VersaMax system, AccuScan Instruments). Counts were taken of the 
number of photobeams broken during the trial in five-minute intervals, with separate measures for 
locomotion (total distance traveled) and rearing movements. Time spent in the center region of the 
open field was measured as an index of anxiety-like behavior. 
 
14 Acoustic Startle and Prepulse Inhibition 
Subjects were given two acoustic startle tests (San Diego Instruments SR_Lab system), one 
at age 10-11 weeks, and another at age 17-19 weeks. Mice were placed in a small Plexiglas cylinder 
within a larger, sound-attenuating chamber. The cylinder was seated upon a piezoelectric transducer, 
which allowed vibrations to be quantified and displayed on a computer. The chamber included a 
ceiling light, fan, and a loudspeaker for the acoustic stimuli. Background sound levels (70 dB) and 
calibration of the acoustic stimuli were confirmed with a digital sound level meter (San Diego 
Instruments).  
Each session consisted of 42 trials that began with a five-minute habituation period. There 
were seven different types of trials: the no-stimulus trials, trials with the acoustic startle stimulus (40 
msec; 120 dB) alone, and trials in which a prepulse stimulus (20 msec; either 74, 78, 82, 87 or 90 dB) 
occurred 100 ms before the onset of the startle stimulus. Measures were taken of the startle 
amplitude for each trial across a 65 ms sampling window, and an overall analysis was performed for 
each subject’s data for levels of prepulse inhibition at each prepulse sound level (calculated as: 100 – 






15 Accelerating Rotarod 
In the first test session, mice were given three trials on an accelerating rotarod (Ugo Basile, 
Stoelting Co.) with 45 s between each trial. Two additional trials were given 48 hr later. Revolutions 
per min was set at an initial value of three, with a progressive increase to a maximum of 30 across 
five min (the maximum trial length). Measures were taken for latency to fall from the top of the rotating 
barrel. 
 
16 Gait Analysis 
A track of Whatman filter paper (Sigma-Aldrich) was placed in a 7.5 cm-wide, 40 cm-long 
Plexiglas corridor closed at one end and open to a 10x10 cm Plexiglas chamber at the other end. The 
chamber was covered with an opaque cloth and filled with several pellets of dry food. Mouse 
forepaws and hindpaws were painted with two colors of Crayola Washable Kids’ Paint (Crayola, LLC) 
before the mouse was placed at the closed end of the Plexiglas corridor. Once mice had walked the 
length of the corridor, they were given 45 s in the recovery chamber before being returned to their 
home cage.  
 
17 Rolling Wire-hang 
Mice were held near a circular rubber gasket, suspended from a pulley, such that the mouse 
grasped the loop 265. Mice were released once all four paws were engaged, and latency to fall was 
recorded in three trials separated by 45 s each. Latency to fall was measured in seconds, and then 
multiplied by weight to produce hang impulse. 
 
18 Three-Chamber Sociability Assay 
This procedure consisted of three 10 min phases: a habituation period, a test for sociability, 
and a test for social novelty preference. For the sociability assay, mice were given a choice between 
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being in the proximity of an unfamiliar, sex-matched C57BL/6J adult mouse (stranger one) versus 
being alone. In the social novelty phase, mice were given a choice between the already-investigated 
stranger one, versus a new unfamiliar mouse (stranger two). The social testing apparatus was a 
rectangular, three chambered box fabricated from clear Plexiglas. Dividing walls had doorways 
allowing access into each chamber. An automated image tracking system (Noldus Ethovision) 
provided measures of time spent within 5 cm of the Plexiglas cages (the cage proximity zone), and 
entries into each side of the social test box.  
At the start of the test, the mouse was placed in the middle chamber and allowed to explore 
for 10 min, with the doorways into the two side chambers open. After the habituation period, the test 
mouse was enclosed in the center compartment of the social test box, and stranger one was placed 
in one of the side chambers. The stranger mouse was enclosed in a small Plexiglas cage drilled with 
holes, which allowed nose contact. An identical empty Plexiglas cage was placed in the opposite side 
chamber. Following the placement of the stranger and the empty cage, the doors were re-opened, 
and the subject was allowed to explore the social test box for a 10 min session. At the end of the 
sociability phase, stranger two was placed in the empty Plexiglas container, and the test mouse was 
given an additional 10 min to explore the social test box. 
 
19 Morris Water Maze 
The water maze consisted of a large circular pool (diameter = 122 cm) partially filled with 
water (45 cm deep, 24-26°C), located in a room with numerous visual cues. The procedure involved 
three different phases: a visible platform test, acquisition in the hidden platform task, and reversal 
learning. In the visible platform test, each mouse was given four trials per day, across two days, to 
swim to an escape platform cued by a patterned cylinder extending above the surface of the water. 
For each trial, the mouse was placed in the pool at one of four possible locations (randomly ordered), 
and then given 60 s to find the visible platform. If the mouse found the platform, the trial ended, and 
the animal was allowed to remain 10 s on the platform before the next trial began. If the platform was 
not found, the mouse was placed on the platform for 10 s, and then given the next trial. Measures 
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were taken of latency to find the platform and swimming speed via an automated tracking system 
(Noldus Ethovision). 
For the hidden platform task, the platform (diameter = 12 cm) was submerged and the water 
made opaque using white Crayola Washable Kids’ Paint (Crayola, LLC). Each animal was given four 
trials per day, with one minute per trial, to swim to the hidden platform. Criterion for learning was an 
average group latency of 15 s or less to locate the platform. Mice were tested until the group reached 
criterion, with a maximum of nine days of testing. When criterion was reached, mice were given a one 
min probe trial in the pool with the platform removed. Selective quadrant search was evaluated by 
measuring percent time spent in the target quadrant and number of crossings over the location where 
the platform (the target) had been placed during training, versus the corresponding area in the 
opposite quadrant. During the subsequent reversal learning phase, the escape platform was placed in 
a different quadrant, and mice were tested until the group reached the learning criterion, using the 
same procedure as with initial acquisition. A second one min probe trial was conducted at the end of 
the reversal learning phase. 
 
20 Colocalization and Growth Cone Analysis 
Pearson’s correlation of colocalization between TRIM67 and Ena/VASP proteins was 
performed using regions of interest (ROI) drawn in filopodia and a Colocalization Test plugin for 
ImageJ with Fay randomization using images acquired with the 100x objective described above. 
Growth cone area, filopodia number, filopodia density and filopodia length were measured in ImageJ. 
Filopodia lengths were measured from the edge of lamellipodial veils to filopodia tips. For filopodia 
rescue assays, images of neurons expressing comparable levels of Myc(TRIM67 variants) were 
acquired with the 100x objective, and the number of growth cone filopodia recorded. TIRF imaging of 
TRIM67 and Ena/VASP proteins was performed after 48 hours in vitro, with the 100x objective and a 
solid state 491, 561 nm laser illumination at 100 nm penetration depth. Images were acquired every 




21 Filopodia Dynamics Measurements  
For filopodial dynamics measurements, wide-field epifluorescence images of mCherry were 
acquired every 2.5 seconds for 5-10 minutes. 600 ng/mL netrin-1 was added 40 minutes prior to 
imaging netrin-1 treated neurons. Filopodial protrusion and retraction rates and phase durations were 
measured from kymographs as the slope and duration of individual events, respectively. Filopodia 
lifetime was measured as the time from initial filopodial protrusion until retraction into the lamellipodial 
veil. Filopodial buckling and folding events were both counted manually; buckling events occurred 
when a filopodium collapsed following a breakage along the length of the filopodium. Folding events 
occurred when a filopodium collapsed into the veil sideways along its length as opposed to retracting 
perpendicularly. 
 
22 FRAP Fluorescence Recovery Calculation  
For FRAP assays neurons expressing GFP-VASP were imaged after 48 hours using 491 nm 
laser in TIRF mode every 0.5 seconds for 15 seconds, followed by a 1-second exposure with a solid 
state 405 nm laser in FRAP mode (bleach spot ~1.25 µm in diameter), followed by imaging every 0.5 
seconds with the 491 laser in TIRF mode for 60 seconds. Netrin-1 treated filopodia were imaged 
within 5 minutes of addition of 400 ng/mL netrin-1. DUB-inhibited filopodia were imaged within 30 
minutes of addition of 9 µM PR-619. For analyzing FRAP imaging data, photobleaching was 
corrected by calculating an exponential decay from the last 30 seconds of imaging in a control region 
distant from the bleach spot (F = F0*e-kt, where F is fluorescence, F0 is initial fluorescence, k is the 
decay time constant, and t is time). Fluorescence recovery t1/2 and % were calculated from an inverse 
exponential decay (F = A*(1-e-τt), where F is fluorescence, A is recovery plateau fluorescence, τ is the 
recovery time constant, and t is time). The % recovery was calculated as the plateau fluorescence 
divided by the average pre-bleach fluorescence, and t1/2 is the inverse of the recovery time constant τ. 
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Both photobleaching and FRAP curves were fit to data using the Solver add-in of Microsoft Excel 
2013. 
 
23 Neuroanatomical Imaging 
All mice used for neuroanatomical studies were anesthetized with an intraperitoneal injection 
of 1.2% avertin and intracardially perfused with 4% paraformaldehyde (PFA). Brains were removed 
and fixed in 4% PFA for a subsequent 48 hrs , rinsed with 1x PBS and rested in 70% EtOH for 24 
hours prior to vibratome  or cryostat sectioning. Embryonic brains were removed at E15.5 and drop-
fixed in 4% PFA for 72 h, rinsed with 1X PBS, and embedded in 1% agarose prior to cryoprotection 
with 30% sucrose and cryostat sectioning at 20 µm thickness. Early postnatal heads were removed 
and fixed with 4% paraformaldehyde for 72 h with mild agitation followed by two 24h rinses with 1X 
PBS. Brains were removed and embedded in 1% agarose prior to vibratome sectioning. For 
projection analysis in Nex-Cre/TauloxP-stop-loxPGFP mice, 80 μm coronal sections were cut and every 
section was permeabilized in detergent solution (1x PBS + 0.1% Tx-100 + 0.2% Tween-20) for 1 hour 
on a shaker at RT. Sections were blocked in 10% BSA in 1x PBS for 5 hours, then placed in primary 
antibody solution (anti-GFP chicken (Aves ab1020 1:2000, in 1% BSA in PBS) for 24 hours on a 
shaker at 4°C. Primary antibodies were removed and sections were rinsed in 1x PBS for 1 hour prior 
to the addition of secondary antibody solution (AlexaFluor 488 chicken + 1% BSA in 1x PBS) for 24 
hours on a covered shaker at 4°C. After post-secondary rinsing with 1x PBS, sections were mounted 
in TRIS/glycerol/n-propyl-gallate and were imaged with the 10x objective on the LSCM described 
above. 
 
24 Histological Measurements 
Five-week-old brains from an equal number of male and female mice from both genotypes 
were sectioned and stained with Black Gold II (Histo-Chem, Inc.) per manufacturer protocol, mounted 
in DPX mounting media (VWR International), and imaged on a Leica WILD M420 macroscope using 
151 
 
an APOZOOM lens. Sections were aligned to Bregma using a reference atlas, and individual regions 
were outlined as described below and measured using ImageJ. White matter in the striatum was 
defined using the Trainable Weka Segmentation v3.2.2 plugin for ImageJ 308 trained on two classes 
(white and gray matter) with at least eight examples per class. Brain regions and fiber tracts were 
measured in each section, then individually aligned by minimizing the total standard deviation, as the 
shapes of regions along the anterior-posterior axis were not apparently different between individual 
animals. 
All structures present in each hemisphere (hippocampus, amygdala, CPu, etc.) were reported 
as the average size of the structure in one hemisphere. Fiber tracts were demarcated by myelin 
staining. The thicknesses of the corpus callosum, hippocampal commissure and anterior commissure 
were measured at the midline perpendicular to the direction of the tract. The cortical thickness was 
determined by measuring the area of a cortical region (Fig.6B, yellow region) divided by the average 
of the lengths of the cingulum and external surfaces (Fig.6B, dashed lines) to produce an average 
thickness along the length of the cortex. Hippocampal area was defined as the area bounded by the 
fimbria, thalamus, habenula, third ventricle, and corpus callosum, which included both the dentate 
gyrus and Ammon’s horn. To measure the area of the lateral and basolateral amygdala, which are 
bounded by the external and amygdalar capsules, boundaries along these capsules were drawn on 
black gold II myelin stained sections and were connected with a straight perpendicular line at the 
medial inferior ends. The striatum was bounded by the lateral ventricles, and black gold stained 
corpus callosum, external capsule, and anterior commissure in anterior sections, and the lateral 
ventricles, corpus callosum, external capsule, globus pallidus, and internal capsule in posterior 
sections. The thalamus was delineated by the habenulae, hippocampus, fimbriae, internal capsules, 
and a straight line drawn between the inferior tip of the internal capsules. Anatomical regions were 






25 Protein Sequence Comparison 
Protein sequences for class 1 TRIM proteins were retrieved from the UniprotKB/Swiss-Prot 
(accession numbers: Q9C026-1, Q8C7M3-3, Q6NZX0, F7E188, A0A1D5Q2P9, Q91ZY8, 
A0A1D5PZ60, M9MRI4, B1GRL4, Q6ZTA4-3, Q505D9-1, A0A286YAS5, F6U581, F6S2G3, D3ZTX1, 
A0A1L8F061, A0A1L8G7R8, O15344, Q9NQ86, Q9UJV3, Q7Z4K8, O70583, Q7TNM2, Q80WG7, 
Q9QUS6, E7FAU0, E7F5U6, F1QUB4, F6P3Q3, E7F8R6, F7A2I4, Q6DEU6, F1NE64, Q90WD1, 
A0A0G2JXN2, A0A0G2JW11, A0A0G2JWJ3, P82458, D8WX03, Q6NU77, T2M630, A0A0V1B9S1, 
A0A087ZYT3, A0A195FV05, A0A0P5WD37, I3LLR6, A0A287BHA8, F1RLE9, F1RGR8, K7GSV3, 
F1SG17, U3JIW9, U3JJW0, U3JGS8, U3JPI3, U3KBH9, E2RAN1, E2QZT5, F6V5Z8, E2RKC8, 
F6V1Y9, E2R7N3, A0A1S3SS87, A0A1S3S8H3, A0A1S3PJZ7, A0A1S3M2Y3, A0A1S3NWR8, 
A0A1S3RQU3, A7S501, A7S7Q5), NCBI GenPept (accession numbers: XP_015139864.1, 
EKC37550.1, XP_017952420.1, XP_015133862, XP_005099658.1, XP_005110236.1, 
XP_012560769.1, XP_014452196.1, XP_014463268.1, XP_014465414.1, XP_006266936.2, 
XP_006030994.1, XP_019349655.1, XP_005043498.1, XP_014770719.1, XP_014769144.1, 
KXJ14478.1, XP_020900170.1, XP_020618149, XP_020618148.1, XP_009012087.1, 
XP_009163316.1, XP_009162620.1, XP_002117207.1, XP_002741117.1, XP_006818271.1, 
XP_006823565.1, XP_022109997.1, XP_022104238.1), and EnsemblMetazoa (accession number 
CapteT155810) databases. Sequences were compared using the ClustalX2 multiple sequence 
alignment, with default parameters and three full alignment iterations 310. Phylogenetic trees were 
generated using the nearest neighbor joining algorithm of ClustalX2 with 1000 bootstrapping 
iterations, and organized with FigTree v1.4.3. 
 
26 Explant Analysis 
Outgrowth was defined as total neurite pixels divided by the total number of pixels 
representing the neurite body. To measure biased outgrowth, explants were bisected in imageJ 
through the center of the explant orthogonal to the direction of the gradient. The number of pixels 
representing neurites on upgradient (U) and downgradient (D) were quantified in ImageJ. The 
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guidance ratio was defined as (U−D)/(U+D), with a positive guidance ratio indicating attraction or 
biased outgrowth toward the netrin source. This analysis controls for growth-related effects (Mortimer 
et al., 2009; Rosoff et al., 2004). 
 
27 Axon Turning Assay 
Micropass gradient devices were used to measure axon turning. Device preparation and 
experimental protocol is as described 22.Briefly, Trim67+/+ and Trim67-/- E15.5 cortical neurons were 
plated in devices; after axons entered the axon viewing area (2-4 days), a control gradient of dextran 
(starting at 1 µM) or gradient of netrin+dextran (600 ng/ml was established. DIC (axons) and 
epifluorescence (dextran) images were acquired every 5 min for 8-18 hrs at 20x magnification. The 
angle of axon turning relative to the initial trajectory of the axon before the gradient is reported, with 
positive angles indicating turning up gradient. Angles for turning were measured for axons in 
attractive netrin concentrations as described (Taylor et al., 2015). 
 
28 Statistics  
At least 3 independent experiments were performed for each assay. Data distribution 
normality was determined using the Shapiro-Wilk test. Normally distributed data were compared by 
unpaired t-test for two independent samples, or ANOVA with Tukey post-hoc correction, for >2 
comparisons. For non-normal data, the Mann-Whitney test was used or Kruskal-Wallis nonparametric 
ANOVA with Benjamini-Hochberg correction for >2 comparisons. All data are presented as means +/- 
standard error of the mean (SEM) or as box plots accompanied by each data point. Statistical 
significance is represented as such: *p<.05, **p<.01, ***p<.005). 
Behavioral data were analyzed using one-way or repeated measures Analysis of Variance 
(ANOVA), with factor genotype. Separate ANOVAs for each sex were conducted for measures of 
body weight. Fisher’s protected least-significant difference (PLSD) tests were used for comparing 
group means only when a significant F value was determined. Within-group comparisons were 
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conducted to determine side preference in the three-chamber test for social approach, and for 
quadrant preference in the Morris water maze. 
For all brain regions measured in multiple sections, comparisons were performed by two-way 
ANOVA. Sections and genotypes were treated as groups with each brain a subject, with genotype as 
the tested factor. For the paired brain weight and Nex-Cre:Trim67fl/fl strain corpus callosum 
comparisons, Wilcoxon signed-rank tests were used. For unpaired single measurements, Mann-
Whitney pairwise comparisons were made. A chi-square test was used to compare the heterozygote 
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